Franciscus Claas
Emeritus hoogleraar Immunogenetica van transplantatie
- Naam
- Prof.dr. F.H.J. Claas
- Telefoon
- +31 71 526 3801
- f.h.j.claas.2@umail.leidenuniv.nl
- ORCID iD
- 0000-0003-4157-6201
Patientgericht onderzoek op het grensgebied tussen basale research en kliniek heeft mij altijd al gefascineerd. Een nieuwe bevinding of benadering, die uiteindelijk klinisch toegepast kan worden en succesvol blijkt, geeft ontzettend veel voldoening. Een bron van inspiratie is ook de internationale samenwerking, die essentieel is voor een optimaal succes bij orgaan- en stamceltransplantatie. In Leiden kunnen wij daarbij een sleutelrol spelen via de door mijn leermeester en voorganger, Jon van Rood, geinitieerde stichtingen Eurotransplant en Europdonor. De ultieme uitdaging is het afweersysteem van de patient op subtiele wijze te kunnen manipuleren, zodat deze het transplantaat volledig als lichaamseigen zal beschouwen. Hierbij kunnen de immuunmechanismen, die ervoor zorgen dat een moeder haar kind niet afstoot tijdens een succesvolle zwangerschap, zeker tot nieuwe inzichten leiden.
Patientgericht onderzoek op het grensgebied tussen basale research en kliniek heeft mij altijd al gefascineerd. Een nieuwe bevinding of benadering, die uiteindelijk klinisch toegepast kan worden en succesvol blijkt, geeft ontzettend veel voldoening. Een bron van inspiratie is ook de internationale samenwerking, die essentieel is voor een optimaal succes bij orgaan- en stamceltransplantatie. In Leiden kunnen wij daarbij een sleutelrol spelen via de door mijn leermeester en voorganger, Jon van Rood, geinitieerde stichtingen Eurotransplant en Europdonor. De ultieme uitdaging is het afweersysteem van de patient op subtiele wijze te kunnen manipuleren, zodat deze het transplantaat volledig als lichaamseigen zal beschouwen. Hierbij kunnen de immuunmechanismen, die ervoor zorgen dat een moeder haar kind niet afstoot tijdens een succesvolle zwangerschap, zeker tot nieuwe inzichten leiden.
Op 13 december 1996 sprak hij zijn oratie uit, getiteld: 'Het subtiele verschil tussen mijn en dijn'.
Emeritus hoogleraar Immunogenetica van transplantatie
- Faculteit Geneeskunde
- Divisie 4
- Immunologie
- IHB algemeen
- van't Hof, L.J.; Schotvanger, N.; Haasnoot, G.W.; Keur, C. van der; Roelen, D.L.; Lashley, L.E.E.L.O.; Claas, F.H.J.; Eikmans, M. & Hoorn, M.L.P. van der (2021), Maternal-fetal HLA compatibility in uncomplicated and preeclamptic naturally conceived pregnancies, Frontiers in Immunology 12.
- van Besouw NM, Yan L, de Kuiper R, Klepper M, Reijerkerk D, Dieterich M, Roelen DL, Claas FH, Clahsen-van Groningen MC, Hesselink DA & Baan CC (2019), The Number of Donor-Specific IL-21 Producing Cells before and after Transplantation Predicts Kidney Graft Rejection., American Journal of Transplantation 19: 757-757.
- Rijkers, M.; Schmidt, D.; Lu, N.; Kramer, C.S.M.; Heidt, S.; Mulder, A.; Porcelijn, L.; Claas, F.H.J.; Leebeek, F.W.G.; Jansen, A.J.G.; Jongerius, I.; Zeerleder, S.S.; Vidarsson, G.; Voorberg, J. & Haas, M. de (2019), Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets, Haematologica 104(2): 403-415.
- Wunderink, H.F.; Haasnoot, G.W.; Brouwer, C.S. de; Zwet, E.W. van; Kroes, A.C.M.; Fijter, J.W. de; Rotmans, J.I.; Claas, F.H.J. & Feltkamp, M.C.W. (2019), Reduced Risk of BK Polyomavirus Infection in HLA-B51-positive Kidney Transplant Recipients, Transplantation 103(3): 604-612.
- Kramer, C.S.M.; Franke-van Dijk, M.E.I.; Priddey, A.J.; Pongracz, T.; Gnudi, E.; Car, H.; Karahan, G.E.; Beelen, E. van; Zilvold-van den Oever, C.C.C.; Rademaker, H.J.; Haan, N. de; Wuhrer, M.; Kosmoliaptsis, V.; Parren, P.W.H.I.; Mulder, A.; Roelen, D.L.; Claas, F.H.J. & Heidt, S. (2019), Recombinant human monoclonal HLA antibodies of different IgG subclasses recognising the same epitope: Excellent tools to study differential effects of donor-specific antibodies, HLA: Immune Response Genetics.
- Harper, I.G.; Gjorgjimajkoska, O.; Siu, J.H.Y.; Parmar, J.; Mulder, A.; Claas, F.H.J.; Hosgood, S.A.; Nicholson, M.L.; Motallebzadeh, R. & Pettigrew, G.J. (2019), Prolongation of allograft survival by passenger donor regulatory T cells, American Journal of Transplantation 19(5): 1371-1379.
- Schonewille, H.; Rood, J.J. van; Verduin, E.P.; Watering, L.M.G. van de; Haasnoot, G.W.; Claas, F.H.J.; Oepkes, D.; Lopriore, E. & Brand, A. (2019), Exposure to non-inherited maternal antigens by breastfeeding affects antibody responsiveness, Haematologica 104(2): 263-268.
- Tran JN, Sherwood K, Fenninger F, Gunther OP, Dobrer S, Allan L, Duquesnoy RJ, Sapir-Pichhadze R, Claas FH & Keown PA (2019), POPULATION ANALYSIS OF HUMAN LEUKOCYTE ANTIGEN ALLELE AND EPLET FREQUENCIES IN KIDNEY PATIENTS AND DONORS TO ASSESS THE FEASIBILITY OF EPITOPE MATCHING IN CANADA, Human Immunology 80: 167-168.
- Kramer, C.S.M.; Israeli, M.; Mulder, A.; Doxiadis, I.I.N.; Haasnoot, G.W.; Heidt, S. & Claas, F.H.J. (2019), The long and winding road towards epitope matching in clinical transplantation, Transplant International 32(1): 16-24.
- Daniels L, Claas F, Senev A, Vanden Driessche L, Emonds MP, Van Laecke S, Hellemans R, Abramowicz D & Naesens M (2019), THE CLINICAL SIGNIFICANCE OF HLA-DP MISMATCHES IN KIDNEY TRANSPLANTATIONS, Transplant International 32: 155-156.
- Almeida, C.A.; Miert, P. van; O'Driscoll, K.; Zoet, Y.M.; Chopra, A.; Witt, C.; John, M.; Claas, F.H.J. & D'Orsogna, L.J. (2019), Virus-specific T-cell clonotypes might contribute to drug hypersensitivity reactions through heterologous immunity.
- Chen, M.; Zoet, Y.; Roelen, D.; Martorell, J.; Middleton, D.; Slavcev, A.; Iniotaki, A.; Claas, F. & Fuggle, S. (2019), Towards uniformity in the definition of acceptable mismatches for highly sensitized patients, Hla 94(2): 147-153.
- Besouw, N.M. van; Yan, L.; Kuiper, R. de; Klepper, M.; Reijerkerk, D.; Dieterich, M.; Roelen, D.L.; Claas, F.H.J.; Groningen, M.C.C.V.; Hesselink, D.A. & Baan, C.C. (2019), The Number of Donor-Specific IL-21 Producing Cells Before and After Transplantation Predicts Kidney Graft Rejection, Frontiers in Immunology 10.
- Reindl-Schwaighofer, R.; Heinzel, A.; Gualdoni, G.A.; Mesnard, L.; Claas, F.H.J. & Oberbauer, R. (2019), Novel insights into non-HLA alloimmunity in kidney transplantation, Transplant International.
- Visentin, J.; Leu, D. le; Mulder, A.; Jambon, F.; Badier, L.; Lee, J.H.; Guidicelli, G.; Bouthemy, C.; Ralazamahaleo, M.; Claas, F.; Primo, C. di & Taupin, J.L. (2019), Measuring anti-HLA antibody active concentration and affinity by surface plasmon resonance: Comparison with the luminex single antigen flow beads and T-cell flow cytometry crossmatch results, Molecular Immunology 108: 34-44.
- Heuvel, H. van den; Meer-Prins, E.M.W. van der; Miert, P.P.M.C. van; Zhang, X.Q.; Anholts, J.D.H. & Claas, F.H.J. (2019), Infection with a virus generates a polyclonal immune response with broad alloreactive potential, Human Immunology 80(2): 97-102.
- Osorio-Jaramillo E, Haasnoot GW, Kaider A, Zuckermann A, Schaefer A, Haberl T, Goekler J, Angleitner P, Moayedifar R, Fischer GF, Laufer G, Claas FH & Aliabadi-Zuckermann AZ (2019), HLA Epitope Mismatching is Associated with Rejection and Worsened Graft Survival in Heart Transplant Recipients, Journal of Heart and Lung Transplantation 38(4): S87-S87.
- Eikmans, M.; Gielis, E.M.; Ledeganck, K.J.; Yang, J.X.; Abramowicz, D. & Claas, F.F.J. (2019), Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies, Frontiers in Medicine 5.
- Wunderink, H.F.; Haasnoot, G.W.; Brouwer, C.S. de; Zwet, E.W. van; Kroes, A.C.M.; Fijter, J.W. de; Rotmans, J.I.; Claas, F.H.J. & Feltkamp, M.C.W. (2019), HLA-B51 Reduces Risk of BK Polyomavirus Viremia After Kidney Transplantation.
- Bruijstens AL, Wong YYM, van Pelt ED, van der Linden PJE, Haasnoot GW, Neuteboom RF, Claas FHJ & Hintzen RQ (2019), HLA association in MOG-IgG and AQP4-IgG related inflammatory diseases of the CNS in the Dutch Caucasian population, Multiple Sclerosis 25: 141-141.
- Melk, A.; Babitsch, B.; Borchert-Morlins, B.; Claas, F.; Dipchand, A.I.; Eifert, S.; Eiz-Vesper, B.; Epping, J.; Falk, C.S.; Foster, B.; Geyer, S.; Gjertson, D.; Greer, M.; Haubitz, M.; Lau, A.; Maecker-Kolhoff, B.; Memaran, N.; Messner, H.A.; Ostendorf, K.; Samuel, U.; Schmidt, B.M.W.; Tullius, S.G.; West, L.; Wong, G.; Zimmermann, T. & Berenguer, M. (2019), Equally Interchangeable? How Sex and Gender Affect Transplantation, Transplantation 103(6): 1094-1110.
- D'Orsogna, L.J.; Almeida, C.A.M.; Miert, P. van; Zoet, Y.M.; Anholts, J.D.H.; Chopra, A.; Watson, M.; Witt, C.; John, M. & Claas, F.H.J. (2019), Drug-induced alloreactivity: A new paradigm for allorecognition, American Journal of Transplantation 19(9): 2606-2613.
- Reindl-Schwaighofer, R.; Heinzel, A.; Kainz, A.; Setten, J. van; Jelencsics, K.; Hu, K.; Loza, B.L.; Kammer, M.; Heinze, G.; Hruba, P.; Konarikova, A.; Viklicky, O.; Boehmig, G.A.; Eskandary, F.; Fischer, G.; Claas, F.; Tan, J.C.; Albert, T.J.; Patel, J.; Keating, B.; Oberbauer, R. & IGeneTRAIN Consortium (2019), Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort, Lancet 393(10174): 910-917.
- Leur, K. de; Dieterich, M.; Hesselink, D.A.; Corneth, O.B.J.; Dor, F.J.M.F.; Graav, G.N. de; Peeters, A.M.A.; Mulder, A.; Kimenai, H.J.A.N.; Claas, F.H.J.; Clahsen-van Groningen, M.C.; Laan, L.J.W. van der; Hendriks, R.W. & Baan, C.C. (2019), Characterization of donor and recipient CD8+tissue-resident memory T cells in transplant nephrectomies, Scientific Reports 9.
- Roelen, D.; Vaal, Y. de; Vierra-Green, C.; Waldvogel, S.; Spellman, S.; Claas, F. & Oudshoorn, M. (2018), HLA mismatches that are identical for the antigen recognition domain are less immunogenic, Bone Marrow Transplantation 53(6): 729-740.
- den Dulk A. C., Shi X., Verhoeven C., Dubbeld J., Claas F. H. J., Wolterbeek R., Brand-Schaaf S. H., Verspaget H. W., Sarasqueta Farina A., van der Laan L. J. W., Metselaar H. J., van Hoek B., Kwekkeboom J. & Roelen D. L. (2018), Donor specific anti-HLA antibodies are not associated with non-anastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation, Transplantation 102: 170-170.
- Kamburova, E.G.; Kardol-Hoefnagel, T.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Meeldijk, J.; Bovenschen, N.; Seelen, M.A.J.; Sanders, J.S.; Hepkema, B.G.; Lambeck, A.J.A.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.A.C.J.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A.M.I. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H. & Otten, H.G. (2018), Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients, Frontiers in Immunology 9.
- Kamburova Elena G., Wisse B. W., Joosten I., Allebes W. A., van der Meer A., Hilbrands L. B., Baas M. C., Spierings Eric, Hack C. E., van Reekum F., van Zuilen A. D., Verhaar M. C., Bots M. L., Plaisier L., Seelen M. A. J., Sanders J. S. F., Hepkema B. G., Lambeck A. J., Bungener L. B., Roozendaal C., Tilanus M. G. J., Voorter C. E., Wieten L., van Duijnhoven E., Gelens M., Christiaans M., van Ittersum F., Nurmohamed A., Lardy N. M., Swelsen W. T., van der Pant K. A. M. I., van der Weerd N. C., ten Berge I. J. M., Bemelman F. J., Hoitsma A. J., van der Boog P. J. M., de Fijter J. W., Betjes M. G. H., Heidt Sebastiaan, Roelen D. L., Claas F. H. J. & Otten H. G. (2018), DECREASED GRAFT SURVIVAL OF RETRANSPLANTS CAN LARGELY BE EXPLAINED BY INCREASED HLA-IMMUNIZATION, Hla 91(5): 372-372.
- Dulk, A.C. den; Shi, X.L.; Verhoeven, C.J.; Dubbeld, J.; Claas, F.H.J.; Wolterbeek, R.; Brand-Schaaf, S.H.; Verspaget, H.W.; Sarasqueta, A.F.; Laan, L.J.W. van der; Metselaar, H.J.; Hoek, B. van; Kwekkeboom, J. & Roelen, D.L. (2018), Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation, Clinical Transplantation 32(2).
- Yang, J.X.; Snijders, M.L.H.; Haasnoot, G.W.; Kooten, C. van; Mallat, M.; Fijter, J.W. de; Clahsen-van Groningen, M.C.; Claas, F.H.J. & Eikmans, M. (2018), Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome, Transplant Immunology 48: 39-46.
- Zwan, A. van der; Meer-Prins, E.M.W. van der; Miert, P.P.M.C. van; Heuvel, H. van den; Anholts, J.D.H.; Roelen, D.L.; Claas, F.H.J. & Heidt, S. (2018), Cross-Reactivity of Virus-Specific CD8+T Cells Against Allogeneic HLA-C: Possible Implications for Pregnancy Outcome, Frontiers in Immunology 9.
- Yang Jianxin, Spruyt-Gerritse Marijke J., Soonawala Darius, Haasnoot Geert W., de Fijter Hans W., Reinders Marlies E. J., Clahsen Marian C., Claas Frans H. J. & Eikmans Michael (2018), ENDOTHELIAL-EPITHELIAL-RELATED TRANSCRIPTIONAL LEVELS IN ACUTE REJECTION BIOPSIES OF KIDNEY TRANSPLANT RECIPIENTS ARE PREDICTIVE FOR A WORSE RESPONSE TO STEROID TREATMENT, Hla 91(5): 343-343.
- Yang, J.X.; Anholts, J.; Kolbe, U.; Stegehuis-Kamp, J.A.; Claas, F.H.J. & Eikmans, M. (2018), Calcium-Binding Proteins S100A8 and S100A9: Investigation of Their Immune Regulatory Effect in Myeloid Cells, International Journal of Molecular Sciences 19(7).
- Rijkers, M.; Saris, A.; Heidt, S.; Mulder, A.; Porcelijn, L.; Claas, F.H.J.; Bierings, R.; Leebeek, F.W.G.; Jansen, A.J.G.; Vidarsson, G.; Voorberg, J. & Haas, M. de (2018), A subset of anti-HLA antibodies induces Fc gamma RIIa-dependent platelet activation, Haematologica 103(10): 1741-1752.
- Kramer Cynthia S. M., Koster Johan, Haasnoot Geert W., Roelen Dave L., Claas Frans H. J. & Heidt Sebastiaan (2018), A NOVEL TOOL TO DEFINE THE IMMUNOGENICITY OF HUMAN LEUKOCYTE ANTIGEN MISMATCHES, Hla 91(5): 378-378.
- Kramer Cynthia S. M., Koster Johan, Haasnoot Geert W., Roelen Dave L., Claas Frans H. J. & Heidt Sebastiaan (2018), A Novel Tool to Define the Immunogenicity of HLA Mismatches, Transplantation 102: S157-S157.
- Yang, J.X.; Claas, F.H.J. & Eikmans, M. (2018), Genome-wide association studies in kidney transplantation: Advantages and constraints, Transplant Immunology 49: 1-4.
- Reindl-Schwaighofer R., Heinzel A., Kainz A., van Setten J., Jelencsics K., Hu K., Loza B. -L., Kammer M., Heinze G., Hruba P., Konarikova A., Viklicky O., Boehmig G. A., Eskandary F., Fischer G., Claas F., Tan J. C., Albert T. J., Patel J., Keating B. & Oberbauer R. (2018), GENOME-WIDE NON-HLA INCOMPATIBILITY BETWEEN DONOR AND RECIPIENT CONTRIBUTES TO KIDNEY ALLOGRAFT ATTRITION, Transplant International 31: 15-15.
- van Besouw Nicole M., Yan Lin, de Kuiper Ronella, Klepper Mariska, Reijerkerk Derek, Roelen Dave L., Claas Frans H. J., Clahsen-van Groningen Marian C., Hesselink Dennis A. & Baan Carla C. (2018), High Numbers of Donor-Specific IL-21 Producing Cells Predict Rejection after Kidney Transplantation: A Cross Validation, Transplantation 102: S141-S141.
- Saris, A.; Tomson, B.; Brand, A.; Mulder, A.; Claas, F.H.; Lorinser, J.; Scharenberg, J.; Ham, S.M. van; Brinke, A. ten; Zwaginga, J.J. & Meer, P.F. van der (2018), Platelets from donors with consistently low HLA-B8,-B12, or-B35 expression do not undergo antibody-mediated internalization, Blood 131(1): 144-152.
- Cao, J.F.; Brouwer, N.J.; Jordanova, E.S.; Marinkovic, M.; Duinen, S.G. van; Waard, N.E. de; Ksander, B.R.; Mulder, A.; Claas, F.H.J.; Heemskerk, M.H.M. & Jager, M.J. (2018), HLA Class I Antigen Expression in Conjunctival Melanoma Is Not Associated With PD-L1/PD-1 Status, Investigative Ophthalmology & Visual Science 59(2): 1005-1015.
- Lim, W.H.; Wong, G.; Heidt, S. & Claas, F.H.J. (2018), Novel aspects of epitope matching and practical application in kidney transplantation, Kidney International 93(2): 314-324.
- Brand, A.; Claas, F.H.J.; Bontrop, R.E. & Vries, R.R.P. de (2018), Obituary: Prof Johannes Joseph van Rood (1926-2017), Vox Sanguinis 113(1): 89-91.
- Car Helena, Kramer Cynthia S. M., Brand-Schaaf Simone, Karahan Gonca E., Van Kooten Cees, Parren Paul W. H. I., Claas F. H. J., Roelen Dave L. & Heidt Sebastiaan (2018), OPTIMIZATION AND VALIDATION OF AN IGA HLA-SPECIFIC LUMINEX SINGLE ANTIGEN BEAD ASSAY, Hla 91(5): 369-369.
- Geneugelijk, K.; Niemann, M.; Drylewicz, J.; Zuilen, A.D. van; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Hack, C.E.; Reekum, F.E. van; Verhaar, M.C.; Kamburova, E.G.; Bots, M.L.; Seelen, M.A.J.; Sanders, J.S.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Vanderlocht, J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, A.; Lardy, J.N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H.; Otten, H.G. & Spierings, E. (2018), PIRCHE-II Is Related to Graft Failure after Kidney Transplantation, Frontiers in Immunology 9.
- Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.A.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H. & Otten, H.G. (2018), Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant, American Journal of Transplantation 18(9): 2274-2284.
- Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.; Hepkema, B.G.; Lambeck, A.J.A.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.A.C.J.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, S.A.; Lardy, N.M.; Swelsen, W.; Pant, K.A.M.I. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.J.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H. & Otten, H.G. (2018), Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure, Journal of the American Society of Nephrology 29(9): 2279-2285.
- Daga, S.; Moyse, H.; Briggs, D.; Lowe, D.; Evans, N.; Jones, J.; Buchli, R.; McMurtrey, C.; Mulder, A.; Hildebrand, W.; Claas, F.; Higgins, R.; Mitchell, D.A. & Zehnder, D. (2018), Response to the comments on "Direct quantitative measurement of the kinetics of HLA-specific antibody interactions with isolated HLA proteins", Human Immunology 79(2): 130-131.
- Tambur, A.R.; Campbell, P.; Claas, F.H.; Feng, S.; Gebel, H.M.; Jackson, A.M.; Mannon, R.B.; Reed, E.F.; Tinckam, K.; Askar, M.; Chandraker, A.; Chang, P.P.; Colvin, M.; Demetris, A.J.; Diamond, J.M.; Dipchand, A.I.; Fairchild, R.L.; Ford, M.L.; Friedewald, J.; Gill, R.G.; Glotz, D.; Goldberg, H.; Hachem, R.; Knechtle, S.; Kobashigawa, J.; Levine, D.J.; Levitsky, J.; Mengel, M.; Milford, E.; Newell, K.A.; O'Leary, J.G.; Palmer, S.; Randhawa, P.; Smith, J.; Snyder, L.; Starling, R.C.; Sweet, S.; Taner, T.; Taylor, C.J.; Woodle, S.; Zeevi, A. & Nickerson, P. (2018), Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report, American Journal of Transplantation 18(7): 1604-1614.
- Claas Frans H. J. (2018), Status of intravenous immunoglobulin in the treatment of recurrent pregnancy loss and implantation failure, Journal of Reproductive Immunology 128: 42-42.
- Karahan, G.E.; Claas, F.H.J. & Heidt, S. (2018), Technical challenges and clinical relevance of single antigen bead C1q/C3d testing and IgG subclass analysis of human leukocyte antigen antibodies, Transplant International 31(11): 1189-1197.
- Heuvel, H. van den; Heutinck, K.M.; Meer-Prins, E.M.W. van der; Franke-van Dijk, M.E.I.; Miert, P.P.M.C. van; Zhang, X.Q.; Berge, I.J.M. ten & Claas, F.H.J. (2018), The avidity of cross-reactive virus-specific T cells for their viral and allogeneic epitopes is variable and depends on epitope expression, Human Immunology 79(1): 39-50.
- Johnsen, G.M.; Storvold, G.L.; Drabbels, J.J.M.; Haasnoot, G.W.; Eikmans, M.; Spruyt-Gerritse, M.J.; Alnaes-Katjavivi, P.; Scherjon, S.A.; Redman, C.W.G.; Claas, F.H.J. & Stafr, A.C. (2018), The combination of maternal KIR-B and fetal HLA-C2 is associated with decidua basalis acute atherosis in pregnancies with preeclampsia, Journal of Reproductive Immunology 129: 23-29.
- van Bentem K., Bos M., van der Keur C., Eikmans M., Heidt S., Claas F. H. J., Lashley E. E. L. O. & van der Hoorn M. L. P. (2018), The development of pre-eclampsia in oocyte donation pregnancies is related to the number of HLA class II mismatches, Journal of Reproductive Immunology 128: 60-60.
- Osorio-Jaramillo E., Haasnoot G. W., Kaider A., Zuckermann A., Schaefer A. -K., Haberl T., Goekler J., Angleitner P., Moayedifar R., Fischer G. F., Laufer G., Claas F. H. & Aliabadi-Zuckermann A. Z. (2018), THE ROLE OF HLA-EPITOPES IN HEART TRANSPLANTATION, Transplant International 31: 7-7.
- Mifsud Nicole, Rowntree Louise, D'Orsogna Lloyd, van den Heuvel Heleen, Claas Frans, Illing Patricia, Gras Stephanie, Kotsimbos Tom & Purcell Anthony (2018), THE ROLE OF T CELL RECEPTOR CROSS-REACTIVITY IN HUMAN DISEASES, Hla 91(5): 346-346.
- de Leur Kitty, Dieterich Marjolein, Corneth Odilia B. J., de Graav Gretchen N., Mulder Arend, Dor Frank J. M. F., Kimenai Hendrikus J. A. N., Claas Frans H. J., Hesselink Dennis A., Clahsen-van Groningen Marian C., van der Laan Luc J. W., Hendriks Rudi W. & Baan Carla C. (2018), Tissue-Resident Memory T Cells of Donor Origin are Short-Lived in Renal Allografts after Transplantation, Transplantation 102: S146-S146.
- Heidt, S. & Claas, F.H.J. (2018), Transplantation in highly sensitized patients: challenges and recommendations, Expert Review of Clinical Immunology 14(8): 673-679.
- van der Zwan Anita, van Unen Vincent, Hollt Thomas, Kapsenberg Hanneke J. M., van der Hoorn Marie-Louise P., Uyar-Mercankaya Merve, Lopes Susana M. Chuva de Sousa, Koning Frits, Claas Frans H. J. & Heidt Sebastiaan (2018), UNRAVELLING DYNAMIC CHANGES IN THE MATERNAL IMMUNE COMPARTMENT AT THE MATERNAL-FETAL INTERFACE DURING PREGNANCY BY MASS CYTOMETRY, Hla 91(5): 325-325.
- Karahan, G.E.; Claas, F.H.J. & Heidt, S. (2018), Technical challenges and clinical relevance of single antigen bead C1q/C3d testing and IgG subclass analysis of human leukocyte antigen antibodies, Transplant International 31(11): 1189-1197.
- Johnsen, G.M.; Storvold, G.L.; Drabbels, J.J.M.; Haasnoot, G.W.; Eikmans, M.; Spruyt-Gerritse, M.J.; Alnaes-Katjavivi, P.; Scherjon, S.A.; Redman, C.W.G.; Claas, F.H.J. & Stafr, A.C. (2018), The combination of maternal KIR-B and fetal HLA-C2 is associated with decidua basalis acute atherosis in pregnancies with preeclampsia, Journal of Reproductive Immunology 129: 23-29.
- Daga, S.; Moyse, H.; Briggs, D.; Lowe, D.; Evans, N.; Jones, J.; Buchli, R.; McMurtrey, C.; Mulder, A.; Hildebrand, W.; Claas, F.; Higgins, R.; Mitchell, D.A. & Zehnder, D. (2018), Direct quantitative measurement of the kinetics of HLA-specific antibody interactions with isolated HLA proteins, Human Immunology 79(2): 122-128.
- Heidt, S.; Haasnoot, G.W. & Claas, F.H.J. (2018), How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survival, Current Opinion in Organ Transplantation 23(4): 493-499.
- Bruijnesteijn, J.; Wiel, M.K.H. van der; Swelsen, W.T.N.; Otting, N.; Vos-Rouweler, A.J.M. de; Elferink, D.; Doxiadis, G.G.; Claas, F.H.J.; Lardy, N.M.; Groot, N.G. de & Bontrop, R.E. (2018), Human and Rhesus Macaque KIR Haplotypes Defined by Their Transcriptomes, Journal of Immunology 200(5): 1692-1701.
- Craenmehr Moniek H. C., Nederlof Iris, Cao Milo, Anholts Jacqueline D. H., Drabbels Jos J. M., Claas Frans H. J., Heidt Sebastiaan & Eikmans Michael (2018), INCREASED FREQUENCY OF THE 14-BP INSERTION IN HLA-G, Hla 91(5): 464-465.
- Meysman, P.; Neuter, N. de; Bartholomeus, E.; Elias, G.; Bergh, J. van den; Emonds, M.P.; Haasnoot, G.W.; Heynderickx, S.; Wens, J.; Michels, N.R.; Lambert, J.; Lion, E.; Claas, F.H.J.; Goossens, H.; Smits, E.; Damme, P. van; Tendeloo, V. van; Beutels, P.; Suls, A.; Mortier, G.; Laukens, K. & Ogunjimi, B. (2018), Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity, Immunogenetics 70(6): 363-372.
- Heidt, S.; Haasnoot, G.W.; Rood, J.J. van; Witvliet, M.D. & Claas, F.H.J. (2018), Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients, Kidney International 93(2): 491-500.
- Meuleman, T.; Drabbels, J.; Lith, J.M.M. van; Dekkers, O.M.; Rozemuller, E.; Cretu-Stancu, M.; Claas, F.H.J.; Bloemenkamp, K.W.M. & Eikmans, M. (2018), Lower frequency of the HLA-G UTR-4 haplotype in women with unexplained recurrent miscarriage, Journal of Reproductive Immunology 126: 46-52.
- Rovito, R.; Claas, F.H.J.; Haasnoot, G.W.; Roelen, D.L.; Kroes, A.C.M. & Vossen, A.C.T.M. (2018), Maternal and child human leukocyte antigens in congenital cytomegalovirus infection, Journal of Reproductive Immunology 126: 39-45.
- Heidt, S.; Feltkamp, M.C.; Karahan, G.E.; Brouwer, C.S. de; Langerak-Langerak, J.; Mulder, A. & Claas, F.H.J. (2018), No Evidence for Cross-reactivity of Virus-specific Antibodies With HLA Alloantigens, Transplantation 102(11): 1844-1849.
- Dulk, A.C. den; Shi, X.; Verhoeven, C.; Dubbeld, J.; Claas, F.H.J.; Wolterbeek, R.; Brand-Schaaf, S.; Verspaget, H.W.; Sarasqueta, A.F.; Laan, L. van der; Metselaar, H.; Hoek, B. van; Kwekkeboom, J. & Roelen, D. (2018), Donor-specific anti-HLA antibodies are not associated with non-anastomotic biliary strictures, but both are independent risk factors for graft loss after liver transplantation, Journal of Hepatology 68: S372-S372.
- Rovito, R.; Claas, F.H.J.; Haasnoot, G.W.; Roelen, D.L.; Kroes, A.C.M.; Eikmans, M. & Vossen, A.C.T.M. (2018), Congenital Cytomegalovirus Infection: Maternal-Child HLA-C, HLA-E, and HLA-G Affect Clinical Outcome, Frontiers in Immunology 8.
- Rovito, R.; Claas, F.H.J.; Haasnoot, G.W.; Roelen, D.L.; Kroes, A.C.M.; Eikmans, M. & Vossen, A.C.T.M. (2018), Congenital Cytomegalovirus Infection: Maternal-Child HLA-C, HLA-E, and HLA-G Affect Clinical Outcome, Frontiers in Immunology 8.
- Bontrop, R.; Brand, A. & Claas, F. (2018), In memoriam Johannes Joseph van Rood (1926-2017), Immunogenetics 70(1): 1-4.
- Zwan, A. van der; Bi, K.; Norwitz, E.R.; Crespo, A.C.; Claas, F.H.J.; Strominger, J.L. & Tilburgs, T. (2018), Mixed signature of activation and dysfunction allows human decidual CD8(+) T cells to provide both tolerance and immunity, Proceedings of the National Academy of Sciences 115(2): 385-390.
- Meuleman, T.; Haasnoot, G.W.; Lith, J.M.M. van; Verduijn, W.; Bloemenkamp, K.W.M. & Claas, F.H.J. (2018), Paternal HLA-C is a risk factor in unexplained recurrent miscarriage, American Journal of Reproductive Immunology 79(2).
- Saris, A.; Tomson, B.; Brand, A.; Mulder, A.; Claas, F.H.; Lorinser, J.; Scharenberg, J.; Ham, S.M. van; Brinke, A. ten; Zwaginga, J.J. & Meer, P.F. van der (2018), Platelets from donors with consistently low HLA-B8,-B12, or-B35 expression do not undergo antibody-mediated internalization, Blood 131(1): 144-152.
- Naiyer, M.M.; Cassidy, S.A.; Magri, A.; Cowton, V.; Chen, K.; Mansour, S.; Kranidioti, H.; Mbirbindi, B.; Rettman, P.; Harris, S.; Fanning, L.J.; Mulder, A.; Claas, F.H.J.; Davidson, A.D.; Patel, A.H.; Purbhoo, M.A. & Khakoo, S.I. (2017), KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C, Science Immunology 2(15).
- Sonderen, A. van; Roelen, D.L.; Stoop, J.A.; Verdijk, R.M.; Haasnoot, G.W.; Thijs, R.D.; Wirtz, P.W.; Schreurs, M.W.J.; Claas, F.H.J.; Smitt, P.A.E.S. & Titulaer, M.J. (2017), Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4, Annals of Neurology 81(2): 193-198.
- Heuvel, H. van den; Heutinck, K.M.; Meer-Prins, E.M.W. van der; Yong, S.L.; Miert, P.P.M.C. van; Anholts, J.D.H.; Franke-van Dijk, M.E.I.; Zhang, X.Q.; Roelen, D.L.; Berge, R.J.M. ten & Claas, F.H.J. (2017), Allo-HLA Cross-Reactivities of Cytomegalovirus-, Influenza-, and Varicella Zoster Virus-Specific Memory T Cells Are Shared by Different Healthy Individuals, American Journal of Transplantation 17(8): 2033-2044.
- Heuvel, H. van den; Heutinck, K.M.; Meer-Prins, E.M.W. van der; Yong, S.L.; Miert, P.P.M.C. van; Anholts, J.D.H.; Franke-van Dijk, M.E.I.; Zhang, X.Q.; Roelen, D.L.; Berge, R.J.M. ten & Claas, F.H.J. (2017), Allo-HLA Cross-Reactivities of Cytomegalovirus-, Influenza-, and Varicella Zoster Virus-Specific Memory T Cells Are Shared by Different Healthy Individuals, American Journal of Transplantation 17(8): 2033-2044.
- Heijmans, C.M.C.; Groot, N.G. de; Mulder, A.; Claas, F.H.J. & Bontrop, R.E. (2017), A METHOD FOR SELECTING MHC CLASS I-SPECIFIC ANTIBODIES IN RHESUS MACAQUES, Hla 89(6): 477-477.
- Kramer, C.S.M.; Roelen, D.L.; Heidt, S. & Claas, F.H.J. (2017), Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation, Hla 90(1): 5-16.
- Rekers, N.V.; Flaig, T.M.; Mallat, M.J.K.; Spruyt-Gerritse, M.J.; Zandbergen, M.; Anholts, J.D.H.; Bajema, I.M.; Clahsen-van Groningen, M.C.; Yang, J.X.; Fijter, J.W. de; Claas, F.H.J.; Brakemeier, S.; Lachmann, N.; Kreutz, R.; Heer, E. de; Budde, K.; Bolbrinker, J. & Eikmans, M. (2017), Donor Genotype and Intragraft Expression of CYP3A5 Reflect the Response to Steroid Treatment During Acute Renal Allograft Rejection, Transplantation 101(9): 2017-2025.
- Claas, F.H.J. & Heidt, S. (2017), Epitope-Based HLA Matching: A Useful Strategy With Many Shortcomings to Overcome, Transplantation 101(8): 1744-1745.
- Kramer, C.S.M.; Roelen, D.L.; Oever, C.C.C. van den; Rademaker, R.; Parren, P.W.H.I.; Claas, F.H.J. & Heidt, S. (2017), HUMAN HLA CLASS II MONOCLONAL ANTIBODIES: CRUCIAL TOOLS TO DEFINE ANTIBODY EPITOPES ON HLA CLASS II MOLECULES, Hla 89(6): 438-438.
- D'Orsogna, L.; Heuvel, H. van den; Kooten, C. van; Heidt, S. & Claas, F.H.J. (2017), Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms, Immunogenetics 69(8-9): 631-641.
- Drabbels, J.J.M.; Welleweerd, R.; Rooy, I. van; Eikmans, M.; Haasnoot, G.W.; Westerink, N.; Claas, F.H.J. & Rozemuller, E.H. (2017), NOVEL HLA-G WHOLE GENE AMPLIFICATION APPROACH REVEALS LINKAGE DISEQUILIBRIUM BETWEEN EXTENDED 3 ' UTR AND HLA-G AT THE ALLELIC RESOLUTION LEVEL, Hla 89(6): 430-430.
- Almeida, C.A.; Miert, P. van; O'Driscoll, K.; Zoet, Y.M.; Chopra, A.; Watson, M.; Santis, D. de; Witt, C.; John, M.; Claas, F.H.J. & D'Orsogna, L.J. (2017), Stimulation of HIV-specific T cell clonotypes using allogeneic HLA, Cellular Immunology 316: 32-40.
- Rood, J.J. van; Brand, A.; Scaradavou, A.; Claas, F.H.; Oudshoorn, M. & Stevens, C.E. (2017), When selecting a cord blood unit from a firstborn donor verify that the patient shares an Ag with the unit that is foreign to the mother of the donor, Bone Marrow Transplantation 52(7): 1039-1040.
- Bank, J.R.; Heidt, S.; Moes, D.J.A.R.; Roelen, D.L.; Mallat, M.J.K.; Boog, P.J.M. van der; Vergunst, M.; Jol-van der Zijde, C.M.; Bredius, R.G.M.; Braat, A.E.; Ringers, J.; Tol, M.J.D. van; Claas, F.H.J.; Reinders, M.E.J. & Fijter, J.W. de (2017), Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients, Transplantation Direct 3(1).
- Sonderen, A. van; Roelen, D.L.; Stoop, J.A.; Verdijk, R.M.; Haasnoot, G.W.; Thijs, R.D.; Wirtz, P.W.; Schreurs, M.W.J.; Claas, F.H.J.; Smitt, P.A.E.S. & Titulaer, M.J. (2017), Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4, Annals of Neurology 81(2): 193-198.
- Guberina, H.; Rebmann, V.; Wagner, B.; Nardi, F.D.; Dziallas, P.; Dolff, S.; Bienholz, A.; Wohlschlaeger, J.; Bankfalvi, A.; Heinemann, F.M.; Witzke, O.; Zoet, Y.M.; Claas, F.H.J.; Horn, P.A.; Kribben, A. & Doxiadis, I.I.N. (2017), Association of high HLA-E expression during acute cellular rejection and numbers of HLA class I leader peptide mismatches with reduced renal allograft survival, Immunobiology 222(3): 536-543.
- Lema, D.; Bracamonte-Baran, W.; Jankowska-Gan, E.; Claas, F.; Rood, J. van; Mulder, A. & Burlingham, W. (2017), Chimerism-Related Allotolerance Is Induced by Exosome Acquisition and Reprogramming of Host Dendritic Cells, American Journal of Transplantation 17: 701-701.
- Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F. van; Zuilen, A. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Voorter, C.E.M.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, H. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H.J. & Otten, H.G. (2017), DIFFERENTIAL EFFECT OF DONOR-SPECIFIC HLA ANTIBODIES IN LIVING VERSUS DECEASED DONOR KIDNEY TRANSPLANTATION, Hla 89(6): 348-348.
- Murray, S.E.; Nesterenko, P.A.; Vanarsdall, A.L.; Munks, M.W.; Smart, S.M.; Veziroglu, E.M.; Sagario, L.C.; Lee, R.; Claas, F.H.J.; Doxiadis, I.I.N.; Mcvoy, M.A.; Adler, S.P. & Hill, A.B. (2017), Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans, Journal of Experimental Medicine 214(7): 1889-1899.
- Yang, J.X.; Dreyer, G.J.; Setten, J. van; Fijter, H.W. de; Keating, B.J.; Claas, F.H.J. & Eikmans, M. (2017), GENOME-WIDE ASSOCIATION STUDY IDENTIFIES NOVEL RISK LOCI FOR ACUTE KIDNEY TRANSPLANT REJECTION, Hla 89(6): 347-347.
- Ravindranath, M.H.; Cai, J.C.; Ferrone, S.; Claas, F.H.J. & Selvan, S.R. (2017), The Humoral Theory of Transplantation, Journal of Immunology Research.
- Karahan, G.E.; Claas, F.H.J. & Heidt, S. (2017), B Cell immunity in Solid Organ Transplantation, Frontiers in Immunology 7.
- Torren, C.R. van der; Suwandi, J.S.; Lee, D.; van't Wout, E.J.T.; Duinkerken, G.; Swings, G.; Mulder, A.; Claas, F.H.J.; Ling, Z.D.; Gillard, P.; Keymeulen, B.; in't Ved, P. & Roep, B.O. (2017), Identification of Donor Origin and Condition of Transplanted Islets In Situ in the Liver of a Type 1 Diabetic Recipient, Cell Transplantation 26(1): 1-9.
- Bracamonte-Baran, W.; Florentin, J.; Zhou, Y.; Jankowska-Gan, E.; Haynes, W.J.; Zhong, W.X.; Brennan, T.V.; Dutta, P.; Claas, F.H.J.; Rood, J.J. van & Burlingham, W.J. (2017), Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance, Proceedings of the National Academy of Sciences 114(5): 1099-1104.
- Wunderink, H.F.; Meijden, E. van der; Blij-de Brouwer, C.S. van der; Mallat, M.J.K.; Haasnoot, G.W.; Zwet, E.W. van; Claas, E.C.J.; Fijter, J.W. de; Kroes, A.C.M.; Arnold, F.; Touze, A.; Claas, F.H.J.; Rotmans, J.I. & Feltkamp, M.C.W. (2017), Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation, American Journal of Transplantation 17(1): 161-172.
- Zwan, A. van der; Li, N.; Keur, C. van der; Koning, F.; Heidt, S.; Claas, F. & Unen, V. van (2017), VISUALIZING THE PLAYERS OF THE MATERNAL IMMUNE RESPONSE AT THE MATERNAL-FETAL INTERFACE BY HIGH-DIMENSIONAL MASS CYTOMETRY, Placenta 57: 244-245.
- Nederlof, I.; Meuleman, T.; Hoorn, M.L.P. van der; Claas, F.H.J. & Eikmans, M. (2017), The seed to success: The role of seminal plasma in pregnancy, Journal of Reproductive Immunology 123: 24-28.
- Priddey, A.; Copley, H.; Buchli, R.; Mallon, D.H.; Claas, F.H.; Taylor, C.J.; Mulder, A. & Kosmoliaptsis, V. (2017), QUANTITATION OF ALLOANTIBODY-HLA BINDING KINETICS USING A NOVEL BIOSENSOR ASSAY TO IMPROVE IMMUNOLOGICAL RISK ASSESSMENT IN TRANSPLANTATION, Transplant International 30: 103-104.
- Bontrop, R.; Brand, A. & Claas, F. (2017), Prof Dr. Johannes Joseph (Jon) van Rood (1926-2017) Obituary, Human Immunology 78(9): 523-525.
- Bontrop, R.E.; Brand, A. & Claas, F.H.J. (2017), Prof. Dr. Johannes Joseph van Rood (1926-2017) OBITUARY, Hla 90(4): 207-210.
- Weijer, M.L. van de; Schuren, A.B.C.; Boomen, D.J.H. van den; Mulder, A.; Claas, F.H.J.; Lehner, P.J.; Lebbink, R.J. & Wiertz, E.J.H.J. (2017), Multiple E2 ubiquitin-conjugating enzymes regulate human cytomegalovirus US2-mediated immunoreceptor downregulation, Journal of Cell Science 130(17): 2883-2892.
- Gielis, E.; Anholts, J.; Fijter, H. de; Claas, F. & Eikmans, M. (2017), MICRORNAS IN URINE HELP TO IDENTIFY ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION, Transplant International 30: 270-270.
- Michelo, C.M.; Cranenbroek, B. van; Touw, P.; Claas, F.H.J.; Meer, A. van der & Joosten, I. (2017), Human Cytomegalovirus Infection Increases Both Antibody- and Non-Antibody-Dependent Cellular Reactivity by Natural Killer Cells, Transplantation Direct 3(12).
- Karahan, G.; Vaal, Y. de; Krop, J.; Wehmeier, C.; Roelen, D.; Claas, F. & Heidt, S. (2017), A NEW TOOL FOR QUANTIFICATION OF THE DONOR HLA-SPECIFIC MEMORY B CELL REPERTOIRE IN IMMUNIZED PATIENTS, Transplant International 30: 33-34.
- Buchli, R.; Buchli, S.; Lowe, D.; VanGundy, R.; Collard, J.; Mulder, A.; Claas, F.; Duquesnoy, R. & Hildebrand, W.H. (2017), DOSE RESPONSE FEATURES AND PARAMETERS TO CONSIDER IN SEROLOGICAL EVALUATION OF TRANSPLANT PATIENTS, Human Immunology 78: 108-108.
- Carapito, R.; Jung, N.; Kwemou, M.; Untrau, M.; Michel, S.; Pichot, A.; Giacometti, G.; Macquin, C.; Ilias, W.; Morlon, A.; Kotovo, I.; Apostolova, P.; Schmitt-Graeff, A.; Cesbron, A.; Gagne, K.; Oudshoorn, M.; Holt, B. van der; Labalette, M.; Spierings, E.; Picard, C.; Loiseau, P.; Tamouza, R.; Toubert, A.; Parissiadis, A.; Dubois, V.; Lafarge, X.; Maumy-Bertrand, M.; Bertrand, F.; Vago, L.; Ciceri, F.; Paillard, C.; Querol, S.; Sierra, J.; Fleischhauer, K.; Nagler, A.; Labopin, M.; Inoko, H.; Borne, P.A. von dem; Kuball, J.; Ota, M.; Katsuyama, Y.; Michallet, M.E.; Lioure, B.; Latour, R.P. de; Blaise, D.; Cornelissen, J.J.; Yakoub-Agha, I.; Claas, F.H.J.; Moreau, P.; Milpied, N.; Charron, D.; Mohty, M.; Zeiser, R.; Socie, G. & Bahram, S. (2017), MATCHING FOR THE NON-CONVENTIONAL MHC-I MICA GENE SIGNIFICANTLY REDUCES THE INCIDENCE OF ACUTE AND CHRONIC GVHD, Hla 89(6): 350-351.
- Karahan, G.E.; Vaal, Y.J.H. de; Krop, J.; Wehmeier, C.; Roelen, D.L.; Claas, F.H.J. & Heidt, S. (2017), A Memory B Cell Crossmatch Assay for Quantification of Donor-Specific Memory B Cells in the Peripheral Blood of HLA-Immunized Individuals, American Journal of Transplantation 17(10): 2617-2626.
- Geneugelijk, K.; Niemann, M.; Drylewicz, J.; Zuilen, A.D. van; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Hack, C.E.; Reekum, F.E. van; Verhaar, M.; Kamburova, E.G.; Bots, M.L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Vanderlocht, J.; Voorter, C.E.M.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.D.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H.J.; Otten, H.G. & Spierings, E. (2017), PIRCHE-II: A NOVEL TOOL TO IDENTIFY PERMISSIBLE HLA MISMATCHES IN KIDNEY TRANSPLANTATION, Hla 89(6): 374-375.
- Geneugelijk, K.; Niemann, M.; Drylewicz, J.; Zuilen, A. van; Joosten, I.; Allebes, W.; Meer, A. van der; Hilbrands, L.; Baas, M.; Hack, E.; Reekum, F. van; Verhaar, M.; Kamburova, E.; Bots, M.; Seelen, M.; Sanders, J.S.; Hepkema, B.; Lambeck, A.; Bungener, L.; Tilanus, M.; Voorter, C.; Vanderlocht, J.; Wieten, L.; Duijnhoven, E.; Gelens, M.; Christiaans, M.; Ittersum, F. van; Nurmohamed, A.; Lardy, N.; Swelsen, W.; Pant, K. van der; Weerd, N. van der; Berge, I. ten; Bemelman, F.; Hoitsma, A.; Boog, P. van der; Fijter, J. de; Betjes, M.; Heidt, S.; Roelen, D.; Claas, F.; Otten, H. & Spierings, E. (2017), PIRCHE-II: A NOVEL TOOL TO IDENTIFY PERMISSIBLE HLA MISMATCHES IN KIDNEY TRANSPLANTATION., Human Immunology 78: 39-39.
- Bergen, C.A.M. van; Luxemburg-Heijs, S.A.P. van; Wreede, L.C. de; Eefting, M.; Borne, P.A. von dem; Balen, P. van; Heemskerk, M.H.M.; Mulder, A.; Claas, F.H.J.; Navarrete, M.A.; Honders, W.M.; Rutten, C.E.; Veelken, H.; Jedema, I.; Halkes, C.J.M.; Griffioen, M. & Falkenburg, J.H.F. (2017), Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response, Journal of Clinical Investigation 127(2): 517-529.
- Zwan, A. van der; Li, N.; Keur, C. van der; Koning, F.; Heidt, S.; Claas, F.H.J. & Unen, V. van (2017), VISUALIZING THE PLAYERS OF THE MATERNAL IMMUNE RESPONSE AT THE MATERNAL-FETAL INTERFACE BY HIGH-DIMENSIONAL MASS CYTOMETRY, Hla 89(6): 339-339.
- Karahan, G.E.; Claas, F.H.J. & Heidt, S. (2017), B Cell Immunity in Solid Organ Transplantation, Frontiers in Immunology 7.
- Groot, N.G. de; Heijmans, C.M.C.; Wiel, M.K.H. van der; Blokhuis, J.H.; Mulder, A.; Guethlein, L.A.; Doxiadis, G.G.M.; Claas, F.H.J.; Parham, P. & Bontrop, R.E. (2016), Complex MHC Class I Gene Transcription Profiles and Their Functional Impact in Orangutans, Journal of Immunology 196(2): 750-758.
- Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Vanderlocht, J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H. & Otten, H.G. (2016), How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?, Hla 88(3): 110-119.
- Yang, J.X.; Haasnoot, G.W.; Kooten, C. van; Mallat, M.J.; Fijter, H.W. de; Bajema, I.M.; Claas, F.H.J. & Eikmans, M. (2016), ELEVATED INTRAGRAFT EXPRESSION OF INNATE IMMUNITY AND CELL DEATH-RELATED MARKERS CHARACTERISES DECEASED DONOR CONDITIONS AND IS A RISK FACTOR FOR ADVERSE GRAFT OUTCOME, HLA: Immune Response Genetics 87(4): 207-207.
- Gielis, E.; Anholts, J.; Fijter, H. de; Bajema, I.; Claas, F. & Eikmans, M. (2016), MicroRNAs in Urinary Sediments as Non-Invasive Tool to Detect Acute Rejection After Kidney Transplantation, American Journal of Transplantation 16: 251-252.
- Gielis, E.M.; Anholts, J.D.H.; Fijter, H.W. de; Bajema, I.M.; Claas, F.H.J. & Eikmans, M. (2016), MICRORNAS IN URINARY SEDIMENTS AS NON-INVASIVE TOOL TO DETECT ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION, HLA: Immune Response Genetics 87(4): 207-207.
- Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Vanderlocht, J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E. van; Gelens, M.; Christiaans, M.; Ittersum, F. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.T.; Pant, K.A.M.I. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.J.; Fijter, J.W. de; Betjes, M.G.H.; Roelen, D.L.; Claas, F.H.J. & Otten, H.G. (2016), PRE-TRANSPLANT DONOR SPECIFIC HLA ANTIBODIES IN 4386 RENAL TRANSPLANT RECIPIENTS: A PRELIMINARY ANALYSIS OF THE PROCARE COHORT, Hla 87(4): 225-226.
- Engert, A.; Balduini, C.; Brand, A.; Coiffier, B.; Cordonnier, C.; Dohner, H.; Wit, T.D. de; Eichinger, S.; Fibbe, W.; Green, T.; Haas, F. de; Iolascon, A.; Jaffredo, T.; Rodeghiero, F.; Salles, G.; Schuringa, J.J.; Andre, M.; Andre-Schmutz, I.; Bacigalupo, A.; Bochud, P.Y.; Boer, M. den; Bonini, C.; Camaschella, C.; Cant, A.; Cappellini, M.D.; Cazzola, M.; Celso, C. lo; Dimopoulos, M.; Douay, L.; Dzierzak, E.; Einsele, H.; Ferreri, A.; Franceschi, L. de; Gaulard, P.; Gottgens, B.; Greinacher, A.; Gresele, P.; Gribben, J.; Haan, G. de; Hansen, J.B.; Hochhaus, A.; Kadir, R.; Kaveri, S.; Kouskoff, V.; Kuhne, T.; Kyrle, P.; Ljungman, P.; Maschmeyer, G.; Mendez-Ferrer, S.; Milsom, M.; Mummery, C.; Ossenkoppele, G.; Pecci, A.; Peyvandi, F.; Philipsen, S.; Reitsma, P.; Ribera, J.M.; Risitano, A.; Rivella, S.; Ruf, W.; Schroeder, T.; Scully, M.; Socie, G.; Staal, F.; Stanworth, S.; Stauder, R.; Stilgenbauer, S.; Tamary, H.; Theilgaard-Monch, K.; Thein, S.L.; Tilly, H.; Trneny, M.; Vainchenker, W.; Vannucchi, A.M.; Viscoli, C.; Vrielink, H.; Zaaijer, H.; Zanella, A.; Zolla, L.; Zwaginga, J.J.; Martinez, P.A.; Akker, E. van den; Allard, S.; Anagnou, N.; Andolfo, I.; Andrau, J.C.; Angelucci, E.; Anstee, D.; Aurer, I.; Avet-Loiseau, H.; Aydinok, Y.; Bakchoul, T.; Balduini, A.; Barcellini, W.; Baruch, D.; Baruchel, A.; Bayry, J.; Bento, C.; Berg, A. van den; Bernardi, R.; Bianchi, P.; Bigas, A.; Biondi, A.; Bohonek, M.; Bonnet, D.; Borchmann, P.; Borregaard, N.; Braekkan, S.; Brink, M. van den; Brodin, E.; Bullinger, L.; Buske, C.; Butzeck, B.; Cammenga, J.; Campo, E.; Carbone, A.; Cervantes, F.; Cesaro, S.; Charbord, P.; Claas, F.; Cohen, H.; Conard, J.; Coppo, P.; Corrons, J.L.V.; Costa, L. da; Davi, F.; Delwel, R.; Dianzani, I.; Domanovic, D.; Donnelly, P.; Drnovsek, T.D.; Dreyling, M.; , M.Q. du; Dufour, C.; Durand, C.; Efremov, D.; Eleftheriou, A.; Elion, J.; Emonts, M.; Engelhardt, M.; Ezine, S.; Falkenburg, F.; Favier, R.; Federico, M.; Fenaux, P.; Fitzgibbon, J.; Flygare, J.; Foa, R.; Forrester, L.; Galacteros, F.; Garagiola, I.; Gardiner, C.; Garraud, O.; Geet, C. van; Geiger, H.; Geissler, J.; Germing, U.; Ghevaert, C.; Girelli, D.; Godeau, B.; Gokbuget, N.; Goldschmidt, H.; Goodeve, A.; Graf, T.; Graziadei, G.; Griesshammer, M.; Gruel, Y.; Guilhot, F.; Gunten, S. von; Gyssens, I.; Halter, J.; Harrison, C.; Harteveld, C.; Hellstrom-Lindberg, E.; Hermine, O.; Higgs, D.; Hillmen, P.; Hirsch, H.; Hoskin, P.; Huls, G.; Inati, A.; Johnson, P.; Kattamis, A.; Kiefel, V.; Kleanthous, M.; Klump, H.; Krause, D.; Hovinga, J.K.; Lacaud, G.; Lacroix-Desmazes, S.; Landman-Parker, J.; LeGouill, S.; Lenz, G.; Lilienfeld-Toal, M. von; Lindern, M. von; Lopez-Guillermo, A.; Lopriore, E.; Lozano, M.; MacIntyre, E.; Makris, M.; Makris, M.; Martens, J.; Mathas, S.; Matzdorff, A.; Medvinsky, A.; Menendez, P.; Migliaccio, A.R.; Miharada, K.; Mikulska, M.; Minard, V.; Montalban, C.; Montalembert, M. de; Montserrat, E.; Morange, P.E.; Mountford, J.; Muckenthaler, M.; Muller-Tidow, C.; Mumford, A.; Nadel, B.; Navarro, J.T.; Nemer, W. el; Noizat-Pirenne, F.; O'Mahony, B.; Oldenburg, J.; Olsson, M.; Oostendorp, R.; Palumbo, A.; Passamonti, F.; Patient, R.; Latour, R.P. de; Pflumio, F.; Pierelli, L.; Piga, A.; Pollard, D.; Raaijmakers, M.; Radford, J.; Rambach, R.; Rao, A.K.; Raslova, H.; Rebulla, P.; Rees, D.; Ribrag, V.; Rijneveld, A.; Rinalducci, S.; Robak, T.; Roberts, I.; Rodrigues, C.; Rosendaal, F.; Rosenwald, A.; Rule, S.; Russo, R.; Saglio, G.; Sanchez, M.; Scharf, R.E.; Schlenke, P.; Semple, J.; Sierra, J.; So-Osman, C.; Soria, J.M.; Stamatopoulos, K.; Stegmayr, B.; Stunnenberg, H.; Swinkels, D.; Barata, J.P.T.; Taghon, T.; Taher, A.; Terpos, E.; Thachil, J.; Tissot, J.D.; Touw, I.; Toye, A.; Trappe, R.; Traverse-Glehen, A.; Unal, S.; Vaulont, S.; Viprakasit, V.; Vitolo, U.; Wijk, R. van; Wojtowicz, A.; Zeerleder, S.; Zieger, B. & EHA Roadmap European Hematology Re (2016), The European Hematology Association Roadmap for European Hematology Research: a consensus document, Haematologica 101(2): 115-208.
- (2016), What is wrong with the regulatory T cells and foetomaternal tolerance in women with recurrent miscarriages?, Hla.
- Romee, R.; Rosario, M.; Berrien-Elliott, M.M.; Wagner, J.A.; Jewell, B.A.; Schappe, T.; Leong, J.W.; Abdel-Latif, S.; Schneider, S.E.; Willey, S.; Neal, C.C.; Yu, L.Y.; Oh, S.T.; Lee, Y.S.; Mulder, A.; Claas, F.; Cooper, M.A. & Fehniger, T.A. (2016), Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia, Science Translational Medicine 8(357).
- Meulernan, T.; Beelen, E. van; Kaaja, R.J.; Lith, J.M.M. van; Claas, F.H.J. & Bloemenkamp, K.W.M. (2016), HLA-C antibodies in women with recurrent miscarriage suggests that antibody mediated rejection is one of the mechanisms leading to recurrent miscarriage, Journal of Reproductive Immunology 116: 28-34.
- Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F.E. van; Zuilen, A.D. van; Verhaar, M.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Vanderlocht, J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E.M. van; Gelens, M.; Christiaans, M.H.L.; Ittersum, F.J. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.; Pant, K.A. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.; Boog, P.J.M. van der; Fijter, J.W. de; Betjes, M.G.H.; Heidt, S.; Roelen, D.L.; Claas, F.H. & Otten, H.G. (2016), How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?, Hla 88(3): 110-119.
- Carapito, R.; Jung, N.; Kwemou, M.; Untrau, M.; Michel, S.; Pichot, A.; Giacometti, G.; Macquin, C.; Ilias, W.; Morlon, A.; Kotova, I.; Apostolova, P.; Schmitt-Graeff, A.; Cesbron, A.; Gagne, K.; Oudshoorn, M.; Holt, B. van der; Labalette, M.; Spierings, E.; Picard, C.; Loiseau, P.; Tamouza, R.; Toubert, A.; Parissiadis, A.; Dubois, V.; Lafarge, X.; Maumy-Bertrand, M.; Bertrand, F.; Vago, L.; Ciceri, F.; Paillard, C.; Querol, S.; Sierra, J.; Fleischhauer, K.; Nagler, A.; Labopin, M.; Inoko, H.; Borne, P.A. von dem; Kuball, J.; Ota, M.; Katsuyama, Y.; Michallet, M.; Lioure, B.; Latour, R.P. de; Blaise, D.; Cornelissen, J.J.; Yakoub-Agha, I.; Claas, F.; Moreau, P.; Milpied, N.; Charron, D.; Mohty, M.; Zeiser, R.; Socie, G. & Bahram, S. (2016), Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD, Blood 128(15): 1979-1986.
- Rekers, N.V.; Filter, J.W. de; Claas, F.H.J. & Eikmans, M. (2016), Mechanisms and risk assessment of steroid resistance in acute kidney transplant rejection, Transplant Immunology 38: 3-14.
- Egmond, A. van; Keur, C. van der; Beelen, E. van; Scherjon, S.A. & Claas, F.H.J. (2016), No direct effect of an elective caesarean section on the phenotypic and functional characteristics of maternal peripheral blood T lymphocytes, Human Immunology 77(10): 898-904.
- Heidt, S. & Claas, F.H.J. (2016), Preventing Memory B Cell Formation: A Story of Mice and Men?, Transplantation 100(8): 1605-1606.
- Reusing, S.B.; Manser, A.R.; Enczmann, J.; Mulder, A.; Claas, F.H.; Carrington, M.; Fischer, J.C.; Borkhardt, A.; Babor, F. & Uhrberg, M. (2016), Selective downregulation of HLA-C and HLA-E in childhood acute lymphoblastic leukaemia, British Journal of Haematology 174(3): 477-480.
- Verduin, E.P.; Brand, A.; Watering, L.M.G. van de; Roelen, D.L.; Kanhai, H.H.H.; Doxiadis, I.I.N.; Claas, F.H.J. & Schonewille, H. (2016), The HLA-DRB1*15 phenotype is associated with multiple red blood cell and HLA antibody responsiveness, Transfusion 56(7): 1849-1856.
- Rowntree, L.; Heuvel, H. van der; Claas, F.; Kotsimbos, T.; Purcell, A. & Mifsud, N. (2016), Understand the role of allo-HLA cross-reactive CD8+T cells in a transplant setting, European Journal of Immunology 46: 551-551.
- Nieuwland, A.J.; Kokje, V.B.C.; Koning, O.H.; Hamming, J.F.; Szuhai, K.; Claas, F.H.J. & Lindeman, J.H.N. (2016), Activation of the vitamin D receptor selectively interferes with calcineurin-mediated inflammation: a clinical evaluation in the abdominal aortic aneurysm, Laboratory Investigation 96(7): 784-790.
- Brand-Schaaf, S.; Langerak-Langerak, J.; Stein, S.; Claas, F.H.J. & Roelen, D.L. (2016), AN INVENTORY OF THE PRESENCE OF PRE-TRANSPLANT DONOR-SPECIFIC HLA ANTIBODIES AS TESTED WITH LUMINEX SINGLE ANTIGEN TESTS OF LIFECODES AND ONE LAMBDA AND THEIR COMPLEMENT VARIANTS, Hla 87(4): 240-240.
- Rekers, N.V.; Bajema, I.M.; Mallat, M.J.K.; Petersen, B.; Anholts, J.D.H.; Swings, G.M.J.S.; Miert, P.P.M.C. van; Kerkhoff, C.; Roth, J.; Popp, D.; Groningen, M.C. van; Baeten, D.; Goemaere, N.; Kraaij, M.D.; Zandbergen, M.; Heidt, S.; Kooten, C. van; Fijter, J.W. de; Claas, F.H.J. & Eikmans, M. (2016), Beneficial Immune Effects of Myeloid-Related Proteins in Kidney Transplant Rejection, American Journal of Transplantation 16(5): 1441-1455.
- Wunderink, H.; Meijden, E. van der; Blij-de Brouwer, C. van der; Mallat, M.; Haasnoot, G.; Zwet, E. van; Claas, E.; Fijter, J. de; Kroes, A.; Arnold, F.; Touze, A.; Claas, F.; Rotmans, J. & Feltkamp, M. (2016), BK Polyomavirus Seroreactivity of Kidney Donors Predicts Viremia and Nephropathy in Recipients., American Journal of Transplantation 16: 356-356.
- Soonawala, D.; Groeneweg, K.; Toorn, F. van der; Heidt, S.; Roelen, D.; Claas, F. & Fijter, J. de (2016), Early Onset Acute Antibody Mediated Rejection (ABMR) Is More Common in Female Than in Male Recipients of a Living Unrelated Donor (LURD) Renal Transplant and Is Associated with the Presence of Preformed Donor Specific Antibodies (DSA)., American Journal of Transplantation 16: 609-610.
- Yang, J.X.; Haasnoot, G.W.; Kooten, C. van; Mallat, M.J.; Fijter, H.W. de; Bajema, I.M.; Claas, F.H.J. & Eikmans, M. (2016), ELEVATED INTRAGRAFT EXPRESSION OF INNATE IMMUNITY AND CELL DEATH-RELATED MARKERS CHARACTERISES DECEASED DONOR CONDITIONS AND IS A RISK FACTOR FOR ADVERSE GRAFT OUTCOME, Hla 87(4): 207-207.
- Eikmans, M.; Yang, J.; Haasnoot, G.; Kooten, C. van; Mallat, M.; Fijter, H. de; Bajema, I. & Claas, F. (2016), Elevated Intragraft Expression of Innate Immunity and Cell Death-Related Markers Characterizes Deceased Donor Conditions and Is a Risk Factor for Adverse Graft Outcome., American Journal of Transplantation 16: 277-277.
- Heidt, S.; Witvliet, M.; Haasnoot, G. & Claas, F. (2016), Highly Sensitized Patients Transplanted via the Eurotransplant Acceptable Mismatch Program Have Excellent Long-Term Graft Survival, American Journal of Transplantation 16: 436-436.
- Meuleman, T.; Cohen, D.; Swings, G.M.J.S.; Veraar, K.; Claas, F.H.J. & Bloemenkamp, K.W.M. (2016), Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage, Journal of Reproductive Immunology 113: 54-60.
- Gielis, E.; Anholts, J.; Fijter, H. de; Bajema, I.; Claas, F. & Eikmans, M. (2016), MicroRNAs in Urinary Sediments as Non-Invasive Tool to Detect Acute Rejection After Kidney Transplantation, American Journal of Transplantation 16: 251-252.
- Gielis, E.M.; Anholts, J.D.H.; Fijter, H.W. de; Bajema, I.M.; Claas, F.H.J. & Eikmans, M. (2016), MICRORNAS IN URINARY SEDIMENTS AS NON-INVASIVE TOOL TO DETECT ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION, Hla 87(4): 207-207.
- Claas, F.H.J.; Lashley, L. & Hoorn, M.L. van der (2016), Oocyte donation pregnancy, a major challenge for the maternal immune system, Journal of Reproductive Immunology 115: 40-40.
- Zwan, A. van der; Norwitz, E.R.; Claas, F.H.J.; Strominger, J.L. & Tilburgs, T. (2016), Perforin-low decidual CD8+T cells are fully functional upon stimulation, Journal of Reproductive Immunology 115: 44-44.
- Kamburova, E.G.; Wisse, B.W.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.C.; Spierings, E.; Hack, C.E.; Reekum, F. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Drop, A.C.A.D.; Plaisier, L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Vanderlocht, J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E. van; Gelens, M.; Christiaans, M.; Ittersum, F. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.T.; Pant, K.A.M.I. van der; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.J.; Fijter, J.W. de; Betjes, M.G.H.; Roelen, D.L.; Claas, F.H.J. & Otten, H.G. (2016), PRE-TRANSPLANT DONOR SPECIFIC HLA ANTIBODIES IN 4386 RENAL TRANSPLANT RECIPIENTS: A PRELIMINARY ANALYSIS OF THE PROCARE COHORT, Hla 87(4): 225-226.
- Egmond, A. van; Keur, C. van der; Swings, G.M.J.S.; Scherjon, S.A. & Claas, F.H.J. (2016), The possible role of virus-specific CD8(+) memory T cells in decidual tissue, Journal of Reproductive Immunology 113: 1-8.
- Yang, J.X.; Kemps-Mols, B.M.; Spruyt-Gerritse, M.J.; Anholts, J.D.H.; Claas, F.H.J. & Eikmans, M. (2016), THE SOURCE OF SYBR GREEN MASTER MIX DETERMINES OUTCOME OF NUCLEIC ACID AMPLIFICATION REACTIONS, Hla 87(4): 285-286.
- Lashley, L.E.E.L.O.; Buurma, A.; Swings, G.M.J.S.; Eikmans, M.; Anholts, J.D.H.; Bakker, J.A. & Claas, F.H.J. (2016), Three is a crowd: Complication after oocyte donation, Journal of Reproductive Immunology 115: 89-89.
- Craenmehr, M.H.C.; Heidt, S.; Eikmans, M. & Claas, F.H.J. (2016), What is wrong with the regulatory T cells and foetomaternal tolerance in women with recurrent miscarriages?, HLA: Immune Response Genetics 87(2): 69-78.
- Heutinck, K.M.; Yong, S.L.; Tonneijck, L.; Heuvel, H. van den; Weerd, N.C. van der; Pant, K.A.M.I. van der; Bemelman, F.J.; Claas, F.H.J. & Berge, I.J.M. ten (2016), Virus-Specific CD8(+) T Cells Cross-Reactive to Donor-Alloantigen Are Transiently Present in the Circulation of Kidney Transplant Recipients Infected With CMV and/or EBV, American Journal of Transplantation 16(5): 1480-1491.
- Prins, J.R.; Hoorn, M.L.P. van der; Keijser, R.; Ris-Stalpers, C.; Beelen, E. van; Afink, G.B.; Claas, F.H.J.; Post, J.A.M. van der & Scherjon, S.A. (2016), Higher decidual EBI3 and HLA-G mRNA expression in preeclampsia: Cause or consequence of preeclampsia, Human Immunology 77(1): 68-70.
- Breman, E.; Ruben, J.M.; Franken, K.L.; Heemskerk, M.H.M.; Roelen, D.L.; Claas, F.H. & Kooten, C. van (2016), Uptake of HLA Alloantigens via CD89 and CD206 Does Not Enhance Antigen Presentation by Indirect Allorecognition, Journal of Immunology Research.
- Karahan, G.E.; Vaal, Y. de; Krop, J.; Roelen, D.; Claas, F. & Heidt, S. (2016), TAKING THE HLA-SPECIFIC MEMORY B CELL ELISPOT TO THE NEXT LEVEL: ASSAYING THE FULL DONOR HLA REPERTOIRE, Human Immunology 77: 22-22.
- Rodova, M.; Slavcev, A.; Kolesar, L.; Janatova, K.; Viklicky, O.; Bloudickova, S.; Zoet, Y.; Roelen, D. & Claas, F. (2015), INTERNATIONAL COLLABORATION ON PROVIDING THE CHANCE FOR A TRANSPLANT OF HIGHLY SENSITIZED PATIENS - THE EUROSTAM PROJECT, Transplant International 28: 818-818.
- Wunderink, H.F.; Meijden, E. van der; Blij-de Brouwer, C.S. van der; Touze, A.; Mallat, M.J.; Haasnoot, G.W.; Zwet, E.W. van; Claas, E.C.J.; Fijter, J.W. de; Kroes, A.C.M.; Claas, F.H.J.; Rotmans, J.I. & Feltkamp, M.C.W. (2015), BK-polyomavirus seroreactivity measured in kidney donors is strongly associated with incidence of viremia and nephropathy in their recipients, Journal of Clinical Virology 70: S19-S20.
- Lashley, L.E.E.L.O.; Haasnoot, G.W.; Spruyt-Gerritse, M. & Claas, F.H.J. (2015), Selective advantage of HLA matching in successful uncomplicated oocyte donation pregnancies, Journal of Reproductive Immunology 112: 29-33.
- Reinders, M.E.J.; Dreyer, G.J.; Bank, J.R.; Roelofs, H.; Heidt, S.; Roelen, D.L.; Zandvliet, M.L.; Huurman, V.A.L.; Fibbe, W.E.; Kooten, C. van; Claas, F.H.J.; Rabelink, T.J. & Fijter, J.W. de (2015), Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study, Journal of Translational Medicine 13.
- Heidt, S.; Witvliet, M.D.; Haasnoot, G.W. & Claas, F.H.J. (2015), The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patients, Transplant Immunology 33(2): 51-57.
- Gielis, E.M.; Ledeganck, K.J.; Winter, B.Y. de; Favero, J. del; Bosmans, J.L.; Claas, F.H.J.; Abramowicz, D. & Eikmans, M. (2015), Cell-Free DNA: An Upcoming Biomarker in Transplantation, American Journal of Transplantation 15(10): 2541-2551.
- Fijter, J.W. de; Holdaas, H.; Lopez, P.; Escrig, C.; Wang, Z.L.; Claas, F.H.J.; Arns, W.; Cruzado, J.M. & Giet, M. van der (2015), DE NOVO DONOR SPECIFIC ANTIBODIES AND ASSOCIATION WITH KIDNEY ALLOGRAFT REJECTION AFTER EARLY SWITCH FROM CALCINEURIN INHIBITOR TO EVEROLIMUS: ANALYSIS OF THE ELEVATE TRIAL, Transplant International 28: 130-130.
- Duquesnoy, R.J.; Gebel, H.M.; Woodle, E.S.; Nickerson, P.; Baxter-Lowe, L.A.; Bray, R.A.; Claas, F.H.J.; Eckels, D.D.; Friedewald, J.J.; Fuggle, S.V.; Gerlach, J.A.; Fung, J.J.; Kamoun, M.; Middleton, D.; Shapiro, R.; Tambur, A.R.; Taylor, C.J.; Tinckam, K. & Zeevi, A. (2015), High-Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms, American Journal of Transplantation 15(10): 2780-2781.
- Karahan, G.; Vaal, Y.J.H. de; Roelen, D.L.; Buchli, R.; Claas, F.H.J. & Heidt, S. (2015), QUANTIFICATION OF HLA CLASS II-SPECIFIC B CELLS IN SENSITIZED INDIVIDUALS, Transplant International 28: 39-39.
- Graav, G. de; Dieterich, M.; Hesselink, D.; Boer, K.; Clahsen-Van Groningen, M.; Kraaijeveld, R.; Litjens, N.; Bouamar, R.; Vanderlocht, J.; Tilanus, M.; Houba, I.; Roelen, D.; Claas, F.; Betjes, M.; Weimar, W. & Baan, C. (2015), FOLLICULAR T HELPER CELLS AND HUMORAL REACTIVITY IN KIDNEY TRANSPLANT PATIENTS, Transplant International 28: 58-58.
- Meuleman, T.; Snaterse, G.; Beelen, E. van; Anholts, J.D.H.; Pilgram, G.S.K.; Westerlaken, L.A.J. van der; Eikmans, M. & Claas, F.H.J. (2015), The immunomodulating effect of seminal plasma on T cells, Journal of Reproductive Immunology 110: 109-116.
- Lashey, L.E.E.L.O.; Buurma, A.; Swings, G.M.J.S.; Eikmans, M.; Anholts, J.D.H.; Bakker, J.A. & Claas, F.H.J. (2015), Three is a crowd; complication after oocyte donation (I), Journal of Reproductive Immunology 111: 18-18.
- Lashley, L.E.E.L.O.; Haasnoot, G.W.; Spruyt-Gerritse, M. & Claas, F.H. (2015), Three is a crowd; complication after oocyte donation (II), Journal of Reproductive Immunology 111: 21-21.
- D'Orsogna, L.; Miert, P. van; Almeida, C.A.; Heuvel, L. van den; Meer-Prins, E. van der; John, M.; Witt, C. & Claas, F. (2015), A NOVEL ASSAY FOR THE DETECTION OF ALLO-HLA CROSSREACTIVITY BY VIRUS-SPECIFIC MEMORY T CELLS, Tissue Antigens 85(5): 307-307.
- Meuleman, T.; Cohen, D.; Swings, G.; Veraar, K.; Claas, F. & Bloemenkamp, K. (2015), Complement C4d as a Footprint of Aberrant Maternal Anti-Fetal Immunity in Recurrent Miscarriage., Reproductive Sciences 22: 382A-382A.
- Roelen, D.; Dreyer, G.; Reinders, M.; Brand, S.; Dekkers, O.; Claas, F. & Fijter, H. de (2015), DE NOVO DONOR-SPECIFIC HLA ANTIBODIES AFTER KIDNEY TRANSPLANTATION ARE ASSOCIATED WITH DONATION AFTER CIRCULATORY DEATH AND HLA-DQ MISMATCH, Tissue Antigens 85(5): 406-406.
- D'Orsogna, L.; Almeida, C.A.; Miert, P. van; John, M.; Witt, C. & Claas, F. (2015), DRUG INDUCED ALLOREACTIVITY: A NEW PARADIGM FOR ALLORECOGNITION, Tissue Antigens 85(5): 301-301.
- D'Orsogna, L.; Almeida, C.A.; Miert, P. van; John, M.; Witt, C. & Claas, F. (2015), ALLO-HLA REACTIVITY BY HIV-SPECIFIC T CELLS: A POTENTIAL ADJUNCT TO HIV VACCINE DESIGN?, Tissue Antigens 85(5): 302-302.
- Graav, G.N. de; Dieterich, M.; Hesselink, D.A.; Boer, K.; Clahsen-van Groningen, M.C.; Kraaijeveld, R.; Litjens, N.H.R.; Bouamar, R.; Vanderlocht, J.; Tilanus, M.; Houba, I.; Boonstra, A.; Roelen, D.L.; Claas, F.H.J.; Betjes, M.G.H.; Weimar, W. & Baan, C.C. (2015), Follicular T helper cells and humoral reactivity in kidney transplant patients, Clinical and Experimental Immunology 180(2): 329-340.
- Tambur, A.R. & Claas, F.H.J. (2015), HLA Epitopes as Viewed by Antibodies: What Is it All About?, American Journal of Transplantation 15(5): 1148-1154.
- Reagan, J.L.; Fast, L.D.; Nevola, M.; Mantripragada, K.; Mulder, A.; Claas, F.H.J.; Rosati, K.; Schumacher, A.; Safran, H.; Young, C.T.; Quesenberry, M.I.; Winer, E.S.; Butera, J.N. & Quesenberry, P.J. (2015), Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia, Blood Cancer Journal 5.
- Graav, G. de; Dieterich, M.; Hesselink, D.; Boer, K.; Chlasen-van Groningen, M.; Kraaijeveld, R.; Litjens, N.; Bouamar, R.; Vanderlocht, J.; Tilanus, M.; Boonsta, A.; Roelen, D.; Claas, F.; Betjes, M.; Weimar, W. & Baan, C. (2015), FOLLICULAR (CD4+CXCR5+) T HELPER CELLS AND DONOR SPECIFIC ANTIBODIES (DSA) IN KIDNEY TRANSPLANT PATIENTS., Transplantation 99(11): S38-S38.
- Karahan, G.; Vaal, Y. de; Krop, J.; Roelofs, H.; Claas, F. & Heidt, S. (2015), MEMORY B CELLS TRANSFERRED BY ALLOGENEIC BONE MARROW TRANSPLANTATION MAY CONTRIBUTE TO THE ANTIBODY REPERTOIRE OF THE RECIPIENT, Tissue Antigens 85(5): 311-312.
- Kosmoliaptsis, V.; Joris, M.M.; Mallon, D.H.; Lankester, A.C.; Borne, P.A. von dem; Kuball, J.; Bierings, M.; Cornelissen, J.J.; Groenendijk-Sijnke, M.E.; Holt, B. van der; Bradley, J.A.; Oudshoorn, M.; Rood, J.J. van; Taylor, C.J. & Claas, F.H.J. (2015), Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT, Bone Marrow Transplantation 50(4): 540-544.
- Duquesnoy, R.J.; Kamoun, M.; Baxter-Lowe, L.A.; Woodle, E.S.; Bray, R.A.; Claas, F.H.J.; Eckels, D.D.; Friedewald, J.J.; Fuggle, S.V.; Gebel, H.M.; Gerlach, J.A.; Fung, J.J.; Middleton, D.; Nickerson, P.; Shapiro, R.; Tambur, A.R.; Taylor, C.J.; Tinckam, K. & Zeevi, A. (2015), Should HLA Mismatch Acceptability for Sensitized Transplant Candidates Be Determined at the High-Resolution Rather Than the Antigen Level?, American Journal of Transplantation 15(4): 923-930.
- Heide, A.; Verduijn, W.; Haasnoot, G.; Drabbels, J.; Lammers, G. & Claas, F. (2015), HLA dosage effect in narcolepsy with cataplexy, Immunogenetics 67(1): 1-6.
- Abramowicz, D.; Cochat, P.; Claas, F.H.J.; Heemann, U.; Pascual, J.; Dudley, C.; Harden, P.; Hourmant, M.; Maggiore, U.; Salvadori, M.; Spasovski, G.; Squifflet, J.P.; Steiger, J.; Torres, A.; Viklicky, O.; Zeier, M.; Vanholder, R.; Biesen, W. van & Nagler, E. (2015), European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care, Nephrology Dialysis Transplantation 30(11): 1790-1797.
- Brand-Schaaf, S.; Brand-Schaaf, S.H.; Ammerlaan, C.; Langerak-Langerak, J.; Stein, S.; Claas, F.H.J. & Roelen, D.L. (2015), VALIDATION OF FLOW CYTOMETRIC CROSS MATCH WITH THE BD ACCURI C6, Tissue Antigens 85(5): 405-405.
- Genders, R.E.; Mazlom, H.; Michel, A.; Plasmeijer, E.I.; Quint, K.D.; Pawlita, M.; Meijden, E. van der; Waterboer, T.; Fijter, H. de; Claas, F.H.; Wolterbeek, R.; Feltkamp, M.C.W. & Bavinck, J.N.B. (2015), The Presence of Betapapillomavirus Antibodies around Transplantation Predicts the Development of Keratinocyte Carcinoma in Organ Transplant Recipients: A Cohort Study, Journal of Investigative Dermatology 135(5): 1275-1282.
- Karahan, G.E.; Vaal, Y.J.H. de; Roelen, D.L.; Buchli, R.; Claas, F.H.J. & Heidt, S. (2015), Quantification of HLA class II-specific memory B cells in HLA-sensitized individuals, Human Immunology 76(2-3): 129-136.
- Israeli, M.; Roelen, D.L.; Loewenthal, R.; Klein, T.; Haasnoot, G.W.; Witvliet, M.D.; Mor, E.; Hadas, L. & Claas, F.H.J. (2015), POPULATION-DEPENDENT DIFFERENTIAL IMMUNOGENICITY OF HLA MISMATCHES: RATIONALE FOR SHARING ORGANS ACROSS POPULATIONS, Tissue Antigens 85(5): 406-406.
- Cassidy, S.; Mukherjee, S.; Myint, T.M.; Mbiribindi, B.; North, H.; Traherne, J.; Mulder, A.; Claas, F.H.J.; Purbhoo, M.A.; , J. das & Khakoo, S.I. (2015), Peptide selectivity discriminates NK cells from KIR2DL2-and KIR2DL3-positive individuals, European Journal of Immunology 45(2): 492-500.
- Meuleman, T.; Lashley, L.E.L.O.; Dekkers, O.M.; Lith, J.M.M. van; Claas, F.H.J. & Bloemenkamp, K.W.M. (2015), HLA associations and HLA sharing in recurrent miscarriage: A systematic review and meta-analysis, Human Immunology 76(5): 362-373.
- Verduin, E.P.; Brand, A.; Watering, L.M.G. van de; Claas, F.H.J.; Oepkes, D.; Lopriore, E.; Doxiadis, I.I.N. & Schonewille, H. (2015), Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions, British Journal of Haematology 168(3): 443-451.
- D'Orsogna, L.J.; Claas, F.H.J.; John, M.; Almeida, C.A.; Miert, P. van; Fernandez, S. & Zoet, Y. (2015), DRUG INDUCED ALLOREACTIVITY: A NEW PARADIGM FOR ALLORECOGNITION, Human Immunology 76: 72-72.
- Karahan, G.E.; Claas, F.H.J. & Heidt, S. (2015), Detecting the Humoral Alloimmune Response: We Need More Than Serum Antibody Screening, Transplantation 99(5): 908-915.
- Punwani, D.; Wang, H.P.; Chan, A.Y.; Cowan, M.J.; Mallott, J.; Sunderam, U.; Mollenauer, M.; Srinivasan, R.; Brenner, S.E.; Mulder, A.; Claas, F.H.J.; Weiss, A. & Puck, J.M. (2015), Combined Immunodeficiency Due to MALT1 Mutations, Treated by Hematopoietic Cell Transplantation, Journal of Clinical Immunology 35(2): 135-146.
- Heidt, S.; Vergunst, M.; Anholts, J.D.H.; Reinders, M.E.J.; Fijter, J.W. de; Eikmans, M. & Claas, F.H.J. (2015), B Cell Markers of Operational Tolerance Can Discriminate Acute Kidney Allograft Rejection From Stable Graft Function, Transplantation 99(5): 1058-1064.
- Israeli, M.; Roelen, D.L.; Carrington, M.; Petersdorf, E.W.; Claas, F.H.J.; Haasnoot, G.W. & Oudshoorn, M. (2015), ASSOCIATION BETWEEN CTL PRECURSOR FREQUENCY TO HLA-C MISMATCHES AND HLA-C ANTIGEN CELL SURFACE EXPRESSION, Human Immunology 76(4): 212-212.
- D'Orsogna, L.J.; Claas, F.H.J.; John, M.; Almeida, C.A.; Miert, P. van; Fernandez, S. & Zoet, Y. (2015), ALLO-HLA REACTIVITY BY HIV-SPECIFIC T-CELLS: A POTENTIAL ADJUNCT TO HIV VACCINE DESIGN?, Human Immunology 76: 9-9.
- Israeli, M.; Oudshoorn, M.; Haasnoot, G.W.; Klein, T.; Zisser, B.; Bach, G. & Claas, F.H.J. (2015), AGE DEPENDENT HLA PROFILES IN A WORLD OF POPULATION MIGRATION: IMPACT ON HEMATOPOIETIC CELL DONOR RECRUITMENT AND AVAILABILITY, Human Immunology 76(4): 213-213.
- Daga, S.; Lowe, D.; Buchli, R.; Collard, J.; Mulder, A.; McMurtrey, C.; Moyse, H.; Evans, N.; Krishnan, N.; Hildebrand, W.; Claas, F.; Briggs, D.; Zehnder, D.; Mitchell, D. & Higgins, R. (2015), Differences in Reactivity of HLA-Specific Antibodies May Be Explained By Differences in Their Affinities for Selected Epitopes on HLA Proteins, American Journal of Transplantation 15.
- Bank, J.; Mallat, M.; Boog, P. van der; Braat, D.; Ringers, J.; Vergunst, M.; Heidt, S.; Claas, F.; Reinders, M. & Fijter, J. de (2015), Inadequate Overall Immunosuppression Is a Risk for Late Acute Rejection Despite Alemtuzumab Induction in Simultaneous Pancreas Kidney Transplant Recipients, American Journal of Transplantation 15.
- Daga, S.; Lowe, D.; Buchli, R.; Collard, J.; Mulder, A.; McMurtrey, C.; Moyse, H.; Evans, N.; Krishnan, N.; Hildebrand, W.; Claas, F.; Briggs, D.; Zehnder, D.; Mithcell, D. & Higgins, R. (2015), Measuring Affinity of Polyclonal HLA-Specific Antibodies in Highly Sensitised Cases Can Serve as an Additional Biomarker to Guide Direct Transplantation, American Journal of Transplantation 15.
- Heuvel, H. van den; Meer-Prins, E. van der & Claas, F. (2015), CROSS-REACTIVE VIRUS-INDUCED CD8+T CELLS EXHIBIT DIFFERENT T-CELL RECEPTOR AFFINITIES FOR ALLOGENEIC HLA ANTIGENS AND VIRAL EPITOPES, Tissue Antigens 85(5): 303-303.
- Lashley, L.E.E.; Buurma, A.; Swings, G.; Eikmans, M.; Anholts, J.; Bakker, J. & Claas, F.H.J. (2015), Preeclampsia in autologous and oocyte donation pregnancy: is there a different pathophysiology?, Human Reproduction 30: 292-293.
- Lashley, L.E.E.L.O.; Buurma, A.; Swings, G.M.J.S.; Eikmans, M.; Anholts, J.D.H.; Bakker, J.A. & Claas, F.H.J. (2015), Preeclampsia in autologous and oocyte donation pregnancy: is there a different pathophysiology?, Journal of Reproductive Immunology 109: 17-23.
- Snanoudj, R.; Claas, F.H.J.; Heidt, S.; Legendre, C.; Chatenoud, L. & Candon, S. (2015), Restricted specificity of peripheral alloreactive memory B cells in HLA-sensitized patients awaiting a kidney transplant, Kidney International 87(6): 1230-1240.
- Lashley, L.E.E.L.O.; Keur, C. van der; Beelen, E. van; Schaap, R.; Westerlaken, L.A.J. van der; Scherjon, S.A. & Claas, F.H.J. (2015), Stronger T-Cell Alloreactivity and Diminished Suppressive Capacity of Peripheral Regulatory T Cells in Infertile Women Undergoing In Vitro Fertilization, American Journal of Reproductive Immunology 74(3): 268-278.
- Heuvel, H. van den; Heidt, S.; Roelen, D.L. & Claas, F.H.J. (2015), T-cell alloreactivity and transplantation outcome: a budding role for heterologous immunity?, Current Opinion in Organ Transplantation 20(4): 454-460.
- Breman, E.; Miert, P.P. van; Steen, D.M. van der; Heemskerk, M.H.; Doxiadis, I.I.; Roelen, D.; Claas, F.H. & Kooten, C. van (2014), HLA monomers as a tool to monitor indirect allorecognition., Transplantation.
- Karahan, G.E.; Vaal, Y.J.H. de; Roelen, D.L.; Buchli, R.; Claas, F.H.J. & Heidt, S. (2014), TOWARDS DETECTION OF HLA CLASS II SPECIFIC MEMORY B CELL RESPONSES IN SENSITIZED PATIENTS, Tissue Antigens 84(1): 24-24.
- Nguyen, H. do; Wong, G.; Howard, K.; Claas, F.H.J.; Craig, J.C.; Fidler, S.; D'Orsogna, L.; Chapman, J.R.; Irish, A.; Ferrari, P.; Christiansen, F.T. & Lim, W.H. (2014), Modeling the Benefits and Costs of Integrating an Acceptable HLA Mismatch Allocation Model for Highly Sensitized Patients, Transplantation 97(7): 769-774.
- Lashley, L.E.E.L.O.; Westerlaken, L.A.J. van der; Haasnoot, G.W.; Drabbels, J.J.M.; Spruyt-Gerritse, M.J.; Scherjon, S.A. & Claas, F.H.J. (2014), Maternal HLA-C2 and 14bp insertion in HLA-G is associated with recurrent implantation failure after in vitro fertilization treatment, Tissue Antigens 84(6): 536-544.
- Snanoudj, R.; Candon, S.; Roelen, D.L.; Jais, J.P.; Claas, F.H.; Legendre, C. & Chatenoud, L. (2014), Peripheral B-Cell Phenotype and BAFF Levels are Associated With HLA Immunization in Patients Awaiting Kidney Transplantation, Transplantation 97(9): 917-924.
- Gjorgjimajkoska, O.; Mallon, D.; Jayaraman, J.; Traherne, J.; Trowsdale, J.; Mulder, A.; Claas, F.H.; Taylor, C.J.; Bolton, E.M.; Bradley, A.; Lewis, C.; Parmar, J. & Pettigrew, G.J. (2014), The Duration of Donor CD4 T Cell Chimerism Following Human lung Transplantation Is Not Affected By Human Leukocyte Antigen and Natural Killer Cell Alloreactivity, Journal of Heart and Lung Transplantation 33(4): S255-S255.
- Buchli, R.; Eggers, R.; Padilla, G.L.; Mulder, A.; Jackson, A.; Tambur, A.R.; Claas, F.H.J.; Hildebrand, W.H. & Hogan, M. (2014), THE HLA PROTEIN CHIP - A HIGH PERFORMANCE MICROARRAY PLATFORM FOR ANTIHLA ANTIBODY DETECTION UTILIZING SOLUBLE HLA., Human Immunology 75: 109-109.
- Meuleman, T.; Beelen, E. van; Anholts, J.; Pilgram, G.; Westerlaken, L.A.J. van der; Eikmans, M. & Claas, F.H.J. (2014), The immunomodulating effect of semen on maternal T cells, Journal of Reproductive Immunology 101: 20-20.
- Joris, M.M.; Lankester, A.C.; Borne, P. von dem; Kuball, J.; Bierings, M.; Cornelissen, J.J.; Groenendijk-Sijnke, M.E.; Holt, B. van der; Rood, J.J. van; Oudshoorn, M. & Claas, F.H.J. (2014), Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome, Transplant Immunology 30(2-3): 59-64.
- Laging, M.; Kal-van Gestel, J.A.; Haasnoot, G.W.; Claas, F.H.J.; Wetering, J. van de; IJzermans, J.N.M.; Weimar, W. & Roodnat, J.I. (2014), Transplantation Results of Completely HLA-Mismatched Living and Completely HLA-Matched Deceased-Donor Kidneys Are Comparable, Transplantation 97(3): 330-336.
- Lashley, L.E.E.L.O.; Hoorn, M.L.P. van der; Haasnoot, G.W.; Roelen, D.L. & Claas, F.H.J. (2014), Uncomplicated oocyte donation pregnancies are associated with a higher incidence of human leukocyte antigen alloantibodies, Human Immunology 75(6): 555-560.
- Buchli, R.; Mulder, A.; Jackson, A.; Tambur, A.R.; Duquesnoy, R.J.; McAdams, R.D.; Morris, A.; Eggers, R.; Padilla, G.L.; Zehnder, D.; Lowe, D.P.; Briggs, D.C.; Higgins, R.; Claas, F.H.J.; Hogan, M. & Hildebrand, W.H. (2014), DETERMINATION OF THE CLINICAL USEFULNESS OF HLA NEUTRALIZATION PROFILES., Human Immunology 75: 107-108.
- Heidt, S.; Eikmans, M.; Roelen, D.L.; Kooten, C. van & Claas, F.H.J. (2014), Immunogenetics and immunology of transplantation in Leiden, Transplant Immunology 31(4): 195-199.
- Tafti, M.; Hor, H.; Dauvilliers, Y.; Lammers, G.J.; Overeem, S.; Mayer, G.; Javidi, S.; Iranzo, A.; Santamaria, J.; Peraita-Adrados, R.; Vicario, J.L.; Arnulf, I.; Plazzi, G.; Bayard, S.; Poli, F.; Pizza, F.; Geisler, P.; Wierzbicka, A.; Bassetti, C.L.; Mathis, J.; Lecendreux, M.; Donjacour, C.E.H.M.; Heide, A. van der; Heinzer, R.; Haba-Rubio, J.; Feketeova, E.; Hogl, B.; Frauscher, B.; Beneto, A.; Khatami, R.; Canellas, F.; Pfister, C.; Scholz, S.; Billiard, M.; Baumann, C.R.; Ercilla, G.; Verduijn, W.; Claas, F.H.J.; Dubois, V.; Nowak, J.; Eberhard, H.P.; Pradervand, S.; Hor, C.N.; Testi, M.; Tiercy, J.M.; Kutalik, Z. & EU-NN (2014), DQB1 Locus Alone Explains Most of the Risk and Protection in Narcolepsy with Cataplexy in Europe, SLEEP 37(1): 19-U228.
- Schonewille, H.; Doxiadis, I.I.N.; Levering, W.H.B.M.; Roelen, D.L.; Claas, F.H.J. & Brand, A. (2014), HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies, Transfusion 54(8): 1971-1980.
- Pascual, J.; Abramowicz, D.; Cochat, P.; Claas, F.; Dudley, C.; Harden, P.; Heeman, U.; Hourmant, M.; Maggiore, U.; Salvadori, M.; Spasovski, G.; Squifflet, J.P.; Steiger, J.; Torres, A.; Vanholder, R.; Biesen, W. van; Viklicky, O.; Zeier, M. & Nagler, E. (2014), European Renal Best Practice Guideline on the Management and Evaluation of the Kidney Donor and Recipient, Nefrolog�a 34(3): 293-301.
- Buchli, R.; Mulder, A.; Jackson, A.; Tambur, A.R.; Duquesnoy, R.J.; McAdams, R.D.; Eggers, R.; Padilla, G.L.; Zehnder, D.; Lowe, D.P.; Briggs, D.C.; Higgins, R.; Claas, F.H.J.; Hogan, M. & Hildebrand, W.H. (2014), THE COMPLEXITY OF ANTI-HLA ANTIBODIES IN IMMUNOLOGICAL RESPONSE PATTERNS OF SENSITIZED TRANSPLANT PATIENTS, Human Immunology 75: 84-85.
- Rood, J.J. van; Claas, F.H.J.; Brand, A.; Tilanus, M.G.J. & Kooten, C. van (2014), Half a century of Dutch transplant immunology, Immunology Letters 162(2): 145-149.
- Eikmans, M.; Rekers, N.; Spruyt-Gerritse, M.; Mallat, M.; Zandbergen, M.; Anholts, J.; Bajema, I.; Clahsen-van Groningen, M.; Fijter, J. de; Claas, F. & Heer, E. de (2014), Donor Genotype and Intragraft Expression of CYP3A5 Reflect the Response to Steroid Treatment During Acute Renal Allograft Rejection, Transplantation 98: 261-261.
- Reinders, M.E.J.; Bank, J.R.; Dreyer, G.J.; Roelofs, H.; Heidt, S.; Roelen, D.L.; Huurman, V.A.L.; Lindeman, J.; Kooten, C. van; Claas, F.H.J.; Fibbe, W.E.; Rabelink, T.J. & Fijter, J.W. de (2014), Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients, Journal of Translational Medicine 12.
- Israeli, M.; Oudshoorn, M.; Haasnoot, G.W.; Klein, T.; Zisser, B.; Bach, G. & Claas, F.H.J. (2014), Age-dependent HLA profiles of the Israeli population: impact on hematopoietic cell donor recruitment and availability, Immunogenetics 66(9-10): 525-533.
- Eikmans, M.; Rekers, N.; Bajema, I.; Mallat, M.; Anholts, J.; Swings, G.; Miert, P. van; Kerkhoff, C.; Roth, J.; Kooten, C. van; Clahsen-van Groningen, M.; Fijter, J. de & Claas, F. (2014), Beneficial Effects of High S100A9 Expression On Graft Infiltrating Myeloid Cells in Kidney Transplantation., Transplantation 98: 229-229.
- Heidt, S.; Vergunst, M.; Anholts, J.; Fijter, J. de; Eikmans, M. & Claas, F. (2014), B Cell Markers of Operational Tolerance Can Discriminate Acute Kidney Allograft Rejection From Stable Graft Function., Transplantation 98: 879-879.
- Israeli, M.; Roelen, D.L.; Carrington, M.; Petersdorf, E.W.; Claas, F.H.J. & Oudshoorn, M. (2014), ASSOCIATION BETWEEN CTL PRECURSOR FREQUENCY TO HLA-C MISMATCHES AND HLA-C ANTIGEN CELL SURFACE EXPRESSION, Tissue Antigens 84(1): 42-42.
- Lashley, L.E.E.L.O.; Buurma, A.; Swings, G.M.J.S.; Bakker, J.A. & Claas, F.H.J. (2014), Classical complement activation in oocyte donation pregnancies complicated by preeclampsia, Journal of Reproductive Immunology 102: 49-49.
- Guberina, H.; Rebmann, V.; Dziallas, P.; Dolff, S.; Wohlschlaeger, J.; Heinemann, F.M.; Witzke, O.; Zoet, Y.M.; Claas, F.H.J.; Horn, P.A.; Kribben, A. & Doxiadis, I.I.N. (2014), HLA-E EXPRESSION AND ITS IMPACT ON RENAL TRANSPLANT OUTCOME, Tissue Antigens 84(1): 24-24.
- Groot, N.G. de; Heijmans, C.M.C.; Wiel, M.K. van der; Blokhuis, J.H.; Mulder, A.; Guethlein, L.A.; Doxiadis, G.G.M.; Claas, F.H.J.; Parham, P. & Bontrop, R.E. (2014), FUNCTIONAL PLASTICITY OF THE MHC CLASS I REGION: DUPLICATED B-LOCUS COMPENSATES FOR THE LOSS OF C, Tissue Antigens 84(1): 8-8.
- Heuvel, H. van den; Meer-Prins, E. van der; Heutinck, K.; Berge, I. ten & Claas, F. (2014), CMV- and FLU-Directed CD8+T Cells Mediate Public Cross-Reactive Responses Against Different Allo-HLA Molecules., Transplantation 98: 310-310.
- Israeli, M.; Oudshoorn, M.; Haasnoot, G.W.; Zisser, B.; Bach, G. & Claas, F.H.J. (2014), AGE DEPENDENT IMMUNOGENETIC PROFILES OF THE ISRAELI POPULATION: IMPACT ON HEMATOPOETIC STEM CELL DONOR SELECTION, Tissue Antigens 84(1): 128-129.
- Graav, G. de; Dieterich, M.; Hesselink, D.; Boer, K.; Clahsen, M.; Kraaijeveld, R.; Litjens, N.; Vanderlocht, J.; Tilanus, M.; Roelen, D.; Claas, F.; Betjes, M.; Weimar, W. & Baan, C. (2014), Blocking Follicular T-Helper Cell Driven B-Cell Stimulation By the IL-21-Receptor Antagonist Is a Novel Therapeutic Option in Kidney-Transplant Patients., Transplantation 98: 383-383.
- Karahan, G.E.; Eikmans, M.; Anholts, J.D.H.; Claas, F.H.J. & Heidt, S. (2014), Polyclonal B cell activation for accurate analysis of pre-existing antigen-specific memory B cells, Clinical & Experimental Immunology 177(1): 333-340.
- Heuvel, H. van den; Meer-Prins, E.M.W. van der; Heutinck, K.M.; Berge, I.J.M. ten & Claas, F.H.J. (2014), IDENTIFICATION OF NOVEL PUBLIC CROSS-REACTIVE ALLO-HLA RESPONSES OF CD8+T CELLS DIRECTED AGAINST CMV AND FLU PEPTIDES, Tissue Antigens 84(1): 7-8.
- Otten, H.G.; Joosten, I.; Allebes, W.A.; Meer, A. van der; Hilbrands, L.B.; Baas, M.; Spierings, E.; Hack, C.E.; Reekum, F. van; Zuilen, A.D. van; Verhaar, M.C.; Bots, M.L.; Seelen, M.A.J.; Sanders, J.S.F.; Hepkema, B.G.; Lambeck, A.J.; Bungener, L.B.; Roozendaal, C.; Tilanus, M.G.J.; Vanderlocht, J.; Voorter, C.E.; Wieten, L.; Duijnhoven, E. van; Gelens, M.; Christiaans, M.; Ittersum, F. van; Nurmohamed, A.; Lardy, N.M.; Swelsen, W.T.; Donselaar-van der Pant, K.A.M.I. van; Weerd, N.C. van der; Berge, I.J.M. ten; Bemelman, F.J.; Hoitsma, A.J.; Fijter, J.W. de; Betjes, M.G.H.; Roelen, D.L. & Claas, F.H.J. (2014), The PROCARE consortium: Toward an improved allocation strategy for kidney allografts, Transplant Immunology 31(4): 184-190.
- Breman, E.; Miert, P.P. van; Steen, D.M. van der; Heemskerk, M.H.; Doxiadis, I.I.; Roelen, D.; Claas, F.H. & Kooten, C. van (2014), HLA Monomers as a Tool to Monitor Indirect Allorecognition, Transplantation 97(11): 1119-1127.
- Berge, I. ten; Heutinck, K.; Yapici, U.; Stokman, G.; Florquin, S.; Kooten, C. van; Garcia-Romo, G.; Ruben, J.; Vrie, M. van de; Hilbrands, L.; Michelo, C.; Joosten, I.; Heuvel, H. van den & Claas, F. (2014), The interplay between antiviral immunity and allo-immune reactivity after renal transplantation Consortium between the Centres Amsterdam, Leiden and Nijmegen (ALLOVIR), Transplant Immunology 31(4): 191-194.
- Kort, H. de; Mallat, M.J.K.; Kooten, C. van; Heer, E. de; Brand-Schaaf, S.H.; Wal, A.M. van der; Roufosse, C.; Roelen, D.L.; Bruijn, J.A.; Claas, F.H.; Fijter, J.W. de & Bajema, I.M. (2014), Diagnosis of Early Pancreas Graft Failure via Antibody-Mediated Rejection: Single-Center Experience With 256 Pancreas Transplantations, American Journal of Transplantation 14(4): 936-942.
- Hoorn, M.L.P. van der; Egmond, A. van; Swings, G.M.J.S.; Beelen, E. van; Keur, C. van der; Tirado-Gonzalez, I.; Blois, S.M.; Karumanchid, S.A.; Bianchi, D.W.; Claas, F.H.J. & Scherjon, S.A. (2014), Differential immunoregulation in successful oocyte donation pregnancies compared with naturally conceived pregnancies, Journal of Reproductive Immunology 101: 96-103.
- Guberina, H.; Rebmann, V.; Dziallas, P.; Dolff, S.; Wohlschlaeger, J.; Heinemann, F.M.; Witzke, O.; Zoet, Y.M.; Claas, F.H.J.; Horn, P.A.; Kribben, A. & Doxiadis, I.I.N. (2014), INCREASED HLA-E EXPRESSION DURING ACUTE CELLULAR REJECTION IN RENAL TRANSPLANTS IS ASSOCIATED WITH GREATER LOSS OF RENAL FUNCTION, Nephrology Dialysis Transplantation 29: 531-531.
- Zoet, Y.M.; Witvliet, M.D.; Haasnoot, G.W.; Korfage, N.; Wams, G.; Doxiadis, I.I.N. & Claas, F.J. (2014), EXTERNAL PROFICIENCY TESTING WITHIN EUROTRANSPLANT: TOWARDS A WEB-BASED DATA ENTRY, Tissue Antigens 84(1): 81-81.
- Roelen, D.L.; Brand-Schaaf, S.; Stein, S. & Claas, F.H.J. (2014), DONOR SPECIFIC HLA ANTIBODIES DETECTED BY LUMINEX CANNOT PREDICT THE OUTCOME OF A CDC OR FLOW CYTOMETRIC CROSSMATCH IN AN INDIVIDUAL PATIENT., Tissue Antigens 84(1): 77-77.
- Eikmans, M.; Anholts, J.D.H.; Heidt, S.; Fijter, H.W. de & Claas, F.H.J. (2013), MICRO-RNA PROFILING IN URINARY SEDIMENT OF TRANSPLANT RECIPIENTS WITH ACUTE REJECTION, Tissue Antigens 81(5): 281-282.
- Dierselhuis, M.P.; Spierings, E.; Drabbels, J.; Hendriks, M.; Alaez, C.; Alberu, J.; Alvarez, M.B.; Burlingham, W.; Campos, E.; Christiaans, M.; Claas, F.; Fasano, M.E.; Gerbase-DeLima, M.; Gervais, T.; Gorodezky, C.; Larriba, J.; Lardy, N.M.; Latinne, D.; Morales-Buenrostro, L.E.; Moreno, M.J.; Oguz, F.; Opelz, G.; Sergeant, R.; Tambutti, M.; Teper, S.; Tilanus, M.; Turkmen, A.; Warrens, A.N.; Weimar, W. & Goulmy, E. (2013), Minor H antigen matches and mismatches are equally distributed among recipients with or without complications after HLA identical sibling renal transplantation, Tissue Antigens 82(5): 312-316.
- Verduin, E.P.; Schonewille, H.; Claas, F.; Roelen, R.L.; Doxiadis, I.I.N. & Brand, A. (2013), HLA-DRB1(star)15 IS A MARKER FOR MULTIPLE ANTIBODY RESPONDERS, Vox Sanguinis 105: 21-21.
- Roelen, D.L.; Vaal, Y. de; Vierra-Green, C.; Waldvogel, S.; Spellman, S.R.; Claas, F.H.J. & Oudshoorn, M. (2013), HLA MISMATCHES THAT ARE IDENTICAL FOR THE ANTIGEN RECOGNITION SITE MAY HAVE FUNCTIONAL CONSEQUENCES: THE DRB1*1401/1454 STUDY, Tissue Antigens 81(5): 276-276.
- Nguyen, H.D.; Wong, G.; Howard, K.; Claas, F.; Craig, J.; Fidler, S.; D'Orsogna, L.; Chapman, J.; Irish, A.; Ferrari, P.; Christiansen, F. & Lim, W. (2013), Modelling the benefits and costs of integrating an acceptable HLA mismatch allocation model for highly-sensitised patients, Transplantation 96(10): S266-S266.
- Hilbrands, R.; Gillard, P.; Torren, C.R. van der; Ling, Z.D.; Verheyden, S.; Jacobs-Tulleneers-Thevissen, D.; Roep, B.O.; Claas, F.H.J.; Demanet, C.; Gorus, F.K.; Pipeleers, D. & Keymeulen, B. (2013), Predictive Factors of Allosensitization After Immunosuppressant Withdrawal in Recipients of Long-Term Cultured Islet Cell Grafts, Transplantation 96(2): 162-169.
- Egmond, A. van; Keur, C. van der; Swings, G.M.J.S.; Beelen, E. van; Zijl, L. van; Scherjon, S.A. & Claas, F.H.J. (2013), Preservation of human placenta facilitates multicenter studies on the local immune response in normal and aberrant pregnancies, Journal of Reproductive Immunology 98(1-2): 29-38.
- Groot, N.G. de; Heijmans, C.M.C.; Wiel, M.K. van der; Blokhuis, J.H.; Mulder, A.; Guethlein, L.A.; Doxiadis, G.G.M.; Claas, F.H.; Parham, P. & Bontrop, R.E. (2013), DIFFERENTIAL TRANSCRIPTION PROFILES FOR MHC CLASS I GENES IN ORANGUTANS: NEGLIGIBLE TRANSCRIPTION OF C AND PARTICULAR B LOCUS/LINEAGE IN PERIPHERAL BLOOD DERIVED CELL-LINES., Human Immunology 74: 106-106.
- Snanoudj, R.; Candon, S.; Roelen, D.; Claas, F.; Legendre, C. & Chatenoud, L. (2013), Pre-Transplant HLA Immunization in Kidney Transplant Recipients Is Characterized by an Activated Peripheral B Cell Phenotype and High Serum Levels of BAFF, American Journal of Transplantation 13: 230-230.
- Benitez, C.; Londono, M.C.; Miquel, R.; Manzia, T.M.; Abraldes, J.G.; Lozano, J.J.; Martinez-Llordella, M.; Lopez, M.; Angelico, R.; Bohne, F.; Sese, P.; Daoud, F.; Larcier, P.; Roelen, D.L.; Claas, F.; Whitehouse, G.; Lerut, J.; Pirenne, J.; Rimola, A.; Tisone, G. & Sanchez-Fueyo, A. (2013), Prospective Multicenter Clinical Trial of Immunosuppressive Drug Withdrawal in Stable Adult Liver Transplant Recipients, Hepatology 58(5): 1824-1835.
- Zito, L.; Sizzano, F.; Crivello, P.; Toffalori, C.; Zino, E.; Vago, L.; Crocchiolo, R.; Sacchi, N.; Rambaldi, A.; Ciceri, F.; Claas, F.H.J.; Oudshoorn, M. & Fleischhauer, K. (2013), ENHANCED ALLOREACTIVITY TO BI-DIRECTIONAL NON-PERMISSIVE HLA-DPB1 MISMATCHES SUPPORTS NON-HIERARCHICAL T-CELL EPITOPE GROUP DIVERSITY AS UNDERLYING BIOLOGICAL MECHANISM, Tissue Antigens 81(5): 289-289.
- Mulder, A.; Heidt, S.; Vergunst, M.; Roelen, D.L. & Claas, F.H.J. (2013), Proteasome Inhibition Profoundly Affects Activated Human B Cells, Transplantation 95(11): 1331-1337.
- D'Orsogna, L.J.; Nguyen, T.H.O.; Claas, F.H.J.; Witt, C. & Mifsud, N.A. (2013), Endogenous-peptide-dependent alloreactivity: new scientific insights and clinical implications, Tissue Antigens 81(6): 399-407.
- Griffin, B.D.; Gram, A.M.; Mulder, A.; Leeuwen, D. van; Claas, F.H.J.; Wang, F.; Ressing, M.E. & Wiertz, E. (2013), EBV BILF1 Evolved To Downregulate Cell Surface Display of a Wide Range of HLA Class I Molecules through Their Cytoplasmic Tail, Journal of Immunology 190(4): 1672-1684.
- Guberina, H.; Rebmann, V.; Dziallas, P.; Dolff, S.; Wohlschlaeger, J.; Heinemann, F.M.; Witzke, O.; Zoet, Y.M.; Claas, F.H.J.; Horn, P.A.; Kribben, A. & Doxiadis, I.I.N. (2013), DURING ACUTE CELLULAR REJECTION HLA-E IS EXPRESSED IN KIDNEY GRAFTS, Transplant International 26: 31-31.
- Haasnoot, G.W.; Witvliet, M.D.; Claas, F.H.J. & Doxiadis, I.I.N. (2013), REDUCED HUMORAL RESPONSE TOWARDS HLA-C IS NOT ONLY DUE TO THEIR LOWER EXPRESSION BUT ALSO TO THEIR LOW IMMUNOGENICITY, Tissue Antigens 81(5): 273-273.
- Verhulst, N.O.; Beijleveld, H.; Qiu, Y.T.; Maliepaard, C.; Verduyn, W.; Haasnoot, G.W.; Claas, F.H.J.; Mumm, R.; Bouwmeester, H.J.; Takken, W.; Loon, J.J.A. van & Smallegange, R.C. (2013), Relation between HLA genes, human skin volatiles and attractiveness of humans to malaria mosquitoes.
- Duquesnoy, R.J.; Marrari, M.; Jelenik, L.; Zeevi, A.; Claas, F.H.J. & Mulder, A. (2013), Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays, Human Immunology 74(10): 1271-1279.
- Cheent, K.S.; Jamil, K.M.; Cassidy, S.; Liu, M.Y.; Mbiribindi, B.; Mulder, A.; Claas, F.H.J.; Purbhoo, M.A. & Khakoo, S.I. (2013), Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94, Proceedings of the National Academy of Sciences 110(42): 16981-16986.
- Zoet, Y.M.; Franke, M.E.I.; Witvliet, M.D.; Haasnoot, G.W.; Mulder, A.; Claas, F.H.J. & Doxiadis, I.I.N. (2013), THE CONUNDRUM OF SOLID PHASE SINGLE ANTIGEN IMMUNO ASSAYS (SPI-SA): RESULTS OF A COMPARATIVE ANALYSIS WITH TWO PROVIDERS., Human Immunology 74: 61-61.
- Joris, M.M.; Lankester, A.C.; Borne, P.A.V.; Kuball, J.; Bierings, M.; Cornelissen, J.J.; Groenendijk-Sijnke, M.E.; Holt, B. van der; Haasnoot, G.W.; Zanden, H.G.M. van der; Walraven, S.M. van; Rood, J.J. van; Claas, F.H.J. & Oudshoorn, M. (2013), The impact of frequent HLA haplotypes in high linkage disequilibrium on donor search and clinical outcome after unrelated haematopoietic SCT, Bone Marrow Transplantation 48(4): 483-490.
- Doxiadis, I.I.N. & Claas, F.H.J. (2013), THE NONSENSE OF REFRAINING HLA MATCHING IN POST MORTAL KIDNEY TRANSPLANTATION RESULTS IN INCREASE SENSITIZATION., Human Immunology 74: 61-61.
- Lemy, A.; Lionet, A.; Noel, C.; Couzi, L.; Taupin, J.L.; Merville, P.; Hiesse, C.; Suberbielle-Boissel, C.; Meyer, M. de; Latinne, D.; Racape, J.; Wissing, K.M.; Claas, F.H.J.; Toungouz, M. & Abramowicz, D. (2013), THE NUMBER OF B CELL EPITOPES AS A POSSIBLE TOOL TO IMPROVE THE PREDICTIVE VALUE OF HLA DONOR-SPECIFIC ANTIBODIES DETECTED BY FLOW BEADS ASSAYS, Nephrology Dialysis Transplantation 28: 14-15.
- Buchli, R.; Mulder, A.; Duquesnoy, R.J.; McAdams, R.D.; VanGundy, R.S.; McMurtrey, C.P.; Cate, S.J.; Zehnder, D.; Lowe, D.P.; Briggs, D.; Higgins, R.; Claas, F.H.J. & Hildebrand, W.H. (2013), THE POWER OF DECONVOLUTION - INHIBITION OF ANTI-HLA ANTIBODY REACTIVITIES USING SPECIFIC SOLUBLE HLA MOLECULES AS NEUTRALIZING AGENTS., Human Immunology 74: 131-131.
- Tambur, A.R. & Claas, F.H.J. (2013), Toward HLA Epitope Matching in Clinical Transplantation, American Journal of Transplantation 13(12): 3059-3060.
- Reinders, M.; Fijter, J. de; Roelofs, H.; Vries, D. de; Claas, F.; Miert, P. van; Roelen, D.; Kooten, C. van & Rabelink, T. (2013), Treatment of Renal Transplant Patients with Autologous Bone Marrow Derived Mesenchymal Stromal Cells Downregulates the Donor Specific Mixed Lymphocyte Reaction., American Journal of Transplantation 13: 340-340.
- Kemps-Mols, B.M.; Drabbels, J.J.M.; Keur, C. van der; Claas, F.H.J. & Eikmans, M. (2013), DETECTION OF MATERNAL MICROCHIMERISM IN UMBILICAL CORD BLOOD AS A POSSIBLE PREDICTOR FOR THE ANTI-LEUKEMIC EFFECT, Tissue Antigens 81(5): 268-268.
- Rekers, N.V.; Bajema, I.M.; Mallat, M.J.K.; Anholts, J.D.H.; Vaal, Y.J.H. de; Zandbergen, M.; Haasnoot, G.W.; Zwet, E.W. van; Fijter, J.W. de; Claas, F.H.J. & Eikmans, M. (2013), Increased Metallothionein Expression Reflects Steroid Resistance in Renal Allograft Recipients, American Journal of Transplantation 13(8): 2106-2118.
- Heidt, S.; Schenk, V.; Eikmans, M.; Fijter, H.W. de & Claas, F.H.J. (2013), CXCL9 AND CXCL 10 LEVELS IN URINE ARE SUITABLE PARAMETERS FOR DIAGNOSIS AND PREDICTION OF ACUTE REJECTION, Tissue Antigens 81(5): 266-267.
- Heidt, S.; Schenk, V.; Eikmans, M.; Fijter, H.W. de & Claas, F. (2013), CXCL9 AND CXCL 10 LEVELS IN URINE ARE SUITABLE PARAMETERS FOR DIAGNOSIS AND PREDICTION OF ACUTE REJECTION, Transplant International 26: 135-135.
- Eikmans, M.; Rekers, N.V.; Anholts, J.D.H.; Heidt, S. & Claas, F.H.J. (2013), Blood cell mRNAs and microRNAs: optimized protocols for extraction and preservation, Blood 121(11): E81-E89.
- Witvliet, M.D.; Haasnoot, G.W.; Claas, F.H.J. & Doxiadis, I.I.N. (2013), DEVELOPMENT OF HARDY-WEINBERG IN THE POPULATION OF PATIENTS AWAITING A RENAL TRANSPLANT, Tissue Antigens 81(5): 339-340.
- Heutinck, K.M.; Heuvel, H. van den; Yong, S.L.; Claas, F.H.J. & Berge, I.J.M. ten (2013), FUNCTIONAL ANALYSIS OF VIRUS-SPECIFIC T CELLS WITH CROSS-REACTIVITY TO ALLO-ANTIGENS.
- Heutinck, K.M.; Heuvel, H. den; Yong, S.L.; Claas, F. & Berge, I.J.M. ten (2013), FUNCTIONAL ANALYSIS OF VIRUS-SPECIFIC T CELLS WITH CROSS-REACTIVITY TO ALLO-ANTIGENS, Transplant International 26: 211-211.
- Jolink, H.; Meijssen, I.C.; Hagedoorn, R.S.; Arentshorst, M.; Drijfhout, J.W.; Mulder, A.; Claas, F.H.J.; Dissel, J.T. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2013), Characterization of the T-Cell-Mediated Immune Response Against the Aspergillus fumigatus Proteins Crf1 and Catalase 1 in Healthy Individuals.
- Tait, B.D.; Susal, C.; Gebel, H.M.; Nickerson, P.W.; Zachary, A.A.; Claas, F.H.J.; Reed, E.F.; Bray, R.A.; Campbell, P.; Chapman, J.R.; Coates, P.T.; Colvin, R.B.; Cozzi, E.; Doxiadis, I.I.N.; Fuggle, S.V.; Gill, J.; Glotz, D.; Lachmann, N.; Mohanakumar, T.; Suciu-Foca, N.; Sumitran-Holgersson, S.; Tanabe, K.; Taylor, C.J.; Tyan, D.B.; Webster, A.; Zeevi, A. & Opelz, G. (2013), Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation, Transplantation 95(1): 19-47.
- Glorie, K.M.; Klerk, M. de; Wagelmans, A.P.M.; Klundert, J.J. van de; Zuidema, W.C.; Claas, F.H.J. & Weimar, W. (2013), Coordinating Unspecified Living Kidney Donation and Transplantation Across the Blood-Type Barrier in Kidney Exchange, Transplantation 96(9): 814-820.
- Bestard, O.; Crespo, E.; Stein, M.; Lucia, M.; Roelen, D.L.; Vaal, Y.J. de; Hernandez-Fuentes, M.P.; Chatenoud, L.; Wood, K.J.; Claas, F.H.; Cruzado, J.M.; Grinyo, J.M.; Volk, H.D. & Reinke, P. (2013), Cross-Validation of IFN- Elispot Assay for Measuring Alloreactive Memory/Effector T Cell Responses in Renal Transplant Recipients, American Journal of Transplantation 13(7): 1880-1890.
- Sanchez-Mazas, A.; Buhler, S.; Bekmane, U.; Buus, S.; Claas, F.H.J.; Dormoy, A.; Dubois, V.; Eberhard, H.P.; Eglite, J.; Eliaou, J.F.; Fischer, G.F.; Gonzalez-Galarza, F.; Grubic, Z.; Ivanova, M.; Lie, B.A.; Ligeiro, D.; Little, A.M.; Lokki, M.L.; Marsh, S.G.E.; Silva, B.M. da; Martorell, J.; Mendona, D.; Middleton, D.; Mueller, C.R.; Voniatis, C.P.; Papasteriades, C.; Poli, F.; Riccio, M.E.; Spyropoulou-Vlachou, M.; Sulcebe, G.; Tiercy, J.M.; Tonks, S.; Tordai, A.; Nevessignsky, M.T.; Vangenot, C.; Walraven, A.M. van; Vidan-Jeras, B.; Viken, M. & Nunes, J.M. (2013), HLA-NET: A REAL EXAMPLE OF 'NETWORKING IN IMMUNOGENETICS', Tissue Antigens 81(5): 300-301.
- Verduin, E.P.; Schonewille, H.; Javadi, A.; Claas, F.; Lopriore, E.; Oepkes, D.; Roelen, R.L.; Doxiadis, I.I.N. & Brand, A. (2013), FETAL MICROCHIMERISM MAY PLAY A ROLE IN MATERNAL RED BLOOD CELL ANTIBODY PERSISTENCE, Vox Sanguinis 105: 249-249.
- Flink, M.; Drabbels, J.J.M.; Verduijn, W.; Mulder, W.; Rozemuller, E.H.; Roelen, D.L. & Claas, F.H.J. (2013), FAST AND RELIABLE FOUR-DIGIT-HLA TYPING RESULTS BY A STRATEGY COMBINING LOW-RESOLUTION TYPING DATA WITH A GSSP PREDICTION METHOD, Tissue Antigens 81(5): 309-309.
- Snanoudj, R.; Candon, S.; Roelen, D.; Claas, F.; Legendre, C. & Chatenoud, L. (2013), B-Cell Repopulation after Antithymocyte Globulin Compared with Anti-IL2 Receptor Induction: Increase in Transitional B Cells and BAFF Serum Levels., American Journal of Transplantation 13: 225-226.
- Reinders, M.E.J.; Fijter, J.W. de; Roelofs, H.; Bajema, I.M.; Vries, D.K. de; Schaapherder, A.F.; Claas, F.H.J.; Miert, P.P.M.C. van; Roelen, D.L.; Kooten, C. van; Fibbe, W.E. & Rabelink, T.J. (2013), Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study, Stem Cells Translational Medicine 2(2): 107-111.
- Verduin, E.P.; Schonewille, H.; Brand, A.; Haasnoot, G.W.; Claas, F.H.J.; Lindenburg, I.T.M.; Lopriore, E.; Oepkes, D.; Roelen, D.L. & Doxiadis, I.I.N. (2013), High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with motherchild HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation, Transfusion 53(5): 939-947.
- Rekers, N.; Bajema, I.; Mallat, M.; Anholts, J.; Kerkhoff, C.; Roth, J.; Swings, G.; Groningen, M.; Fijter, H.W. de; Claas, F. & Eikmans, M. (2013), HIGH EXPRESSION OF S100 CALCIUM BINDING PROTEINS A8 AND A9 IN MACROPHAGES DURING ACUTE TRANSPLANT REJECTION IS ASSOCIATED WITH A BENEFICIAL IMMUNE RESPONSE, Transplant International 26: 122-123.
- Zoet, Y.M.; Witvliet, M.D.; Haasnoot, G.W.; Claas, F.H.J. & Doxiadis, I.I.N. (2013), EXTERNAL PROFICIENCY TESTING (EPT) FOR TRANSPLANTATION RELATED HISTOCOMPATIBILITY ASSAYS, Tissue Antigens 81(5): 334-335.
- Eikmans, M.; Anholts, J.D.H.; Heidt, S.; Fijter, J.W. de & Claas, F.H.J. (2013), IDENTIFICATION OF URINARY MICRORNAS THAT ARE DISCRIMINATIVE OF ACUTE REJECTION IN KIDNEY TRANSPLANTATION., Human Immunology 74: 29-29.
- Rekers, N.V.; Bajema, I.M.; Mallat, M.; Anholts, J.D.H.; Kerkhoff, C.; Roth, J.; Swings, G.M.J.S.; Groningen, M.C. van; Fijter, H.W. de; Claas, F.H.J. & Eikmans, M. (2013), HIGH EXPRESSION OF S100 CALCIUM BINDING PROTEINS A8 AND A9 IN MACROPHAGES DURING ACUTE TRANSPLANT REJECTION IS ASSOCIATED WITH A BENEFICIAL IMMUNE RESPONSE, Tissue Antigens 81(5): 279-280.
- Buchli, R.; Mulder, A.; Duquesnoy, R.J.; McAdams, R.D.; VanGundy, R.S.; McMurtrey, C.P.; Cate, S.J.; Zehnder, D.; Lowe, D.P.; Briggs, D.; Higgins, R.; Claas, F.H.J. & Hildebrand, W.H. (2013), HLA ANTIBODY TITRATION ANALYSIS THE FIRST STEP IN QUANTITATIVE SIGNAL PATTERN INTERPRETATION., Human Immunology 74: 131-131.
- Stevanovic, S.; Bergen, C.A.M. van; Luxemburg-Heijs, S.A.P. van; Zouwen, B. van der; Jordanova, E.S.; Kruisselbrink, A.B.; Meent, M.V. de; Harskamp, J.C.; Claas, F.H.J.; Marijt, E.W.A.; Zwaginga, J.J.; Halkes, C.J.M.; Jedema, I.; Griffioen, M. & Falkenburg, J.H.F. (2013), HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+donor lymphocyte infusion, Blood 122(11): 1963-1973.
- Donckier, V.; Craciun, L.; Miqueu, P.; Troisi, R.I.; Lucidi, V.; Rogiers, X.; Boon, N.; Degre, D.; Buggenhout, A.; Moreno, C.; Gustot, T.; Sainz-Barriga, M.; Bourgeois, N.; Colle, I.; Vlierberghe, H. van; Amrani, M.; Remmelink, M.; Lemmers, A.; Roelen, D.L.; Claas, F.H.; Reinke, P.; Sawitzki, B.; Volk, H.D.; Moine, A. le; Hemptinne, B. de & Goldman, M. (2013), Expansion of Memory-Type CD8(+) T Cells Correlates With the Failure of Early Immunosuppression Withdrawal After Cadaver Liver Transplantation Using High-Dose ATG Induction and Rapamycin, Transplantation 96(3): 306-315.
- Heidt, S.; Vergunst, M.; Anholts, J.D.H.; Eikmans, M.; Fijter, H.W. de & Claas, F.I.J. (2013), EVIDENCE FOR A POSSIBLE ROLE OF MEMORY B CELLS IN ACUTE KIDNEY GRAFT REJECTION, Human Immunology 74: 47-47.
- Roelen, D.; Vaal, Y. de; Vierra-Green, C.; Waldvogel, S.; Spellman, S.; Claas, F. & Oudshoorn, M. (2013), A NEXT GENERATION HLA SEQUENCING METHOD PROVIDES ROBUST RELIABLE CLASS II TYPING OF AN HSCT COHORT., Human Immunology 74: 12-12.
- Susal, C.; Roelen, D.L.; Fischer, G.; Campos, E.F.; Gerbase-DeLima, M.; Honger, G.; Schaub, S.; Lachmann, N.; Martorell, J. & Claas, F. (2013), Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients, Tissue Antigens 82(2): 83-92.
- Askar, M.; Daghstani, J.; Thomas, D.; Leahy, N.; Dunn, P.; Claas, F.; Doran, S.; Saji, H.; Kanangat, S.; Karoichane, M.; Tambur, A.; Monos, D.; El-Khalifa, M.; Turner, V.; Kamoun, M.; Mustafa, M.; Ramon, D.; Gandhi, M.; Vernaza, A.; Gorodezky, C.; Wagenknecht, D.; Gautreaux, M.; Hajeer, A.; Kashi, Z. & Fernandez-Vina, M. (2013), 16th IHIW: Global distribution of extended HLA haplotypes, International Journal of Immunogenetics 40(1): 31-38.
- Lashley, E.E.L.O.; Meuleman, T. & Claas, F.H.J. (2013), Beneficial or Harmful Effect of Antipaternal Human Leukocyte Antibodies on Pregnancy Outcome? A Systematic Review and Meta-Analysis, American Journal of Reproductive Immunology 70(2): 87-103.
- Nguyen, H.D.; Wong, G.; Howard, K.; Claas, F.H.J.; Craig, J.; Fidler, S.; D'Orsogna, L.; Chapman, J.; Irish, A. & Ferrari, P. (2013), BENEFITS AND COSTS OF AN ACCEPTABLE HUMAN LEUKOCYTE ANTIGEN MISMATCH PROGRAM IN AUSTRALIA, Nephrology 18: 17-17.
- Verduijn, W.; Heide, A. van der; Drabbels, J.J.M.; Haasnoot, G.W.; Roelen, D.L.; Lammers, G.J. & Claas, F.H.J. (2013), EVIDENCE FOR A MODULATING EFFECT OF THE TRANS DQB1-DQA1 ALLELES ON THE SUSCEPTIBILITY FOR NARCOLEPSY WITH CATAPLEXY IN DQB1*06:02-DQA1*01:02-POSITIVE PATIENTS, Tissue Antigens 81(5): 283-283.
- Heuvel, H. van den; Meer-Prins, E.M.W. van der; Heutinck, K.M.; Berge, I.J.M. ten; Doxiadis, I.I.N. & Claas, F.H.J. (2013), IMMUNE REACTIVITY OF AN INDIVIDUAL AGAINST VIRUSES INDUCES A BROAD REPERTOIRE OF ALLOREACTIVE MEMORY T CELLS, Tissue Antigens 81(5): 266-266.
- Drabbels, J.J.M.; Spruyt-Gerritse, M.J.; Mirabile, M.; Haasnoot, G.W.; Roelen, D.L.; Claas, F.H.J. & Eikmans, M. (2013), INTRODUCTION OF REAL-TIME PCR IN DIAGNOSTIC HLA LABORATORIES, Tissue Antigens 81(5): 323-324.
- Gjorgjimajkoska, O.; Mallon, D.; Sharples, L.D.; Jayaraman, J.; Traherne, J.; Trowsdale, J.; Mulder, A.; Claas, F.; Bolton, E.M.; Taylor, C.J.; Bradley, J.A.; Lewis, C.; Parmar, J. & Pettigrew, G.J. (2013), KILLER IMMUNOGLOBULIN-LIKE RECEPTOR (KIR)-LIGAND MISMATCHES DO NOT AFFECT THE DURATION OF PERIPHERAL BLOOD DONOR CD4 T CELL CHIMERISM FOLLOWING LUNG TRANSPLANTATION, Transplant International 26: 179-179.
- Karahan, G.E.; Claas, F.H.J. & Heidt, S. (2013), KINETICS OF POLYCLONALLY STIMULATED NAIVE AND MEMORY B-CELL RESPONSES, Tissue Antigens 81(5): 280-281.
- Roelen, D.; Rowshani, A.; Brand-Schaaf, S.; Wetering, J. van der; Roodnat, J.; Stein, S.; Weimar, W. & Claas, F. (2012), RENAL TRANSPLANTATION IN THE PRESENCE OF ANTI-HLA ANTIBODIES, Human Immunology 73: 78-78.
- Rekers, N.V.; Bajema, I.M.; Mallat, M.J.K.; Zuidwijk, K.; Anholts, J.D.H.; Goemaere, N.; Haasnoot, G.W.; Groningen, M.C. van; Kooten, C. van; Fijter, J.W. de; Claas, F.H.J. & Eikmans, M. (2012), Quantitative Polymerase Chain Reaction Profiling of Immunomarkers in Rejecting Kidney Allografts for Predicting Response to Steroid Treatment, Transplantation 94(6): 596-602.
- Eikmans, M.; Canck, I. de; Pol, P. van der; Baan, C.C.; Haasnoot, G.W.; Mallat, M.J.K.; Vergunst, M.; Meester, E. de; Roodnat, J.I.; Anholts, J.D.H.; Thielen, M. van; Doxiadis, I.I.N.; Fijter, J.W. de; Linden, P.J.E. van der; Beelen, E. van; Kooten, C. van; Kal-van Gestel, J.A.; Peeters, A.M.A.; Weimar, W.; Roelen, D.L.; Rossau, R. & Claas, F.H.J. (2012), The Functional Polymorphism Ala258Ser in the Innate Receptor Gene Ficolin-2 in the Donor Predicts Improved Renal Transplant Outcome, Transplantation 94(5): 478-485.
- Roodnat, J.I.; Wetering, J. van de; Claas, F.H.; IJzermans, J. & Weimar, W. (2012), Persistently low transplantation rate of ABO blood type O and highly sensitised patients despite alternative transplantation programs.
- Joris, M.M.; Bierings, M.B.; Egeler, R.M.; Claas, F.H.J.; Rood, J.J. van & Oudshoorn, M. (2012), Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group, Bone Marrow Transplantation 47(5): 677-683.
- Sanchez-Mazas, A.; Vidan-Jeras, B.; Nunes, J.M.; Fischer, G.; Little, A.M.; Bekmane, U.; Buhler, S.; Buus, S.; Claas, F.H.J.; Dormoy, A.; Dubois, V.; Eglite, E.; Eliaou, J.F.; Gonzalez-Galarza, F.; Grubic, Z.; Ivanova, M.; Lie, B.; Ligeiro, D.; Lokki, M.L.; Silva, B.M. da; Martorell, J.; Mendonca, D.; Middleton, D.; Voniatis, D.P.; Papasteriades, C.; Poli, F.; Riccio, M.E.; Vlachou, M.S.; Sulcebe, G.; Tonks, S.; Nevessignsky, M.T.; Vangenot, C.; Walraven, A.M. van & Tiercy, J.M. (2012), Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations, International Journal of Immunogenetics 39(6): 459-476.
- Heidt, S.; Roelen, D.L.; Vaal, Y.J.H. de; Kester, M.G.D.; Eijsink, C.; Thomas, S.; Besouw, N.M. van; Volk, H.D.; Weimar, W.; Claas, F.H.J. & Mulder, A. (2012), A Novel ELISPOT Assay to Quantify HLA-Specific B Cells in HLA-Immunized Individuals, American Journal of Transplantation 12(6): 1469-1478.
- Roelen, D.L.; Doxiadis, I.I.N. & Claas, F.H.J. (2012), Detection and clinical relevance of donor specific HLA antibodies: a matter of debate.
- Duquesnoy, R.J.; Marrari, M.; Mulder, A. & Claas, F. (2012), REACTIVITY OF HLA EPITOPE-SPECIFIC ANTIBODIES IN IG-BINDING, C1Q-BINDING AND LYMPHOCYTOTOXICITY ASSAYS, Human Immunology 73: 13-13.
- Rooijen, D.E. van; Roelen, D.L.; Verduijn, W.; Haasnoot, G.W.; Huygen, F.J.P.M.; Perez, R.S.G.M.; Claas, F.H.J.; Marinus, J.; Hilten, J.J. van & Maagdenberg, A.M.J.M. van den (2012), Genetic HLA Associations in Complex Regional Pain Syndrome With and Without Dystonia, Journal of Pain 13(8): 784-789.
- Huurman, V.A.L.; Torren, C.R. van der; Gillard, P.; Hilbrands, R.; Meer-Prins, E.P.M.W. van der; Duinkerken, G.; Gorus, F.K.; Claas, F.H.J.; Keymeulen, B.; Roelen, D.L.; Pipeleers, D.G.; Roep, B.O. & JDRF Ctr Beta Cell Therapy Diabet (2012), Immune responses against islet allografts during tapering of immunosuppression - a pilot study in 5 subjects, Clinical and Experimental Immunology 169(2): 190-198.
- Lochem, A. van; Beelen, E. van; Keur, C. van der; Swings, G.; Zijl, L. van; Claas, F. & Scherjon, S. (2012), Preservation of human placenta is feasible and facilitates studies on the local immune regulation in normal and aberrant pregnancies, Journal of Reproductive Immunology 94(1): 45-45.
- Joris, M.M.; Rood, J.J. van; Roelen, D.L.; Oudshoorn, M. & Claas, F.H.J. (2012), A Proposed Algorithm Predictive for Cytotoxic T Cell Alloreactivity, Journal of Immunology 188(4): 1868-1873.
- D'Orsogna, L.J.; Roelen, D.L.; Doxiadis, I.I.N. & Claas, F.H.J. (2012), TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition, Immunogenetics 64(2): 77-85.
- Claas, F.H.J. (2012), It Takes Two to Tango: Both Donor and Recipients' Immune Repertoire Affect Outcome of Renal Transplants, Transplantation 93(3): 247-248.
- D'Orsogna LJ, van der Meer-Prins EM, Zoet YM, Roelen DL, Doxiadis II & Claas FH (2012), Detection of allo-HLA cross-reactivity by virus-specific memory T-cell clones using single HLA-transfected K562 cells., Methods in Molecular Biology 882: 339-49.
- Duquesnoy, R.J.; Marrari, M.; Mulder, A.; Claas, F.H.J.; Mostecki, J. & Balazs, I. (2012), Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies, Human Immunology 73(3): 267-277.
- Roodnat, J.I.; Wetering, J. van de; Claas, F.H.; IJzermans, J.N.M. & Weimar, W. (2012), A Plea for a Fair Kidney Allocation System for ABO Blood Type O Patients, American Journal of Transplantation 12: 128-128.
- Higgins, R.; Lowe, D.; Mulder, A.; Claas, F.; Zehnder, D. & Briggs, D. (2012), From Median Fluorescence Intensity to Microgrammes Per Millilitre; Quantification of HLA Antibody Levels, American Journal of Transplantation 12: 310-310.
- Rekers, N.V.; Anholts, J.D.H.; Haasnoot, G.W.; Mallat, M.J.K.; Bajema, I.M.; Fijter, J.W. de; Claas, F.H.J. & Eikmans, M. (2012), Intragraft Expression of Metallothioneins in Kidney Transplant Patients May Be a Novel Marker of Response to Anti-Rejection Treatment with Corticosteroids, American Journal of Transplantation 12: 456-457.
- Sizzano, F.; Zito, L.; Crivello, P.; Claas, F.H.J.; Fleischhauer, K. & Oudshoorn, M. (2012), MIXED LYMPHOCYTE CULTURE TYPING REVISITED: THE STRENGTH OF PROLIFERATIVE ALLORESPONSES TO HLA-DP REFLECTS THE PRESENCE OR ABSENCE OF NON-PERMISSIVE T CELL EPITOPE GROUP MISMATCHES, Tissue Antigens 79(6): 468-468.
- D'Orsogna, L.J.; Heuvel, H. van den; Roelen, D.L.; Meer-Prins, E. van der; Doxiadis, I.I.N. & Claas, F. (2012), STIMULATION OF EBV AND CMV SPECIFIC CYTOLYTIC EFFECTOR FUNCTION USING ALLOGENEIC CELL IMMUNOTHERAPY, Tissue Antigens 79(6): 427-427.
- Eikmans, M.; Canck, I. de; Pol, P. van der; Baan, C.C.; Haasnoot, G.W.; Mallat, M.J.K.; Vergunst, M.; Meester, E. de; Roodnat, J.I.; Anholts, J.D.H.; Thielen, M. van; Doxiadis, I.I.N.; Fijter, H.W. de; Linden, C.J.E. van der; Beelen, E. van; Kooten, C. van; Kal-van Gestel, J.; Peeters, A.M.A.; Weimar, W.; Roelen, D.L.; Rossau, R. & Claas, F.H.J. (2012), The Functional Polymorphism Ala258Ser in Ficolin-2 in the Donor Kidney Predicts Improved Renal Transplant Outcome, American Journal of Transplantation 12: 312-312.
- Rood, J.J. van; Zanden, H.G. van der; Oudshoorn, M.; Claas, F.H. & Rubinstein, P. (2012), THE NUMBER OF ACCEPTABLE HLA MISMATCHES CAN INCREASE ALMOST THREE FOLD BY MATCHING NOW AVAILABLE CORD BLOOD UNITS FOR NON INHERITED MATERNAL ANTIGENS, Tissue Antigens 79(6): 408-408.
- D'Orsogna, L.J.; Roelen, D.L.; Doxiadis, I.I.N. & Claas, F.H.J. (2012), TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition., Immunogenetics 64(2): 77-85.
- Joris, M.M.; Lankester, A.C.; Borne, P.A.V.; Boelens, J.J.; Kuball, J.; Cornelissen, J.J.; Haasnoot, G.W.; Zanden, H. van der; Groenendijk-Sijnke, M.E.; Holt, B. van der; Rood, J.J. van; Oudshoorn, M. & Claas, F.H.J. (2012), DONOR-PATIENT PAIRS WITH FREQUENT 5 LOCUS HIGH RESOLUTION TYPED HLA-HAPLOTYPES IN HIGH LINKAGE DISEQUILIBRIUM BETWEEN HLA-B/-C AND-DRB1 HAVE DECREASED RISK OF ACUTE GRAFT-VERSUS-HOST DISEASE, Tissue Antigens 79(6): 460-460.
- Staal, F.J.T. & Fibbe, W.E. (2012), Wnt cross-talk in the niche., Blood 119(7): 1618-9.
- D'Orsogna, L.J.; Heuvel, H. van den; Meer-Prins, E.M.W. van der; Roelen, D.L.; Doxiadis, I.I.N. & Claas, F.H.J. (2012), Stimulation of human EBV- and CMV-specific cytolytic effector function using allogeneic HLA molecules.
- Duquesnoy, R.J.; Marrari, M.; Mulder, A. & Claas, F. (2012), DIFFERENCES BETWEEN LUMINEX REACTIVITY PATTERNS OF CLASS I EPITOPE-SPECIFIC ANTIBODIES: POSSIBLE EFFECT OF PEPTIDES IN THE GROOVE, Human Immunology 73: 3-3.
- Wisgerhof, H.C.; Wolterbeek, R.; Haasnoot, G.W.; Claas, F.H.J.; Fijter, J.W. de; Willemze, R. & Bavinck, J.N.B. (2012), The risk of cancer is not increased in patients with multiple kidney transplantations., Transplant Immunology 27(4): 189-94.
- Buurma, A.; Cohen, D.; Veraar, K.; Schonkeren, D.; Claas, F.H.; Bruijn, J.A.; Bloemenkamp, K.W. & Baelde, H.J. (2012), Preeclampsia Is Characterized by Placental Complement Dysregulation, Hypertension 60(5): 1332-+.
- Huurman, V.A.L.; Torren, C.R. van der; Gillard, P.; Hilbrands, R.; Meer-Prins, E.P.M.W. van der; Duinkerken, G.; Gorus, F.K.; Claas, F.H.J.; Keymeulen, B.; Roelen, D.L.; Pipeleers, D.G.; Roep, B.O. & JDRF Ctr Beta Cell Therapy Diabet (2012), Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects., Clinical and Experimental Immunology 169(2): 190-8.
- Joris, M.M.; Lankester, A.C.; Borne, P.A.V.; Kuball, J.; Bierings, M.; Cornelissen, J.J.; Groenendijk-Sijnke, M.E.; Holt, B. van der; Haasnoot, G.W.; Zanden, H.G.M. van der; Walraven, S.M. van; Rood, J.J. van; Claas, F.H.J. & Oudshoorn, M. (2012), The impact of frequent HLA haplotypes in high linkage disequilibrium on donor search and clinical outcome after unrelated haematopoietic SCT., Bone Marrow Transplantation.
- Verduin, E.P.; Schonewille, H.; Brand, A.; Haasnoot, G.W.; Claas, F.H.J.; Lindenburg, I.T.M.; Lopriore, E.; Oepkes, D.; Roelen, D.L. & Doxiadis, I.I.N. (2012), High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation., Transfusion.
- Schonkeren, D.; Swings, G.; Roberts, D.; Claas, F.; Heer, E. de & Scherjon, S. (2012), Pregnancy Close to the Edge: An Immunosuppressive Infiltrate in the Chorionic Plate of Placentas from Uncomplicated Egg Cell Donation, PLoS ONE 7(3): -.
- D'Orsogna, L.J.A.; Roelen, D.L.; Meer-Prins, E.M.W. van der; Besouw, N.M. van; Pol, P. van der; Franke-van Dijk, M.; Zoet, Y.M.; Slik, A. van der; Weimar, W.; Kooten, C. van; Doxiadis, I.I.N. & Claas, F.H.J. (2011), VACCINE INDUCED ALLO-HLA REACTIVE MEMORY T-CELLS IN A KIDNEY TRANSPLANTATION CANDIDATE, Human Immunology 72: S60-S60.
- Eikmans, M.; Canck, I. de; Pol, P. van der; Baan, C.C.; Haasnoot, G.W.; Mallat, M.J.K.; Bryson-Vergunst, M.; Meester, E. de; Roodnat, J.I.; Anholts, J.D.H.; Thielen, M. van; Doxiadis, I.I.N.; Fijter, H.W. de; Linden, P.J.E. van der; Beelen, E. van; Kooten, C. van; Kal-van Gestel, J.A.; Peeters, A.M.A.; Weimar, W.; Roelen, D.L.; Rossau, R. & Claas, F.H.J. (2011), A FUNCTIONAL POLYMORPHISM IN FICOLIN-2 IN THE DONOR KIDNEY IS ASSOCIATED WITH IMPROVED RENAL TRANSPLANT OUTCOME., Human Immunology 72: S191-S191.
- Hoorn, M.L. van der; Helmerhorst, F.; Claas, F. & Scherjon, S. (2011), Dizygotic twin pregnancy after transfer of one embryo, Fertility and Sterility 95(2).
- Schonkeren, D.; Hoorn, M.L. van der; Khedoe, P.; Swings, G.; Beelen, E. van; Claas, F.; Kooten, C. van; Heer, E. de & Scherjon, S. (2011), Differential Distribution and Phenotype of Decidual Macrophages in Preeclamptic versus Control Pregnancies, American Journal of Pathology 178(2): 709-717.
- Zoet, Y.M.; Brand-Schaaf, S.H.; Roelen, D.L.; Mulder, A.; Claas, F.H.J. & Doxiadis, I.I.N. (2011), Challenging the golden standard in defining donor-specific antibodies: does the solid phase assay meet the expectations?, Tissue Antigens 77(3): 225-228.
- Verhulst, N.O.; Qiu, Y.T.; Beijleveld, H.; Maliepaard, C.; Knights, D.; Schulz, S.; Berg-Lyons, D.; Lauber, C.L.; Verduijn, W.; Haasnoot, G.W.; Mumm, R.; Bouwmeester, H.J.; Claas, F.H.J.; Dicke, M.; Loon, J.J.A. van; Takken, W.; Knight, R. & Smallegange, R.C. (2011), Composition of Human Skin Microbiota Affects Attractiveness to Malaria Mosquitoes, PLoS ONE 6(12): -.
- Heidt, S.; Roelen, D.L.; Vaal, Y.J.H. de; Eijsink, C.; Thomas, S.; Volk, H.D.; Kester, M.G.D.; Claas, F.H.J. & Mulder, A. (2011), A NOVEL ELISPOT ASSAY TO QUANTIFY HLA-SPECIFIC B CELLS IN HLA-IMMUNIZED INDIVIDUALS, Human Immunology 72: S6-S6.
- Zoet, Y.M.; Brand-Schaaf, S.H.; Vittoraki, A.; Roelen, D.L.; Mulder, A.; Claas, F.H.J. & Doxiadis, I.I.N. (2011), CHALLENGING THE DEFINITION OF DONOR SPECIFIC ANTIBODIES: TOO MUCH ABOUT NOTHING?, Human Immunology 72: S27-S27.
- Lashley, L.E.E.L.O.; Hoorn, M.L.P. van der; Mast, B.J. van der; Tilburgs, T.; Lee, N. van der; Keur, C. van der; Beelen, E. van; Roelen, D.L.; Claas, F.H.J. & Scherjon, S.A. (2011), Changes in cytokine production and composition of peripheral blood leukocytes during pregnancy are not associated with a difference in the proliferative immune response to the fetus, Human Immunology 72(10): 805-811.
- Hoorn, M.L.P. van der; Scherjon, S.A. & Claas, F.H.J. (2011), Egg donation pregnancy as an immunological model for solid organ transplantation, Transplant Immunology 25(2-3): 89-95.
- Drabbels, J.J.M.; Keur, C.V. van de; Kemps, B.M.; Mulder, A.; Scherjon, S.A.; Claas, F.H.J. & Eikmans, M. (2011), HLA-targeted flow cytometric sorting of blood cells allows separation of pure and viable microchimeric cell populations, Blood 118(19): E149-E155.
- Jin, Y.P.; Zhang, X.H.; Mulder, A.; Claas, F.H.J.; Lee, J.H. & Reed, E.F. (2011), NOT ALL CLASS I MOLECULES ASSOCIATE WITH INTEGRIN BETA4 TO TRANSDUCE SIGNALS: MECHANISMS AND CLINICAL IMPLICATIONS, Human Immunology 72: S178-S178.
- Zoet, Y.M.; Brand-Schaaf, S.H.; Vittoraki, A.; Roelen, D.L.; Mulder, A.; Claas, F.H.J. & Doxiadis, I.I.N. (2011), Challenging the definition of donor specific antibodies, Tissue Antigens 77(5): 454-454.
- Duquesnoy, R.J.; Marrari, M.; Mulder, A.; Mostecki, J.; Claas, F.H.J. & Balazs, I. van (2011), Human monoclonal antibody reactivity with HLA class I epitopes defined by pairs of mismatched eplets and self eplets, Tissue Antigens 77(5): 376-377.
- Wisgerhof, H.C.; Geest, L.G.M. van der; Fijter, J.W. de; Haasnoot, G.W.; Claas, F.H.J.; Cessie, S. le; Willemze, R. & Bavinck, J.N.B. (2011), Incidence of cancer in kidney-transplant recipients: A long-term cohort study in a single center, Cancer Epidemiology 35(2): 105-111.
- Mulder, A.; Eikmans, M.; Franke, M.E.I.; Anholts, J.D.H.; Verduijn, W.; Scherjon, S.; Roelen, D.L. & Claas, F.H.J. (2011), Limited expression of HLA Class I antigens on endothelial cells, Tissue Antigens 77(5): 461-461.
- D'Orsogna, L.J.A.; Roelen, D.L.; Doxiadis, I.I.N. & Claas, F.H.J. (2011), Screening of viral specific T-cell lines for HLA alloreactivity prior to adoptive immunotherapy may prevent GvHD, Transplant Immunology 24(3): 141-141.
- D'Orsogna, L.J.A.; Roelen, D.L.; Meer-Prins, E.M.W. van der; Pol, P. van der; Franke-van Dijk, M.E.; Eikmans, M.; Anholts, J.; Rossjohn, J.; McCluskey, J.; Mulder, A.; Kooten, C. van; Doxiadis, I.I.N. & Claas, F.H.J. (2011), Tissue Specificity of Cross-Reactive Allogeneic Responses by EBV EBNA3A-Specific Memory T Cells, Transplantation 91(5): 494-500.
- Lowe, D.; Zehnder, D.; Higgins, R.; Mulder, A.; Claas, F. & David, B. (2011), CLASS I HLA-SPECIFIC ANTIBODY QUANTIFICATION.
- Scherjon, S.; Lashley, L.; Hoorn, M.L. van der & Claas, F. (2011), Fetus specific T cell modulation during fertilization, implantation and pregnancy, Placenta 32: S291-S297.
- Claas, F.; Hoorn, M.L. van der; Schonkeren, D.; Tilburgs, T. & Scherjon, S. (2011), Immunoregulation during human pregnancy, Journal of Reproductive Immunology 90(2): 132-132.
- Cohen, D.; Visser, J.; Claas, F.; Bruijn, J.A.; Bajema, I.M. & Bloemenkamp, K.W.M. (2011), Placental C4d and anti-HLA antibodies in patients with recurrent miscarriage of unknown etiology: humoral rejection of the fetal allograft?, Journal of Reproductive Immunology 90(2): 151-152.
- Joris, M.; Rood, J. van; Roelen, D.; Oudshoorn, M. & Claas, F. (2011), Specific amino acid sequence positions of single MHC class I mismatches are related to T-cell alloreactivity, Tissue Antigens 77(5): 415-415.
- Nielsen, H.S.; Witvliet, M.D.; Steffensen, R.; Haasnoot, G.W.; Goulmy, E.; Christiansen, O.B. & Claas, F. (2011), The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth (vol 87, pg 67, 2010), Journal of Reproductive Immunology 89(2): 216-216.
- D'Orsogna, L.J.A.; Besouw, N.M. van; Meer-Prins, E.M.W. van der; Pol, P. van der; Franke-van Dijk, M.; Zoet, Y.M.; Slik, A. van der; Weimar, W.; Kooten, C. van; Mulder, A.; Roelen, D.L.; Doxiadis, I.I.N. & Claas, F.H.J. (2011), Vaccine-Induced Allo-HLA-Reactive Memory T Cells in a Kidney Transplantation Candidate, Transplantation 91(6): 645-651.
- Joris, M.M.; Bierings, M.B.; Egeler, R.M.; Claas, F.H.J.; Rood, J.J. van & Oudshoorn, M. (2011), Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group., Bone Marrow Transplantation.
- Lashley, L.E.E.L.O.; Hoorn, M.L.P. van der; Mast, B.J. van der; Tilburgs, T.; Lee, N. van der; Keur, C. van der; Beelen, E. van; Roelen, D.L.; Claas, F.H.J. & Scherjon, S.A. (2011), Changes in cytokine production and composition of peripheral blood leukocytes during pregnancy are not associated with a difference in the proliferative immune response to the fetus., Human Immunology 72(10): 805-11.
- Hoorn, M.L.P. van der; Scherjon, S.A. & Claas, F.H.J. (2011), Egg donation pregnancy as an immunological model for solid organ transplantation., Transplant Immunology 25(2-3): 89-95.
- Scherjon, S.; Lashley, L.; Hoorn, M.L. van der & Claas, F. (2011), Fetus specific T cell modulation during fertilization, implantation and pregnancy., Placenta 32 Suppl 4: S291-7.
- Drabbels, J.J.M.; Keur, C.V. van de; Kemps, B.M.; Mulder, A.; Scherjon, S.A.; Claas, F.H.J. & Eikmans, M. (2011), HLA-targeted flow cytometric sorting of blood cells allows separation of pure and viable microchimeric cell populations., Blood 118(19): e149-55.
- Bergen, J. van; Thompson, A.; Haasnoot, G.W.; Roodnat, J.I.; Fijter, J.W. de; Claas, F.H.J.; Koning, F. & Doxiadis, I.I.N. (2011), KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation., American Journal of Transplantation 11(9): 1959-64.
- D'Orsogna, L.J.A.; Besouw, N.M. van; Meer-Prins, E.M.W. van der; Pol, P. van der; Franke-van Dijk, M.; Zoet, Y.M.; Slik, A. van der; Weimar, W.; Kooten, C. van; Mulder, A.; Roelen, D.L.; Doxiadis, I.I.N. & Claas, F.H.J. (2011), Vaccine-Induced Allo-HLA-Reactive Memory T Cells in a Kidney Transplantation Candidate.
- Botermans, J.M.; Kort, H. de; Eikmans, M.; Koop, K.; Baelde, H.J.; Mallat, M.J.K.; Zuidwijk, K.; Kooten, C. van; Heer, E. de; Goemaere, N.N.T.; Claas, F.H.J.; Bruijn, J.A.; Fijter, J.W. de; Bajema, I.M. & Groningen, M.C. van (2011), C4d Staining In Renal Allograft Biopsies with Early Acute Rejection and Subsequent Clinical Outcome, Clinical Journal of the American Society of Nephrology 6(5): 1207-1213.
- D'Orsogna, L.J.A.; Roelen, D.L.; Meer-Prins, E.M.W. van der; Pol, P. van der; Franke-van Dijk, M.E.; Eikmans, M.; Anholts, J.; Rossjohn, J.; McCluskey, J.; Mulder, A.; Kooten, C. van; Doxiadis, I.I.N. & Claas, F.H.J. (2011), Tissue Specificity of Cross-Reactive Allogeneic Responses by EBV EBNA3A-Specific Memory T Cells.
- Bergen, J. van; Thompson, A.; Haasnoot, G.W.; Roodnat, J.J.; Fijter, J.W. de; Claas, F.H.J.; Koning, F. & Doxiadis, I.I.N. (2011), KIR-LIGAND MISMATCHES ARE ASSOCIATED WITH REDUCED LONG-TERM GRAFT SURVIVAL IN HLA FULLY COMPATIBLE KIDNEY TRANSPLANTATION., Human Immunology 72: S192-S192.
- Bergen, J. van; Thompson, A.; Haasnoot, G.W.; Roodnat, J.I.; Fijter, J.W. de; Claas, F.H.J.; Koning, F. & Doxiadis, I.I.N. (2011), KIR-Ligand Mismatches Are Associated With Reduced Long-Term Graft Survival in HLA-Compatible Kidney Transplantation, American Journal of Transplantation 11(9): 1959-1964.
- Nielsen, H.S.; Steffensen, R.; Halteren, A.G. van; Spiering, E.; Miklos, D.; Claas, F.; Goulmy, E. & Christiansen, O.B. (2011), Anti H-Y immunity in secondary recurrent miscarriage-immunogenetic and immunologic evidence, Journal of Reproductive Immunology 90(2): 142-143.
- Brand-Schaaf, S.H.; Roelen, D.L.; Doxiadis, I.I.N.; Stein, S.; Fijter, J.W. de & Claas, F.H.J. (2011), Case study: proving old concepts and providing new insights, Tissue Antigens 77(5): 445-445.
- Meer-Prins, E.M.W. van der; Besouw, N.M. van; D'Orsogna, L.J.A.; Pol, P. van der; Franke-van Dijk, M.; Zoet, Y.M.; Slik, A. van der; Weimar, W.; Kooten, C. van; Mulder, A.; Roelen, D.L.; Doxiadis, I.I.N. & Claas, F.H.J. (2011), Vaccine induced Allo-HLA reactive memory T-cells in a kidney transplantation candidate, Tissue Antigens 77(5): 389-390.
- Eikmans, M.; Canck, I. de; Pol, P. van der; Baan, C.C.; Haasnoot, G.W.; Mallat, M.J.K.; Bryson-Vergunst, M.; Meester, E. de; Roodnat, J.I.; Anholts, J.D.H.; Thielen, M. van; Doxiadis, I.I.N.; Fijter, H.W. de; Linden, P.J.E. van der; Beelen, E. van; Kooten, C. van; Kal-van Gestel, J.; Peeters, A.M.A.; Weimar, W.; Roelen, D.L.; Rossau, R. & Claas, F.H.J. (2011), A functional polymorphism in Ficolin-2 in the donor kidney is associated with improved renal transplant outcome, Tissue Antigens 77(5): 384-384.
- Doxiadis, I.I.N.; Thompson, A.; Haasnot, G.W.; Roodnat, J.I.; Fijter, J.W. de; Claas, F.H.J.; Koning, F. & Bergen, J. van (2010), EVIDENCE FOR NATURAL KILLER CELL INDUCED GRAFT LOSS IN HLA FULL COMPATIBLE KIDNEY TRANSPLANTATION., Human Immunology 71: S139S139.
- Claas, F.H.J.; Tilburgs, T.; Eijkmans, M.; Roelen, D.L. & Scherjon, S.A. (2010), HLA-C mediated immune regulation at the fetal-maternal interface, Journal of Reproductive Immunology 86(1): 15-15.
- Tilburgs, T.; Claas, F.H.J. & Scherjon, S.A. (2010), Elsevier Trophoblast Research Award Lecture: Unique Properties of Decidual T Cells and their Role in Immune Regulation during Human Pregnancy, Placenta 31: S82S86.
- Tilburgs, T.; Schonkeren, D.; Eikmans, M.; Nagtzaam, N.M.; Datema, G.; Swings, G.M.; Prins, F.; Lith, J.M. van; Mast, B.J. van der; Roelen, D.L.; Scherjon, S.A. & Claas, F.H. (2010), Human Decidual Tissue Contains Differentiated CD8(+) Effector-Memory T Cells with Unique Properties, Journal of Immunology 185(7): 4470-4477.
- Tilburgs, T.; Schonkeren, D.; Eikmans, M.; Strominger, J.; Roelen, D.; Scherjon, S. & Claas, F. (2010), Human Decidual Tissue Contains Disarmed CD8+Effector-memory T Cells, Clinical Immunology 135: S119S119.
- Marrari, M.; Mostecki, J.; Mulder, A.; Claas, F.; Balazs, I. & Duquesnoy, R.J. (2010), Human Monoclonal Antibody Reactivity With Human Leukocyte Antigen Class I Epitopes Defined by Pairs of Mismatched Eplets and Self-Eplets, Transplantation 90(12): 1468-1472.
- Heidt, S.; Roelen, D.L.; Vergunst, M.; Doxiadis, I.I.N.; Claas, F.H.J. & Mulder, A. (2010), Bortezomib affects the function of human B cells: possible implications for desensitization protocols, Tissue Antigens 75(5): 482-482.
- Brand-Schaaf, S.H.; Roelen, D.L.; Linden, M. van der; Doxiadis, I.I.N.; Stein, S.; Witvliet, M. & Claas, F.H.J. (2010), Detection of donor specific antibodies with DynaChip technology: a pilot study, Tissue Antigens 75(5): 595-596.
- Mulder, A.; Eikmans, M.; Franke, M.E.I.; Eijsink, C.; Anholts, J.D.H.; Verduijn, W.; Scherjon, S. & Claas, F.H.J. (2010), Limited expression of HLA class I antigens on endothelial cells, Tissue Antigens 75(5): 582-583.
- Hoorn, M.L.P. van der; Keijser, R.; Ris-Stalpers, C.; Afink, G.; Claas, F.H.J.; Post, J.A.M. van der & Scherjon, S.A. (2010), Increased EBI3 expression in placentas of preeclamptic patients, Journal of Reproductive Immunology 86(1): 61-61.
- Mulder, A.; Eikmans, M.; Franke, M.E.I.; Verduijn, W.; Anholts, J.D.H.; Roelen, D.L.; Scherjon, S. & Claas, F.H.J. (2010), LIMITED EXPRESSION OF HLA CLASS I ANTIGENS ON ENDOTHELIAL CELLS., Human Immunology 71: S46S46.
- Eikmans, M.; Waanders, M.M.; Roelen, D.L.; Miert, P.P.M.C. van; Anholts, J.D.H.; Fijter, H.W. de; Brand, A. & Claas, F.H.J. (2010), Differential Effect of Pretransplant Blood Transfusions on Immune Effector and Regulatory Compartments in HLA-Sensitized and Nonsensitized Recipients, Transplantation 90(11): 1192-1199.
- Eikmans, M.; Waanders, M.M.; Roelen, D.L.; Miert, P.P.M.C. van; Anholts, J.D.H.; Fijter, J.W. de; Brand, A. & Claas, F.H.J. (2010), DIFFERENTIAL EFFECT OF PRE-TRANSPLANT BLOOD TRANSFUSIONS ON IMMUNE EFFECTOR AND REGULATORY COMPARTMENTS IN HLA-SENSITIZED- AND NON-SENSITIZED RECIPIENTS., Human Immunology 71: S152S152.
- Tilburgs, T.; Scherjon, S.A. & Claas, F.H.J. (2010), Major histocompatibility complex (MHC)-mediated immune regulation of decidual leukocytes at the fetal-maternal interface.
- D'Orsogna, L.; Meer-Prins, E. van der; Pol, P. van der; Franke-van Dijk, M.; Zoet, Y.; Eikmans, M.; Anholts, J.; Mulder, A.; Kooten, C. van; Rossjohn, J.; McCluskey, J.; Roelen, D.; Doxiadis, I. & Claas, F. (2010), ORGAN SPECIFIFITY OF CROSS-REACTIVE ALLOGENEIC RESPONSES BY VIRAL SPECIFIC MEMORY T-CELLS., Human Immunology 71: S69S69.
- Hiby, S.E.; Apps, R.; Sharkey, A.M.; Farrell, L.E.; Gardner, L.; Mulder, A.; Claas, F.H.; Walker, J.J.; Redman, C.C.; Morgan, L.; Tower, C.; Regan, L.; Moore, G.E.; Carrington, M. & Moffett, A. (2010), Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2, Journal of Clinical Investigation 120(11): 4102-4110.
- Doxiadis, I.I.N.; Roelen, D. & Claas, F.H.J. (2010), Mature wines are better: CDC as the leading method to define highly sensitized patients, Current Opinion in Organ Transplantation 15(6): 716-719.
- Heidt, S.; Roelen, D.L.; Eijsink, C.; Eikmans, M.; Kooten, C. van; Claas, F.H.J. & Mulder, A. (2010), Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help., Clinical & Experimental Immunology 159(2): 199-207.
- Fadda, L.; Borhis, G.; Ahmed, P.; Cheent, K.; Pageon, S.V.; Cazaly, A.; Stathopoulos, S.; Middleton, D.; Mulder, A.; Claas, F.H.J.; Elliott, T.; Davis, D.M.; Purbhoo, M.A. & Khakoo, S.I. (2010), Peptide antagonism as a mechanism for NK cell activation, Proceedings of the National Academy of Sciences 107(22): 10160-10165.
- D'Orsogna, L.J.A.; Roelen, D.L.; Doxiadis, I.I.N. & Claas, F.H.J. (2010), Alloreactivity from human viral specific memory T-cells., Transplant Immunology 23(4): 149-55.
- Mulder, A.; Kardol, M.J.; Arn, J.S.; Eijsink, C.; Franke, M.E.I.; Schreuder, G.M.T.; Haasnoot, G.W.; Doxiadis, I.I.N.; Sachs, D.H.; Smith, D.M. & Claas, F.H.J. (2010), Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation.
- Doxiadis, I.I.N.; Roelen, D. & Claas, F.H.J. (2010), Mature wines are better: CDC as the leading method to define highly sensitized patients., Current Opinion in Organ Transplantation.
- Wisgerhof, H.C.; Edelbroek, J.R.J.; Fijter, J.W. de; Haasnoot, G.W.; Claas, F.H.J.; Willemze, R. & Bavinck, J.N.B. (2010), Subsequent Squamous- and Basal-Cell Carcinomas in Kidney-Transplant Recipients After the First Skin Cancer: Cumulative Incidence and Risk Factors, Transplantation 89(10): 1231-1238.
- Lochem, A. van; Ziji, L. van; Beelen, E. van; Claas, F.H.J. & Scherjon, S.A. (2010), Preservation of human placenta for immunoregulation studies is feasible, Journal of Reproductive Immunology 86(2): 107-108.
- Klerk, M. de; Deijl, W.M. van der; Witvliet, M.D.; Haase-Kromwijk, B.J.J.M.; Claas, F.H.J. & Weimar, W. (2010), The optimal chain length for kidney paired exchanges: an analysis of the Dutch program, Transplant International 23(11): 1120-1125.
- Nielsen, H.S.; Witvliet, M.D.; Steffensen, R.; Haasnoot, G.W.; Goulmy, E.; Christiansen, O.B. & Claas, F. (2010), The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth, Journal of Reproductive Immunology 87(1-2): 67-73.
- Hor, H.; Kutalik, Z.; Dauvilliers, Y.; Valsesia, A.; Lammers, G.J.; Donjacour, C.E.H.M.; Iranzo, A.; Santamaria, J.; Adrados, R.P.; Vicario, J.L.; Overeem, S.; Arnulf, I.; Theodorou, I.; Jennum, P.; Knudsen, S.; Bassetti, C.; Mathis, J.; Lecendreux, M.; Mayer, G.; Geisler, P.; Beneto, A.; Petit, B.; Pfister, C.; Burki, J.V.; Didelot, G.; Billiard, M.; Ercilla, G.; Verduijn, W.; Claas, F.H.J.; Vollenwider, P.; Waeber, G.; Waterworth, D.M.; Mooser, V.; Heinzer, R.; Beckmann, J.S.; Bergmann, S. & Tafti, M. (2010), Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy, Nature Genetics 42(9): 786U80.
- Tilburgs, T.; Scherjon, S.A. & Claas, F.H.J. (2010), Major histocompatibility complex (MHC)-mediated immune regulation of decidual leukocytes at the fetal-maternal interface.
- Rekers, N.V.; Bajema, I.M.; Mallat, M.; Zuidwijk, K.; Anholts, J.D.H.; Goemaere, N.; Groningen, M.C. van; Kooten, C. van; Fijter, J.W. de; Claas, F.H.J. & Eikmans, M. (2010), Quantitative PCR profiling of kidney transplant patients for prediction of response to anti-rejection treatment with steroids, Tissue Antigens 75(5): 595-595.
- Amir, A.L.; D'Orsogna, L.J.A.; Roelen, D.L.; Loenen, M.M. van; Hagedoorn, R.S.; Boer, R. de; Hoorn, M.A.W.G. van der; Kester, M.G.D.; Doxiadis, I.I.N.; Falkenburg, J.H.F.; Claas, F.H.J. & Heemskerk, M.H.M. (2010), Allo-HLA reactivity of virus-specific memory T cells is common, Blood 115(15): 3146-3157.
- Eikmans, M.; Waanders, M.M.; Roelen, D.L.; Miert, P.P.M.C. van; Anholts, J.D.H.; Fijter, H.W. de; Brand, A. & Claas, F.H.J. (2010), Differential effect of pre-transplant blood transfusions on immune effector and regulatory mechanisms in individuals with and without previous HLA alloantigen exposure, Tissue Antigens 75(5): 485-486.
- Jin, Y.P.; Zhang, X.H.; Mulder, A.; Claas, F.; Lee, J.H. & Reed, E.F. (2010), ALLELE SPECIFIC ANTI-HLA CLASS I ANTIBODIES DIFFER IN THEIR CAPACITY TO TRANSDUCE CELL SURVIVAL AND PROLIFERATION SIGNAL TRANSDUCTION IN ENDOTHELIAL CELLS., Human Immunology 71: S143S143.
- D'Orsogna, L.J.A.; Roelen, D.L.; Doxiadis, I.I.N. & Claas, F.H.J. (2010), Alloreactivity from human viral specific memory T-cells, Transplant Immunology 23(4): 149-155.
- Bronson, P.G.; Komorowski, L.K.; Ramsay, P.P.; May, S.L.; Noble, J.; Lane, J.A.; Thomson, G.; Claas, F.H.; Seldin, M.F.; Kelly, J.A.; Harley, J.B.; Moser, K.L.; Gaffney, P.M.; Behrens, T.; Criswell, L.A. & Barcellos, L.F. (2010), Analysis of Maternal-Offspring HLA Compatibility, Parent-of-Origin Effects, and Noninherited Maternal Antigen Effects for HLA-DRB1 in Systemic Lupus Erythematosus, Arthritis and Rheumatism 62(6): 1712-1717.
- Hoorn, M.L.P. van der; Lashley, E.E.L.O.; Bianchi, D.W.; Claas, F.H.J.; Schonkeren, C.M.C. & Scherjon, S.A. (2010), Clinical and immunologic aspects of egg donation pregnancies: a systematic review, Human Reproduction Update 16(6): 704-712.
- Claas, F.H.J. (2010), Clinical relevance of circulating donor-specific HLA antibodies, Current Opinion in Organ Transplantation 15(4): 462-466.
- Roelen, D.L.; Brand-Schaaf, S.; Linden, M. van der; Witvliet, M.; Doxiadis, I.I.N. & Claas, F.H.J. (2010), DETECTION OF DONOR SPECIFIC ANTIBODIES WITH DynaChip TECHNOLOGY: A PILOT STUDY., Human Immunology 71: S49S49.
- Huurman VAL, Velthuis JHL, Hilbrands R, Tree TIM, Gillard P, van der Meer-Prins PMW, Duinkerken G, Pinkse GGM, Keymeulen B & Roelen DL (2009), Allograft-Specific Cytokine Profiles Associate with Clinical Outcome After Islet Cell Transplantation, American Journal of Transplantation 9(2): 382-388.
- Rekers, N.V.; Bajema, I.M.; Zuidwijk, K.; Mallat, M.J.; Goemaere, N.; Groningen, M.C. van; Kooten, C. van; Fijter, H.W. de; Claas, F.H. & Eikmans, M. (2009), Intragraft expression profiles by quantitative PCR in kidney transplant patients reflect variability in the response to anti-rejection treatment with corticosteroids, Tissue Antigens 73(5): 389-389.
- Amir AL, D'Orsogna LJ, van Loenen MM, Kester M, Roelen DL, Doxiadis II, Falkenburg F, Heemskerk M & Claas FH (2009), Alloreactivity of Virus Specific Memory T-Cells., American Journal of Transplantation 9: 361-361.
- Opelz G & Claas FHJ (2009), Which human leukocyte antigen antibodies are really clinically relevant?, Human Immunology 70(8): 561-562.
- Claas FHJ (2009), Towards Selective HLA Mismatching in Clinical Transplantation, Transplantation 88(6): 760-761.
- Mulder A, Franke MEI, Eijsink C, Verduijn W, Scherjon S & Claas FHJ (2009), LIMITED EXPRESSION OF HLA CLASS I ANTIGENS ON ENDOTHELIAL CELLS., Human Immunology 70: S11S11.
- Heidt S, Roelen DL, Doxiadis IIN, Claas FHJ & Mulder A (2009), BORTEZOMIB AFFECTS THE FUNCTION OF HUMAN B CELLS: POSSIBLE IMPLICATIONS FOR DESENSITIZATION PROTOCOLS, Human Immunology 70: S157S157.
- Andresdottir MB, Haasnoot GW, Persijn GG & Claas FHJ (2009), HLA-B8, DR3: a new risk factor for graft failure after renal transplantation in patients with underlying immunoglobulin A nephropathy, Clinical Transplantation 23(5): 660-665.
- Walshe VA, Hattotuwagama CK, Doytchinova IA, Wong M, Macdonald IK, Mulder A, Claas FHJ, Pellegrino P, Turner J, Williams I, Turnbull EL, Borrow P & Flower DR (2009), Integrating In Silico and In Vitro Analysis of Peptide Binding Affinity to HLA-Cw*0102: A Bioinformatic Approach to the Prediction of New Epitopes, PLoS ONE 4(11).
- Heemskerk MBA, Haase-Kromwijk BJJM, Claas FHJ, Doxiadis IIN, Haasnoot GW, van der Heide JJH, Weimar WW & Hoitsma AJ (2009), Regional Kidney Allocation Based Only on Full HLA-DR Compatibility Is Not Feasible, Transplantation 88(4): 600-601.
- Claas FHJ & Doxiadis IIN (2009), Management of the highly sensitized patient, Current Opinion in Immunology 21(5): 569-572.
- Claas FH & Doxiadis II (2009), Management of the highly sensitized patient.
- D'Orsogna LJ, Amir AL, Zoet YM, Meer-Prins PMWD, Slik ARD, Kester MGD, Heemskerk MHM, Doxiadis IIN, Roelen DL & Claas FHJ (2009), New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire, Tissue Antigens 74(4): 290-297.
- Claas FHJ & Doxiadis IIN (2009), Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant, Human Immunology 70(8): 636-639.
- Amir A, Dorsogna L, van Loenen M, Kester M, Doxiadis I, Roelen D, Falkenburg F, Heemskerk M & Claas F (2009), Alloreactivity of virus specific memory T-cells is common, Tissue Antigens 73(5): 385-385.
- Tilburgs T, Schonkeren D, Eijkmans M, Roelen DL, Scherjon SA & Claas FHJ (2009), MHC mediated immunoregulation at the fetal-maternal interface, Journal of Reproductive Immunology 81(2): 124-124.
- Gerrits JH, van de Wetering J, Drabbels JJ, IJzermans JNM, Claas FHJ, Weimar W & van Besouw NM (2009), Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation, Clinical Transplantation 23(5): 740-747.
- Verduijn W, Anholts JDH, van de Slik AR, Spruyt-Gerritse MJ, Oudshoorn M & Claas FHJ (2009), Spontaneous (point) mutation in the HLA-B allele of offspring, Tissue Antigens 73(5): 476-476.
- de Rooij AM, Gosso MF, Haasnoot GW, Marinus J, Verduijn W, Claas FHJ, van den Maagdenberg AMJM & van Hilten JJ (2009), HLA-B62 and HLA-DQ8 are associated with Complex Regional Pain Syndrome with fixed dystonia, PAIN 145(1-2): 82-85.
- Tilburgs T, Scherjon SA, van der Mast BJ, Haasnoot GW, Versteeg-van der Voort-Maarschalk M, Roelen DL, van Rood JJ & Claas FHJ (2009), Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells, Journal of Reproductive Immunology 82(2): 148-157.
- Drabbels, J.J.M.; Kleijburg, C.; Kemps-Mols, B.M.; Spruijt-Gerritse, M.J.; Mulder, A.; Roelen, D.L.; Claas, F.H.J. & Eikmans, M. (2009), RELIABLE MICROCHIMERISM DETECTION BY COMBINING HLA-TARGETED FLOW CYTOMETRIC CELL SORTING AND REAL-TIME PCR., Human Immunology 70: S89S89.
- Claas FHJ, Rahmel A & Doxiadis ILN (2009), Enhanced Kidney Allocation to Highly Sensitized Patients by the Acceptable Mismatch Program, Transplantation 88(4): 447-452.
- Wisgerhof HC, van der Boog PJM, de Fijter JW, Wolterbeek R, Haasnoot GW, Claas FHJ, Willemze R & Bavinck JNB (2009), Increased Risk of Squamous-Cell Carcinoma in Simultaneous Pancreas Kidney Transplant Recipients Compared with Kidney Transplant Recipients, Journal of Investigative Dermatology 129(12): 2886-2894.
- de Klerk M, Witvliet MD, Haase-Kromwijk BJJM, Claas FHJ & Weimar W (2009), 5-YEARS EVALUATION OF THE NATIONAL LIVING DONOR KIDNEY EXCHANGE PROGRAM IN THE NETHERLANDS, Transplant International 22: 64-64.
- Tilburgs T, Scherjon SA, van der Mast BJ, Haasnoot GW, Versteeg-V D Voort-Maarschalk M, Roelen DL, van Rood JJ & Claas FH (2009), Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells.
- Roelen DL, Huurman VAL, Hilbrands R, Gillard P, Duinkerken G, van der Meer-Prins PWM, Maarschalk MFJVVV, Mathieu C, Keymeulen B & Pipeleers DG (2009), Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation, Clinical and Experimental Immunology 156(1): 141-148.
- de Rooij AM, Florencia Gosso M, Haasnoot GW, Marinus J, Verduijn W, Claas FH, van den Maagdenberg AM & van Hilten JJ (2009), HLA-B62 and HLA-DQ8 are associated with Complex Regional Pain Syndrome with fixed dystonia., PAIN 145(1-2): 82-5.
- Verheyden S, Ferrone S, Mulder A, Claas FH, Schots R, De Moerloose B, Benoit Y & Demanet C (2009), Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells, Cancer Immunology, Immunotherapy 58(6): 855-865.
- Heidt, S.; Roelen, D.L.; Eijsink, C.; Eikmans, M.; Claas, F.H.J. & Mulder, A. (2009), Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production., Clinical & Experimental Immunology 158(1): 99-105.
- Tilburgs T, van der Mast BJ, Nagtzaam NMA, Roelen DL, Scherjon SA & Claas FHJ (2009), Expression of NK cell receptors on decidual T cells in human pregnancy, Journal of Reproductive Immunology 80(1-2): 22-32.
- Doxiadis IIN & Claas FHJ (2009), Transplantation of highly sensitized patients via the acceptable mismatch program or desensitization? We need both, Current Opinion in Organ Transplantation 14(4): 410-413.
- Roelen, D.L.; Mast, B.J. van der; Anker, P.S.I.; Kleijburg, C.; Eikmans, M.; Beelen, E. van; Groot-Swings, G.M.J.S. de; Fibbe, W.E.; Kanhai, H.H.H.; Scherjon, S.A. & Claas, F.H.J. (2009), Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells, Human Immunology 70(1): 16-23.
- D'Orsogna LJ, Amir AL, Zoet YM, van der Meer-Prins PM, van der Slik AR, Kester MG, Heemskerk MH, Doxiadis II, Roelen DL & Claas FH (2009), New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire.
- Claas FH (2009), Towards selective HLA mismatching in clinical transplantation.
- Tilburgs T, Scherjon SA, Roelen DL & Claas FHJ (2009), Decidual CD8+CD28-T cells express CD103 but not perforin, Human Immunology 70(2): 96-100.
- Westerink N, Ogrzewalla K, Bacelar M, Anholts J, Verduyn W, Tillmann G, Enczmann J, Claas F, Lauber J & Rozemuller E (2009), Multi-centre study to evaluate the ambiguity resolving power of a novel HLA-DRB1 SBT excellerator strategy, Tissue Antigens 73(5): 453-453.
- Doxiadis II & Claas FH (2009), Transplantation of highly sensitized patients via the acceptable mismatch program or desensitization? We need both., Current Opinion in Organ Transplantation 14(4): 410-3.
- D'Orsogna L, Amir A, Zoet Y, van Miert P, van der Meer-Prins E, Kester M, Falkenburg F, Heemskerk M, Doxiadis I & Roelen D (2009), New Tools To Monitor the Impact of Viral Infection on the Alloreactive T-Cell Repertoire., American Journal of Transplantation 9: 478-478.
- Huurman VA, Velthuis JH, Hilbrands R, Tree TI, Gillard P, van der Meer-Prins PM, Duinkerken G, Pinkse GG, Keymeulen B, Roelen DL, Claas FH, Pipeleers DG & Roep BO (2009), Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation., American Journal of Transplantation 9(2): 382-8.
- Tilburgs T, Scherjon SA, Swings GMJS, Kleijburg C, Roelen DL & Claas FHJ (2009), Concentration of Fetus Specific CD4+CD25(bright) Regulatory T Cells in the Decidua during Human Pregnancy, Reproductive Sciences 16(3): 181A182A.
- Tilburgs T, Scherjon SA, Roelen DL & Claas FH (2009), Decidual CD8+CD28- T cells express CD103 but not perforin., Human Immunology 70(2): 96-100.
- Roelen DL, van der Mast BJ, in't Anker PS, Kleijburg C, Eikmans M, van Beelen E, de Groot-Swings GM, Fibbe WE, Kanhai HH, Scherjon SA & Claas FH (2009), Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells., Human Immunology 70(1): 16-23.
- Tilburgs T, van der Mast BJ, Nagtzaam NM, Roelen DL, Scherjon SA & Claas FH (2009), Expression of NK cell receptors on decidual T cells in human pregnancy.
- Wisgerhof HC, van der Boog PJ, de Fijter JW, Wolterbeek R, Haasnoot GW, Claas FH, Willemze R & Bouwes Bavinck JN (2009), Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients.
- Claas FH & Doxiadis II (2009), Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant., Human Immunology 70(8): 636-9.
- Gerrits JH, van de Wetering J, van Beelen E, Claas FHJ, Weimar W & van Besouw NM (2009), A Multiplex Bead Array Analysis to Monitor Donor-Specific Cytokine Responses After Withdrawal of Immunosuppression in HLA-Identical living Related Kidney Transplant Patients, Transplantation Proceedings 41(5): 1577-1582.
- Roelen DL, Huurman VA, Hilbrands R, Gillard P, Duinkerken G, van der Meer-Prins PW, Versteeg-van der Voort Maarschalk MF, Mathieu C, Keymeulen B, Pipeleers DG, Roep BO & Claas FH (2009), Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation., Clinical and Experimental Immunology 156(1): 141-8.
- Heidt S, Roelen DL, van Kooten C, Eijsink C, Claas FHJ & Mulder A (2009), The effects of immunosuppressive drugs on T cell dependent B cell cultures, Tissue Antigens 73(5): 390-390.
- Heidt, S.; Roelen, D.L.; Kooten, C. van; Eijsink, C.; Claas, F. & Mulder, A. (2009), THE EFFECTS OF IMMUNOSUPPRESSIVE DRUGS ON T CELL DEPENDENT B CELL CULTURES, Human Immunology 70: S74S74.
- van Bergen J, Thompson A, Haasnoot GW, Roodnat JI, de Fijter JW, Claas FHJ, Koning F & Doxiadis II (2009), COMBINED KIR/HLA GENOTYPING INDICATES A ROLE FOR ALLOREACTIVE NATURAL KILLER CELLS IN KIDNEY TRANSPLANTATION, Transplant International 22: 354-354.
- Aalten J, Bemelman FJ, van den Berg-Loonen EM, Claas FH, Christiaans MH, de Fijter JW, Hepkema BG, Hene RJ, van der Heide JJH, van Hooff JP, Lardy NM, Lems SP, Otten HG, Weimar W, Allebes WA & Hoitsma AJ (2009), Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study, Nephrology Dialysis Transplantation 24(8): 2559-2566.
- Dorsogna L, Amir A, Zoet Y, van Miert P, van der Meer-Prins E, Kester M, Falkenburg F, Heemskerk M, Doxiadis I & Roelen D (2009), New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire, Tissue Antigens 73(5): 387-387.
- Oudshoorn M, Lie JL, Roelen DL, Verduyn W & Claas FHJ (2008), Is an HLA-DRB1*1454/HLA-DRB1*1401 mismatch an acceptable mismatch in hematopoietic stem cell transplantation?, Tissue Antigens 71(4).
- Roelen DL, Huurman VAL, Hilbrands R, Gillard P, Duinkerken G, Meer-Prins PWMD, Versteegi MFJ, Mathieu C, Keymeulen B, Pipeleers DG, Roep BO & Claas FHJ (2008), Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation, Tissue Antigens 71(4).
- Huurman V, Hilbrands R, Pinkse G, Gillard P, Duinkerken G, Van der Linde P, Meer-Prins EV, Maarschalk MVVV, Verbeeck K, Alizadeh B, Mathieu C, Gorus F, Roelen D, Claas F, Keymeulen B, Pipeleers D & Roep B (2008), Cellular islet autoimmunity influences clinical outcome of islet cell transplantation, American Journal of Transplantation 8.
- Heidt S, Roelen DL, Kooten C, Eijsink C, Claas F & Mulder A (2008), The effects of immunosuppressive drugs on in vitro stimulated B cells, Tissue Antigens 71(4).
- Roelen DL, Huurman VAL, Hilbrands R, Gillard P, Duinkerken G, van der Meer-Prins EMW, Maarschalk MFJVVDV, Mathieu C, Keymeulen B, Pipeleers DG, Roep BO & Claas FHJ (2008), Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation, American Journal of Transplantation 8.
- Heidt S, Roelen DL, van Kooten C, Eijsink C, Claas FHJ & Mulder A (2008), The effects of immunosuppressive drugs on in vitro stimulated B cells, American Journal of Transplantation 8.
- Doxiadis IIN, Haasnoot GW, Rahmel A & Claas FHJ (2008), Identification of parameters that contribute to a successful kidney retransplantation, Tissue Antigens 72(3).
- Repnik U, Tilburgs T, Roelen DL, van der Mast BJ, Kanhai HHH, Scherjon S & Claas FHJ (2008), Comparison of macrophage phenotype between decidua basalis and decidua parietalis by flow cytometry, Placenta 29(5).
- Doxiadis IIN, Haasnoot GW, Rahmel A & Claas FHJ (2008), Identification of parameters that contribute to a successful kidney retransplantation, Tissue Antigens 71(4).
- Huurman VAL, Hilbrands R, Pinkse GGM, Gillard P, Duinkerken G, van de Linde P, van der Meer-Prins PMW, Maarschalk MFJV, Verbeeck K, Alizadeh BZ, Mathieu C, Gorus FK, Roelen DL, Claas FHJ, Keymeulen B, Pipeleers DG & Roep BO (2008), Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation, PLoS ONE 3(6): -.
- van den Berg-Loonen EM, Billen EVA, Voorter CEM, van Heurn LWE, Claas FHJ, van Hooff JP & Christiaans MHL (2008), Clinical relevance of pietransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients, Transplantation 85(8).
- Hutchinson JA, Brem-Exner BG, Riquelme P, Roelen D, Schulze M, Ivens K, Grabensee B, Witzke O, Philipp T, Renders L, Humpe A, Sotnikova A, Matthai M, Heumann A, Govert F, Schulte T, Kabelitz D, Claas FHJ, Geissler EK, Kunzendorf U & Fandrich F (2008), A cell-based approach to the minimization of immunosuppression in renal transplantation, Transplant International 21(8).
- Waanders MM, Roelen DL, de Fijter JW, Mallat MJK, Ringers J, Doxiadis IIN, Brand A & Claas FHJ (2008), Protocolled blood transfusions in recipients of a simultaneous pancreas-kidney transplant reduce severe acute graft rejection, Transplantation 85(11).
- Wisgerhoi HC, de Fijter JW, Claas FH, Willemze R & Bavinck JNB (2008), Immunosuppression with rnycofenolatemofetil in stead of azathioprine significantly reduces the risk of skin cancer in kidney transplant recipients, Journal of Investigative Dermatology 128.
- Vidan-Jeras B, Kovac D, Voncina J, Haasnoot G, Gourraud PA, Cambon-Thomsen A, Claas FHJ & Doxiadis IIN (2008), Joining a large organ exchange organisation: implications for a single center country, Tissue Antigens 71(4).
- Zoet YM, Pereira E, Franke MEI, Eijsink C, Rebmann V, Weiss E, Von der Elsen P, Mulder A, Claas FHJ & Doxiadis IIN (2008), Potential relevance of HLA-E specific antibodies in renal transplantation, Tissue Antigens 72(3).
- Tilburgs T, Roelen DL, van der Mast BJ, de Groot-Swings GM, Kleijburg C, Scherjon SA & Claas FH (2008), Evidence for a selective migration of fetus-specific CD4(+)CD25(bright) regulatory T cells from the peripheral blood to the decidua in human pregnancy, Journal of Immunology 180(8).
- Gerrits JH, van de Wetering J, Drabbels JJM, Claas FHJ, Weimar W & van Besouw NM (2008), Donor-reactive cytokine profiles after HLA-identical living-related kidney transplantation, Nephrology Dialysis Transplantation 23(6).
- Tilburg T, Roelen DL, Van der Mast BJ, De Groot GM, Kleijburg C, Scherjon SA & Claas FHJ (2008), Evidence for a selective migration of fetus specific CD4(+)CD25(bright) regulatory T cells from the peripheral blood to the decidua in human pregnancy, Reproductive Sciences 15(2).
- Eikmans M, Nacken W, Bajema IM, Zuidwijk K, Roos-van Groningen MC, van Kooten C, de Fijter JW, Bruijn JA, Roth J & Claas FHJ (2008), Presence of macrophage-expressed S100 calcium binding proteins AS and A9 during transplant rejection is associated with expression of IL-4, IL-10, and TGF-beta, Tissue Antigens 71(4).
- Doxiadis GGM, de Groot N, Claas FHJ, Doxiad IIN, Rood JJ & Bontrop RE (2008), A highly divergent microsatellite fascilitating fast and accurate DRB haplotyping in humans and rhesus macaques, Tissue Antigens 71(4).
- Hutchinson JA, Roelen D, Riquelme P, Brem-Exner BG, Witzke O, Philipp T, Matthai M, Govert F, Claas FHJ, Westphal E, Kunzendorf U, Geissler EK & Fandrich F (2008), Preoperative treatment of a presensitized kidney transplant recipient with donor-derived transplant acceptance-inducing cells, Transplant International 21(8).
- Heidt S, Roelen DL, Eijsink C, van Kooten C, Claas FHJ & Mulder A (2008), Effects of Immunosuppressive Drugs On Purified Human B Cells: Evidence Supporting the Use of MMF and Rapamycin, Transplantation 86(9).
- Waanders MM, Heidt S, Koekkoek KM, Zoet YM, Doxiadis IIN, Amir A, Heemskerk MHM, Mulder A, Brand A, Roelen DL & Claas FHJ (2008), Monitoring of indirect allorecognition: wishful thinking or solid data?, Tissue Antigens 71(1).
- Zoet YM, Pereira E, Franke MEI, Eijsink C, Rebmann V, Elsen PJV, Weiss E, Claas FHJ, Mulder A & Doxiadis IIN (2008), Potential relevance of HLA-E specific antibodies in renal transplantation, Tissue Antigens 71(4).
- Eikmans M, Roelen DL, van Kooten C, de Fijter HW & Claas FHJ (2008), Increased mRNA expression of transforming growth factor-beta and FoxP3 in urine from renal allograft recipients is associated with occurrence of graft rejection, American Journal of Transplantation 8.
- Tilburgs T, Scherjon SA, van der Mast BJ, de Groot-Swings GMJS, Kleijburg C, Roelen DL & Claas FHJ (2008), Fetus specific CD4+CD25 bright regulatory T cells in decidua during human pregnancy, Placenta 29(8).
- Roelen DL, van den Boogaardt DEM, van Miert PPMC, Koekkoek K, Offringa R & Claas FHJ (2008), Differentially modulated dendritic cells induce regulatory T cells with different characteristics, Transplant Immunology 19(3-4).
- Wisgerhof HC, de Fijter JW, Claas FHJ, Willemze R & Bavinck JNB (2008), Patients with an increased number of kidney grafts have a decreased risk to develop squamous-cell carcinoma after transplantation, Journal of Investigative Dermatology 128(10).
- Bronson PG, Ramsay PP, Komorowski L, Clark SL, Noble J, Lane J, Thomson G, Claas FH, Seldin MF, Kelly J, Harley JB, Moser KL, Gaffney PM, Behrens TW, Criswell LA & Barcellos LF (2008), Analysis of maternal-offspring HLA compatibility, parent-of-origin and noninherited maternal effects for HLA-DRB1 in SLE, Arthritis and Rheumatism 58(9).
- Claas FHJ & Duquesnoy RJ (2008), The polymorphic alloimmune response in clinical transplantation, Current Opinion in Immunology 20(5).
- Claas FHJ (2008), HLA antibody testing: a tool to facilitate not to prevent organ transplantation, International Journal of Immunogenetics 35(4-5).
- Waanders MM, Roelen DL, de Fijter JW, Mallat MJ, Doxiadis IIN, Brand A & Claas FHJ (2007), The effect of pretransplant blood transfusions in recipients of a simultaneous pancreas-kidney transplant, Tissue Antigens 69(5).
- van de Linde P, van der Boog PJM, Tysma OMH, Elliott JF, Roelen DL, Claas FHJ, de Fijter JW & Roep BO (2007), Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin, Clinical and Experimental Immunology 149(1).
- Eijsink C, Zoet YM, Kardol MJ, Witvliet MD, Claas FHJ, Mulder A & Doxiadis IIN (2007), Identification of acceptable HLA mismatches in immunized patients using single-antigen-expressing cell lines, Tissue Antigens 69(4).
- Heidt S, Roelen D, Vankooten C, Eijsink C, Claas F & Minder A (2007), The effects of immunosuppressive drugs on in vitro stimulated B cells, Human Immunology 68.
- Heemskerk MBA, Cornelissen JJ, Roelen DL, van Rood JJ, Claas FHJ, Doxiadis IIN & Oudshoorn M (2007), Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation, Bone Marrow Transplantation 40(3).
- Doxiadis GGM, de Groot N, Claas FHJ, Doxiadis IIN, van Rood JJ & Bontrop RE (2007), A highly divergent microsatellite facilitating fast and accurate DRB haplotyping in humans and rhesus macaques, Proceedings of the National Academy of Sciences 104(21).
- Doxiadis I, Haasnoot G, Witvliet M & Claas F (2007), The virtual PRA: An excellent tool to predict the chance to find a crossmatch negative donor, Human Immunology 68.
- Heidt S, Roelen DL, van Kooten C, Eijsink C, Claas FHJ & Mulder A (2007), The effects of immunosuppressive drugs on in vitro stimulated B cells, Tissue Antigens 69(5).
- Verdegaal EME, Hoogstraten C, Sandel MH, Kuppen PJK, Brink AATP, Claas FHJ, Gorsira MCB, van Roggen JFG & Osanto S (2007), Functional CD8(+) T cells infiltrate into nonsmall cell lung carcinoma, Cancer Immunology, Immunotherapy 56(5).
- Duquesnoy RJ & Claas FHJ (2007), 14th International HLA and Immunogenetics Workshop: Report on the structural basis of HLA compatibility, Tissue Antigens 69.
- Zachary AA, Montgomery RA, Jordan SC, Reinsmoen NL, Claas FHJ & Reed EF (2007), 14th International HLA and Immunogenetics Workshop: Report on understanding antibodies in transplantation, Tissue Antigens 69.
- Doxiadis IIN, de Fijter JW, Mallat MJK, Haasnoot GW, Ringers J, Persijn GG & Claas FHJ (2007), Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility, Transplantation 83(9).
- Maat W, Haasnoot GW, Claas FHJ, Schalij-Delfos NE, Schreuder GMT & Jager MJ (2006), HLA class I and II genotype in uveal melanoma: Relation to occurrence and prognosis, Investigative Ophthalmology & Visual Science 47(1).
- de Klerk M, Haase-Kromwijk BJJM, Claas FHJ, Witvliet M & Weimar W (2006), Living donor kidney exchange for both ABO-incompatible and crossmatch positive donor-recipient combinations, Transplantation Proceedings 38(9).
- Jindra PT, Zhang XH, Mulder A, Claas F, Veale J, Jin YP & Reed EF (2006), Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration, Transplantation 82(1).
- Eijsink, C.; Kester, M.G.D.; Franke, M.E.I.; Franken, K.L.M.C.; Heemskerk, M.H.M.; Claas, F.H.J. & Mulder, A. (2006), Rapid assessment of the antigenic integrity of tetrameric HLA complexes by human monoclonal HLA antibodies, Journal of Immunological Methods 315(1-2).
- van den Boogaardt DEM, van Rood JJ, Roelen DL & Claas FHJ (2006), The influence of inherited and noninherited parental antigens on outcome after transplantation, Transplant International 19(5).
- Dierssen JWF, De Miranda NFCC, Mulder A, van Puijenbroek M, Verduyn W, Claas FHJ, de Velde CJHV, Fleuren GJ, Cornelisse CJ, Corver WE & Morreau H (2006), High-resolution analysis of HLA class I alterations in colorectal cancer, BMC Cancer 6.
- Claas FHJ, Roelen DL, Mulder A, Doxiadis IIN, Oudshoorn M & Heemskerk M (2006), Differential immunogenicity of HLA class I alloantigens for the humoral versus the cellular immune response: "Towards tailor-made HLA mismatching"', Human Immunology 67(6).
- Doxiadis I, Witvliet M, Duquesnoy R, Persijn G & Claas F (2006), The alternative to desensitization of highly sensitized kidney patients is the acceptable mismatch program: Short waiting time, reduced costs, and excellent graft outcome, Nephrology Dialysis Transplantation 21.
- Ouldshoorn M, van Walraven SM, Bakker JNA, Lie JLWT, van der Zanden HGM, Heemskerk MBA & Claas FHJ (2006), Hematopoietic stem cell donor selection: the Europdonor experience, Human Immunology 67(6).
- Koene G, Mulder A, van der Ven K, Eijsink C, Franke M, Slootweg P, Claas F & Tilanus M (2006), Human monoclonal antibodies as a tool for the detection of HLA class I allele-specific expression loss in head-and-neck squamous cell carcinoma and corresponding lymph node metastases, Human Immunology 67(9).
- Heidt S, Roelen DL, Eijsink C, Claas FHJ & Mulder A (2006), Differential effect of intravenous immunoglobulins on human B cell hybridomas compared to B and T cells, Human Immunology 67(10).
- van den Boogaardt DEM, van Miert PPMC, de Vaal YJH, de Fijter JW, Claas FHJ & Roelen DL (2006), The ratio of interferon-gamma and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients, Transplantation 82(6).
- Mulder A, Eijsink C, Franke MEI, Doxiadis IIN & Claas FHJ (2006), The significance of human monoclonal antibodies in the HLA field, Tissue Antigens 67(6).
- Ivanova M, Mihaylova A, Penkova K, Mulder A, Claas F & Naumova E (2006), Identification and characterization of a new HLA-A*02 allele with aberrant expression, Tissue Antigens 67(6).
- Heidt S, Roelen DL, Eijsink C, Claas FHJ & Mulder A (2006), Differential effect of intravenous immunoglobulins on human B cell hybridomas compared to B and T cells, Tissue Antigens 67(6).
- Doxiadis I, Haasnoot G, Persijn G & Claas F (2006), The role of historical donor specific HLA antibodies in renal transplantation, Tissue Antigens 67(6).
- Zhang XH, Jindra PT, Jin YP, Claas F, Mulder A & Reed EF (2006), AKT phosphorylation and growth factor receptor expression triggered by anti-HLA antibodies is depenedent on antibody binding capacity, Human Immunology 67(10).
- Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, De Groot-Swings GM, Kanhai HHH, Claas FHJ & Scherjon SA (2006), Differential distribution of CD4(+) CD25(bright) and CD8(+) CD28(-) T-cells in decidua and maternal blood during human pregnancy, Placenta 27.
- de Klerk M, Witvliet MD, Haase-Kromwijk BJJM, Claas FHJ & Weimar W (2006), A highly efficient living donor kidney exchange program for both blood type and crossmatch incompatible donor-recipient combinations, Transplantation 82(12).
- van der Mast B, van der Lee N, Kleijburg C, Tilburgs T, Roelen D, Claas F & Scherjon S (2006), Minor changes in the systemic immune response during pregnancy: Non-specific-, and specific stimulation with fetal (allo)antigens, Journal of Reproductive Immunology 71(2).
- van der Mast B, Roelen D, t'Anker PI, Kleijburg C, van Beelen E, de Groot-Swings G, van Schip J, Fibbe W, Kanhai H, Scherjon S & Claas F (2005), The immunomodulatory effect of mesenchymal stem cells derived from the foeto-maternal interface, Placenta 26(8-9).
- Tilburgs T, Roelen D, van der Mast B, van Schip J, Kleijburg C, de Groot-Swings G, Kanhai H, Claas F & Scherjon S (2005), Differential distribution of CD4(+)CD25(BRIGHT) T-cells in decidua and maternal peripheral blood during human pregnancy., Placenta 26(8-9).
- Heemskerk MBA, van Walraven SM, Cornelissen JJ, Barge RMY, Bredius RGM, Egeler RM, Lie JLWT, Revesz T, Sintnicolaas K, Wulffraat NM, Donker AE, Hoogerbrugge PM, van Rood JJ, Claas FHJ & Oudshoorn M (2005), How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!, Bone Marrow Transplantation 35(7).
- Roelen DL, In't Anker ES, Van Beelen E, Kleyburg C, De Groot-Swings G, Van Schip JJ, Fibbe WE, Kanhai HHH, Scherjon SA & Claas FHJ (2005), The immunomodulatory effect of mesenchymal stem cells derived from the feto-maternal interface, American Journal of Transplantation 5.
- Mulder A, Eijsink C, Kardol MJ, Franke MEI, Kesler M, van Kooten C, Doxiadis IN & Claas FHJ (2005), Dissection of the humoral response against HLA-A2 by molecular analysis of antibodies produced by single B-CELLS., American Journal of Transplantation 5.
- Mulder A, Eijsink C, Kester MGD, Franke MEI, Kardol MJ, Heemskerk MHM, van Kooten C, Verreck FA, Drijfhout JW, Koning F, Doxiadis IIN & Claas FHJ (2005), Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies, Journal of Immunology 175(9).
- Zoet YM, Eijsink C, Kardol MJ, Franke-van Dijk MEI, Wilson GL, de Paus R, Mickelson E, Heemskerk M, van den Elsen PJ, Claas FHJ, Mulder A & Doxiadis IIN (2005), The single antigen expressing lines (SALs) concept: An excellent tool for screening for HLA-specific antibodies, Human Immunology 66(5).
- Claas FHJ & Oudshoorn M (2005), Role of NK cells in mismatched unrelated haematopoietic stem-cell transplantation: fact or fiction?, Tissue Antigens 65(6).
- Zoet YM, Eijsink C, Bohmova R, Witvliet MD, Kardol MJ, Franke MEI, Claas FHJ, Mulder A & Doxiadis IIN (2005), Single-antigen-expressing cell lines are excellent tools for detecting human leukocyte antigen-C-reactive antibodies in kidney transplant recipients, Transplantation 79(9).
- Scherjon S, Sindram A, Roelen D, Claas F & Kanhai H (2005), Decidual leukocytes inhuman pregnancy associated with intrauterine growth restriction with and without preeclampsia, American Journal of Obstetrics and Gynecology 193(6).
- Gourraud PA, Betard C, Raffoux C, Sacchi N, Rajczy K, Oudshorn M, Gut I, Eliaou JF, Claas F & Cambon-Thomsen A (2005), Correlation of frequent HLA haplotypes with HLA microsatellite haplotypes, Genes and Immunity 6.
- Spierings E, Drabbels J, Pool J, Hendriks M, Claas F & Goulmy E (2005), A uniform methodology for minor histocompatibility antigen typing, Tissue Antigens 66(5).
- Gourraud P, Betard C, Raffoux C, Sacchi N, Rajczy K, Oudshoorn M, Eliaou JF, Gut I, Claas F & Cambon-Thomsen A (2005), Strong linkage disequilibrium demonstrating the microsatellite haplotypes predictive power on HLA genes, Tissue Antigens 66(5).
- Harskamp J, Zoet Y, Kessler J, Claas F, Mulder A & Doxiadis I (2005), Application of single antigen lines (SALs) for cellular testing, Tissue Antigens 66(5).
- Eijsink C, Zoet Y, Kardol M, Witvliet M, Claas F, Mulder A & Doxiadis I (2005), The use of single antigen lines (SALs) for the detection of acceptable mismatches in highly sensitized patients, Genes and Immunity 6.
- van Kampen CA, de Linde PV, Duinkerken G, van Schip JJ, Roelen DL, Keymeulen B, Pipeleers DG, Claas FHJ & Roep BO (2005), Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients, Transplantation 80(1).
- Mulder A, Eijsink C, Franke M, Kester M, van Kooten C, Doxiadis I & Claas F (2005), Dissection of the humoral response against HLA-A2 by molecular analysis of antibodies produced by single B-cells, Genes and Immunity 6.
- Koene G, Mulder A, van der Ven K, Eijsink C, Franke M, Slootweg P, Claas F & Tilanus M (2005), Human monoclonal HLA antibodies as probes for the determination of HLA class 1 allele-specific expression-loss in HNSCC and corresponding lymph node metastases, Genes and Immunity 6.
- van den Boogaardt DEM, van Hulst-van Miert PPMC, Koekkoek K, Melief KJM, Ossendorp F, Offringa R, Claas FHJ & Roelen DL (2005), Differentially modulated dendritic cells induce different types of regulatory T cells, Genes and Immunity 6.
- Andresdottir MB, Haasnoot GW, Doxiadis IIN, Persijn GG & Claas FHJ (2005), Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: A retrospective analysis of registry data, Transplantation 80(8).
- de Klerk M, Keizer KM, Claas FHJ, Witvliet M, Haase-Kromwijk BJJM & Weimar W (2005), The Dutch national living donor kidney exchange program, American Journal of Transplantation 5(9).
- Doxiadis IIN, Duquesnoy RJ & Claas FHJ (2005), Extending options for highly sensitized patients to receive a suitable kidney graft, Current Opinion in Immunology 17(5).
- Claas FHJ, Dankers MK, Oudshoorn M, van Rood JJ, Mulder A, Roelen DL, Duquesnoy RJ & Doxiadis IIN (2005), Differential immunogenicity of HLA mismatches in clinical transplantation, Transplant Immunology 14(3-4).
- van Rood JJ, Roelen DL & Claas FHJ (2005), The effect of noninherited maternal antigens in allogeneic transplantation, Seminars in Hematology 42(2).
- Mulder, A.; Eijsink, C.; Kester, M.G.D.; Franke, M.E.I.; Franken, K.L.M.C. & Claas, F.H.J. (2005), Assessment of the antigenic integrity of tetrameric HLA complexes by human monoclonal HLA antibodies, Human Immunology 66.
- Harskamp J, Zoet Y, Kessler J, Claas F, Mulder A & Doxiadis I (2005), Application of single antigen lines (SALs) for cellular cytotoxicity testing, Human Immunology 66.
- Doxiadis I, Witvliet M, Duquesnoy R, Persijn G & Claas F (2005), The alternative to desensitization of highly sensitized kidney patients is the acceptable mismatch program: Short waiting time, reduced costs, and excellent graft outcome, Human Immunology 66.
- Zhang XH, Jindra PT, Jin YP, Claas F, Mulder A & Reed EF (2005), Induction of AKT phosphorylation and FGFR expression in human endothelial cells by anti-HLA antibodies is locus and titer dependent, Human Immunology 66.
- Claas FHJ (2005), Transplantation: changing dogmas in clinical transplantation immunology - Editorial overview, Current Opinion in Immunology 17(5).
- Mulder A, Franke MEI, Eijsink C, Doxiadis IIN & Claas FHJ (2005), The significance of human monoclonal antibodies in the HLA field, Human Immunology 66.
- Doxiadis I, Haasnoot G, Persijn G & Claas F (2005), The disadvantage of being an HLA homozygous kidney patient: Longer waiting time, more mismatches and poorer graft survival, Human Immunology 66.
- Doxiadis I, de Fijter J, Haasnoot G, Mallat M, Persijn G & Claas F (2005), Identification of parameters that contribute to a successful kidney retransplantation, Human Immunology 66.
- Nauta AJ, Kruisselbrink AB, Lurvink E, Mulder A, Claas FH, Noort WA, Willemze R & Fibbe WE (2005), Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit, Experimental Hematology 33(10).
- Waanders MM, Roelen DL, Brand A & Claas FHJ (2005), The putative mechanism of the immuno modulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response, Transfusion Medicine Reviews 19(4).
- Duquesnoy RJ, Mulder A, Askar M, Fernandez-Vina M & Claas FHJ (2005), HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes, Human Immunology 66(7).
- Oudshoorn M., Lie J.L.W.T., Bakker J.N.A., Zanden H.G.M. van der & Claas F.H.J. (2004), Finding the most suitable allogeneic hematopoietic stem cell donor. In: Atkinson K. (red.), Clinical Bone Marroe and Blood Stem Cell Transplantation. Cambridge: Cambridge University Press. 369-382.
- Schreuder G.M.T., Oudshoorn M. & Claas F.H.J. (2004), Histocompatibility typing procedures for stem cell transplantation. In: Atkinson K. (red.), Clinical Bone Marrow and Blood Stem Cell Transplantation. Cambridge: Cambridge Univ. Press. 101-112.
- Mayer K, Birnbaum F, Reinhard T, Reis A, Braunstein S, Claas F & Sundmacher R (2004), FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations, British Journal of Ophthalmology 88(7).
- Anker ESI, Scherjon SA, Devlieger R, Deprest JA, Claas FJH, Fibbe WE & Kanhai HHH (2004), Human fetal membranes as a novel source of mesenchymal stem cells., Journal of the Society for Gynecologic Investigation 11(2).
- Duquesnoy RJ, Witvliet M, Doxiadis IIN, de Fijter H & Claas FHJ (2004), HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates, Transplant International 17(1).
- Eijsink C, Zoet Y, Kardol MJ, Franke-van Dijk MEI, Witvliet MD, Claas FHJ, Doxiadis IIN & Mulder A (2004), Evaluation of serological techniques using human HLA specific monoclonal antibodies, Genes and Immunity 5.
- Radder CM, Roelen DL, van de Meer-Prins EMW, Claas FHJ, Kanhai HHH & Brand A (2004), The immunologic profile of infants born after maternal immunoglobulin treatment and intrauterine platelet transfusions for fetal/neonatal alloimmune thrombocytopenia, American Journal of Obstetrics and Gynecology 191(3).
- Kushihata F, Watanabe J, Mulder A, Claas F & Scornik J (2004), Critical importance of hla antibody (AB) epitope specificity to activate human complement (C), Human Immunology 65.
- Roelen DL, van den Boogaardt DEM, van Miert PPMC, Koekkoek K, Melief CJM, Offringa R, Ossendorp F & Claas FHJ (2004), Specific modulation of the alloimmune response with alternatively activated dendritic cells, Genes and Immunity 5.
- Heemskerk MBA, Dankers MKA, Roelen DL, van Rood JJ, Claas FHJ, Doxiadis IIN & Oudshoorn M (2004), The impact of amino-acid substitutions at specific positions of the HLA class I molecules on alloreactive T-cell precursor frequencies, Genes and Immunity 5.
- Mulder A, Eijsink C, Kardol MJ, Franke-van Dijk MEI, van der Burg SH, Kester M, Doxiadis IIN & Claas FHJ (2004), Identification, isolation and culture of HLA-A2 specific B-lymphocytes using MHC class I-tetramers, Genes and Immunity 5.
- Claas FHJ, Witvliet MD, Duquesnoy RJ, Persijn GG & Doxiadis IIN (2004), The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: Short waiting time and excellent graft outcome, Transplantation 78(2).
- Roelen DL, in't Anker ES, van Beelen E, van Schip JJ, Kleyburg C, de Groot G, Fibbe WE, Kanhai HHH, Scherjon SA & Claas FHJ (2004), The use of mesenchymal stem cells as a tool for immunomodulation of the alloimmune response in pregnancy and solid organ transplantation, Genes and Immunity 5.
- Roelen D, Brand A & Claas FHJ (2004), Pretransplant blood transfusions revisited: A role for CD4(+) regulatory T cells?, Transplantation 77(1).
- Dankers MKA, Witvliet MD, Roelen DL, De Lange P, Korfage N, Persijn GG, Duquesnoy R, Doxiadis IIN & Claas FHJ (2004), The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens, Transplantation 77(8).
- Dankers MKA, Witvliet M, Doxiadis II, de Lange P, Korfage N, Persijn GG, Roelen DL & Claas FH (2004), The number of amino acid sequence differences between patient and donor is predictive for the antibody reactivity against the mismatched HLA antgens, Genes and Immunity 5.
- Mulder A, Eijsink C, Kester M, Kardol M, Franke M, Drijfhout JW, Koning F, Doxiadis I & Claas F (2004), The impact of peptides on the recognition of HLA class I molecules by human HLA antibodies, Genes and Immunity 5.
- Baan C, Peeters A, Lemos F, Uitterlinden A, Doxiadis I, Claas F, Ijzermans J, Roodnat J & Weimar W (2004), Fundamental role for HO-1 in the self-protection of renal allografts, American Journal of Transplantation 4(5).
- Takemoto S, Port FK, Claas FHJ & Duquesnoy RJ (2004), HLA matching for kidney transplantation, Human Immunology 65(12).
- Doxiadis ILN, Smits JMA, Persijn GG, Frei U & Claas FHJ (2004), It takes six to boogie: Allocating cadaver kidneys in Eurotransplant, Transplantation 77(4).
- Dankers MKA, Heemskerk MBA, Duquesnoy RJ, Doxiadis IIN, Oudshoorn M, Roelen DL & Claas FHJ (2004), HLAMatchmaker algorithm is not a suitable tool to predict the alloreactive cytotoxic T-lymphocyte response in vitro, Transplantation 78(1).
- Kushihata F, Watanabe J, Mulder A, Claas F & Scornik JC (2004), Human leukocyte antigen antibodies and human complement activation: Role of IgG subclass, specificity, and cytotoxic potential, Transplantation 78(7).
- Mulder A, Eijsink C, Kardol MJ, El Franke M, Kester M, Doxiadis IIN & Claas FHJ (2004), Microheterogeneity within the humoral response against HLA-A2 as detected among the antibodies produced by single, tetrameric HLA-A2 isolated B-cells, Human Immunology 65.
- Sindram-Trujillo AP, Scherjon SA, van Hulst-van Miert PP, Kanhai HHH, Roelen DL & Claas FHJ (2004), Comparison of decidual leukocytes following spontaneous vaginal delivery and elective cesarean section in uncomplicated human term pregnancy, Journal of Reproductive Immunology 62(1-2).
- Dankers MKA, Roelen DL, Nagelkerke NJD, de Lange P, Persijn GG, Doxiadis IIN & Claas FHJ (2004), The HLA-DR phenotype of the responder is predictive of humoral response against HLA class I antigens, Human Immunology 65(1).
- de Vijlder HC, Westerhof W, Schreuder GMT, de Lange P & Claas FHJ (2004), Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study, Pigment Cell Research 17(3).
- Claas F (2004), Chimerism as a tool to induce clinical transplantation tolerance, Current Opinion in Immunology 16(5).
- Demanet C, Mulder A, Deneys V, Worsham MJ, Maes P, Claas FH & Ferrone S (2004), Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?, Blood 103(8).
- in't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GMJS, Claas FHJ, Fibbe WE & Kanhai HHH (2004), Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta.
- Bohringer D, Reinhard T, Duquesnoy RJ, Bohringer S, Enczmann J, Lange P, Claas F & Sundmacher R (2004), Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasy, Transplantation 77(3).
- Ilias D, de Fijter J, Mallat M, de Lange P, Paul L & Claas F (2003), HLA matching in cadaveric renal transplantation revisited: Major impact of the full HLA-DR compatibility allowing simpler and equitable allocation of organs., Genes and Immunity 4.
- Sindram-Trujillo A, Scherjon S, Kanhai H, Roelen D & Claas F (2003), Increased T-cell activation in decidua parietalis compared to decidua basalis in uncomplicated human term pregnancy, American journal of reproductive immunology and microbiology : AJRIM 49(5).
- Roelen DL, van den Boogaardt DEM, van Miert PPMC, Koekkoek K, Melief CJM, Offringa R, Ossendorp F & Claas FHJ (2003), Specific modulation of the alloimmune response with alternatively activated dendritic cells, Genes and Immunity 4.
- Sijpkens YWJ, Doxiadis IIN, Mallat MJK, De Fijter JW, Bruijn JA, Claas FHJ & Paul LC (2003), Early versus late acute rejection episodes in renal transplantation, Transplantation 75(2).
- Claas FHJ (2003), Towards clinical transplantation tolerance, Lancet 361(9368).
- Kardol MJ, Eijsink C, Franke-van Dijk MEI, van Oevelen MJH, Stein SY, Witvliet MD, Zoet YM, Claas FHJ, Mulder A & Doxiadis IIN (2003), HLA antibody screening using a panel of single MHC class I antigen transfected cell lines., Genes and Immunity 4.
- Sindram-Trujillo AP, Scherjon SA, van Hulst-van Miert PP, van Schip JJ, Kanhai HHH, Roelen DL & Claas FHJ (2003), Differential distribution of NK cells in decidua basalis compared with decidua parietalis after uncomplicated human term pregnancy, Human Immunology 64(10).
- Mayer K, Reinhard T, Reis A, Niehues T, Claas F & Sundmacher R (2003), Differential contribution of natural killer cells to corneal graft rejection in three week old versus mature rats, Investigative Ophthalmology & Visual Science 44.
- Dankers MKA, Roelen DL, Korfage N, de Lange P, Witvliet M, Sandkuijl L, Doxiadis IIN & Claas FHJ (2003), Differential immunogenicity of paternal HLA class I antigens in pregnant women, Human Immunology 64(6).
- Engelfriet CP, Reesink HW, Lee K, Bierling P, Taaning E, Zupanska B, Kurz M, Hocker P, Mayr WR, Panzer S, Shibata Y, Nelson KA, Gernsheimer TB, Kekomaki R, Sanz C, Pereira A, Kiefel V, Brand A, Claas FHJ, Tomson TAS, Witvliet M, Navarrete C, Brown C & Lucas G (2003), Detection of platelet-reactive antibodies in patients who are refractory to platelet transfusions, and the selection of compatible donors, Vox Sanguinis 84(1).
- in 'tAnker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FHJ, Willemze R, Fibbe WE & Kanhai HHH (2003), Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation, Blood 102(4).
- van der Mast BJ, van den Dorpel MA, Drabbels JJM, Claas FHJ & Weimer W (2003), Transfusion-associated graft vs. host disease after donor-specific leukocyte transfusion before kidney transplantation, Clinical Transplantation 17(5).
- Mulder A, Eijsink C, Kardol MJ, Franke-van Dijk MEI, van der Burg SH, Kester M, Doxiadis IIN & Claas FHJ (2003), Identification, isolation, and culture of HLA-A2-specific B lymphocytes using MHC class I tetramers, Journal of Immunology 171(12).
- Mayer K, Reinhard T, Reis A, Niehues T, Claas FH & Sundmacher R (2003), Differential contribution of natural killer cells to corneal graft rejection in 3-week-old versus mature rats, Transplantation 76(3).
- Roelen DL, Schuurhuis DH, Van Den Boogaardt DEM, Koekkoek K, Van Miert PPMC, Van Schip JJ, Laban S, Rea D, Melief CJM, Offringa R, Ossendorp F & Claas FHJ (2003), Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells, Transplantation 76(11).
- Duquesnoy RJ, Takemto S, de Lange P, Doxiadis IIN, Schreuder GMT, Persijn GG & Claas FHJ (2003), HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival, Transplantation 75(6).
- Roodnat JI, van Riemsdijk IC, Mulder PGH, Doxiadis I, Claas FHJ, IJzermans JNM, van Gelder T & Weimar W (2003), The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis., Transplantation 75(12).
- Dankers MKA, Roelen DL, Van Der Meer-Prins EMW, De Lange P, Korfage N, Smits JMA, Persijn GG, Welsh KI, Doxiadis IIN & Claas FHJ (2003), Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28, Transplantation 75(3).
- Sijpkens YWJ, Doxiadis IIN, van Kemenade FJ, Zwinderman AH, de Fijter JW, Claas FHJ, Bruijn JA & Paul LC (2003), Chronic rejection with or without transplant vasculopathy, Clinical Transplantation 17(3).
- van Kampen CA, Maarschalk MFJVV, Langerak-Langerak J, Roelen DL & Claas FHJ (2002), Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child, Human Immunology 63(6).
- Claas FHJ (2002), Predictive parameters for in vivo alloreactivity, Transplant Immunology 10(2-3).
- Oudshoorn M, Doxiadis IIN, van den Berg-Loonen PM, Voorter CEM, Verduyn W & Claas FHJ (2002), Functional versus structural matching: Can the CTLp test be replaced by HLA allele typing?, Human Immunology 63(3).
- Mulder A, Zoet YM, Eijsink C, Kardol MJ, Franke-van Dijk MEI, Wilson GL, de Paus RA, Heemskerk MHM, Mickelson E, Fernandez-Vina M, Schreuder GMT, van den Elsen PJ, Claas FHJ & Doxiadis IIN (2002), Single MHC antigen expressing cell lines for the definition of monoclonal HLA antibody specificities, Tissue Antigens 59.
- van Kampen CA, Maarschalk MFJVVV, Roelen DL & Claas FHJ (2002), Primed CTLs specific for HLA class I may still be present in sensitized patients when anti-HLA antibodies have disappeared: Relevance for donor selection, Transplantation 73(8).
- Roelen DL, van Bree S, van Hulst P, van Beelen E & Claas FHJ (2002), Regulatory functions of human CD4(+) T cells recognizing allopeptides in the context of self-HLA class II, Human Immunology 63(10).
- Kennedy C, Naipal A, Gruis NA, Struijk L, ter Schegget J, Willemze R, Claas FHJ, Bavinck JNB & Doxiadis IIN (2002), MICA gene polymorphism is not associated with an increased risk for skin cancer, Journal of Investigative Dermatology 118(4).
- van Rood JJ, Loberiza FR, Zhang MJ, Oudshoorn M, Claas F, Cairo MS, Champlin RE, Gale RP, Ringden O, Hows JM & Horowitz MH (2002), Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling, Blood 99(5).
- Andresdottir MB, Doxiadis I, de Lange P, Persijn G, Wetzels JF & Claas FH (2002), Association between the HLA-B8DR3 haplotype and the original renal disease in renal transplant recipients., Journal of the American Society of Nephrology 13.
- van der Molen RG, Garssen J, de Klerk A, Claas FHJ, Norval M, van Loveren H, Koerten HK & Mommaas AM (2002), Application of a systemic herpes simplex virus type 1 infection in the rat as a tool for sunscreen photoimmunoprotection studies, Photochemical & Photobiological Sciences Photochemical and Photobiological Sciences 1(8).
- Smits JMA, Persijn GG, van Houwelingen HC, Claas FHJ & Frei U (2002), Evaluation of the eurotransplant senior program. The results of the first year, American Journal of Transplantation 2(7).
- Brouwer RE, van der Heiden P, Schreuder GMT, Mulder A, Datema G, Anholts JDH, Willemze R, Claas FHJ & Falkenburg JHF (2002), Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon, Human Immunology 63(3).
- Welters MJP, Oei FBS, Witvliet MD, Vaessen LMB, Cromme-Dijkhuis AH, Bogers AJJC, Weimar W & Claas FHJ (2002), A broad and strong humoral immune response to donor HLA after implantation of cryopreserved human heart valve allografts, Human Immunology 63(11).
- De Meester J, Doxiadis IIN, Persijn GG & Claas FHJ (2002), Renal transplantation of highly sensitised patients via prioritised renal allocation programs - Shorter waiting time and above-average graft survival, Nephron 92(1).
- Wassmuth R, Hauser IA, Schuler K, Erxleben H, Arnold ML, Koelman CA, Claas FHJ & Kalden JR (2001), Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitro, Transplantation 71(10).
- van Kampen CA, Maarschalk MFJVD, Langerak-Langerak J, van Beelen E, Roelen DL & Claas FHJ (2001), Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens, Human Immunology 62(3).
- van der Molen RG, Out-Luiting C, Claas FHJ, Norval M, Koerten HK & Mommaas AM (2001), Ultraviolet-B radiation induces modulation of antigen presentation of herpes simplex virus by human epidermal cells, Human Immunology 62(6).
- Doxiadis IIN, de Lange P, de Vries E, Persijn GG & Claas FHJ (2001), Protective and susceptible HLA polymorphisms in IgA nephropathy patients with end-stage renal failure, Tissue Antigens 57(4).
- Doxiadis IIN, De Meester J, Persijn GG & Claas FHJ (2001), Efficiency of special programs for highly sensitized patients within eurotransplant, Transplantation Proceedings 33(1-2).
- Claas FHJ, Roelen DL, van Rood JJ & Brand A (2001), Modulation of the alloimmune response by blood transfusions, Transfusion Clinique et Biologique 8(3).
- De Fijter JW, Mallat MJK, Doxiadis IIN, Ringers J, Rosendaal FR, Claas FHJ & Paul LC (2001), Increased immunogenicity and cause of graft loss of old donor kidneys, Journal of the American Society of Nephrology 12(7).
- van Kampen CA, Maarschalk MFJVV, Roelen DL, ten Berge IJM & Claas FHJ (2001), Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens, Transplantation 71(7).
- van der Mast BJ, van Besouw NM, de Kuiper P, Vaessen LMB, Gregoor PJHS, IJzermans JNM, van Gelder T, Claas FHJ & Weimar W (2001), Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression., Transplantation 72(5).
- Roelen DL, Stobbe I, Young NT, van Bree SPMJ, Doxiadis IIN, Oudshoorn M, Morris PJ, Wood KJ & Claas FHJ (2001), Permissible and immunogenic HLA-A mismatches: Cytotoxic T-cell precursor frequencies reflect graft survival data, Human Immunology 62(7).
- Radder C, De MH, van der Meer E, Roelen D, Claas F, Brand A & Kanhai H (2001), Clinical and immunological follow up of infants born after platelet transfusions and transplacental immunoglobulin treatment, American Journal of Obstetrics and Gynecology 185(6).
- Jonker M, van den Hout Y, Noort RC, Maarschalk MFJVV, Claas FHJ, von der Woude FJ, Hollander D, Perico N & Remuzzi G (2001), Immunomodulation by intrathymic injection of donor leukocytes in rhesus monkeys, Transplantation 72(8).
- Mulder A, Kardol MJ, Kamp J, Broek CUH, Schreuder GMT, Doxiadis IIN & Claas FHJ (2001), Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals, Clinical and Experimental Immunology 124(1).
- Roelen DL, van Rood JJ, Brand A & Claas FHJ (2000), Immunomodulation by blood transfusions.
- Niimi M, Roelen DL, Witzke O, van Rood JJ, Claas FHJ & Wood KJ (2000), The importance of H-2 haplotype sharing in the induction of specific unresponsiveness by pretransplant blood transfusions.
- Koelman CA, van Beelen E, Witvliet MD, Doxiadis IIN & Claas FHJ (2000), Determination of acceptable HLA mismatches in highly sensitized patients by soluble HLA class I ELISA inhibition.
- Vietor HE, Hamel BCJ, van Bree SPMJ, van der Meer EMW, Smeets DFCM, Otten BJ, Holl RA & Claas FHJ (2000), Immunological tolerance in an HLA non-identical chimeric twin.
- Bavinck JNB, Bastiaens MT, Marugg ME, Beckers RCY, Westendorp RGJ, Vermeer BJ & Claas FHJ (2000), Further evidence for an association of HLA-DR7 with basal cell carcinoma on the tropical island of Saba.
- Volker-Dieben HJ, Claas FHJ, Schreuder GMT, Schipper RF, Pels E, Persijn GG, Smits J & D'Amaro J (2000), Beneficial effect of HLA-DR matching on the survival of corneal allografts.
- van Rood JJ & Claas F (2000), Both self and non-inherited maternal HLA antigens influence the immune response.
- Vietor HE, Hallensleben E, van Bree SPMJ, van der Meer EMW, Kaal SEJ, Bennebroek-Gravenhorst J, Kanhai HHH, Brand A & Claas FHJ (2000), Survival of donor cells 25 years after intrauterine transfusion.
- van der Molen RG, Out-Luiting C, Driller H, Claas FHJ, Koerten HK & Mommaas AM (2000), Broad-spectrum sunscreens offer protection against urocanic acid photoisomerization by artificial ultraviolet radiation in human skin.
- Hurks HMH, Metzelaar-Blok JAW, Mulder A, Claas FHJ & Jager MJ (2000), High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.
- De Meester J, Persijn GG, Claas FHJ & Frei U (2000), In the queue for a cadaver donor kidney transplant: new rules and concepts in the Eurotransplant International Foundation.
- Datema G, Stein S, Eijsink C, Mulder A, Claas FHJ & Doxiadis IIN (2000), HLA-C expression on platelets: Studies with an HLA-Cw1-specific human monoclonal antibody, Vox Sanguinis 79(2).
- Stobbe I, van der Meer-Prins EMW, de Lange P, Oudshoorn M, Doxiadis IIN & Claas FHJ (2000), In vitro CTL precursor frequencies do not reflect a beneficial effect of cross-reactive group (CREG) matching, Human Immunology 61(9).
- Koelman CA, Coumans ABC, Nijman HW, Doxiadis IIN, Dekker GA & Claas FHJ (2000), Correlation between oral sex and a low incidence of preeclampsia: a role for soluble HLA in seminal fluid?
- Stobbe I, van der Meer-Prins EMW, de Lange P, Oudshoorn M, De Meester J, Doxiadis IIN & Claas FHJ (2000), Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys.
- Koelman CA, Vaessen LMB, Balk AHMM, Weimar W, Doxiadis IIN & Claas FHJ (2000), Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipients.
- Smits JMA, van Houwelingen HC, De Meester J, le Cessie S, Persijn GG, Claas FHJ & Frei U (2000), Permanent detrimental effect of nonimmunological factors on long-term renal graft survival - A parsimonious model of time-dependency.
- Claas FHJ (2000), A predictive parameter for good graft survival with limited relevance?
- Brand A, van de Watering LMG & Claas FHJ (2000), Clinical significance of leukoreduktion of blood components.
- Verdegaal EME, Huinink DT, Hoogstraten C, Marijnissen AK, Gorsira MB, Claas FHJ & Osanto S (1999), Isolation of broadly reactive, tumor-specific, HLA class-I restricted CTL from blood lymphocytes of a breast cancer patient.
- Stobbe I, van der Meer-Prins E, Smits JMA, Doxiadis IIN & Claas FHJ (1999), In vitro reactivity of allospecific cytotoxic T lymphocytes does not explain the taboo phenomenon.
- Raad van Toezicht
- Raad van Toezicht
- Gasthoogleraar
- Editor in chief Transplantation Immunology